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Malaria remains a public health problem despite the large decline in infection and 
disease between 2000 and 2015, due largely to the massive deployment of 
insecticide-treated nets (ITN). Recent years have been marked, however, by a 
stagnation in progress in high burden countries. In 2020, the World Health 
Organisation (WHO) reported that the key targets of WHO’s global malaria strategy 
have been missed. The 11 high burden high impact countries (10 in sub-Saharan 
Africa including Burkina Faso, plus India) accounted for approximately 70% or 
more of the world’s malaria case burden and 71% of global estimated deaths from 
malaria in 2020. About 253 million ITNs have been distributed in malaria endemic 
countries in 2019 with an increase of 56 million ITNs compared with 2018. 
Approximatively 84% of these ITNs were delivered to countries in sub-Saharan 
Africa. In parallel, the WHO global malaria 2020 report on insecticide resistance 
on malaria vectors highlights resistance to the four common insecticide classes 
(pyrethroids, organochlorines, carbamates, organophosphates) in 74 out the of 
the 82 endemic countries. The resistance to pyrethroids, the only insecticide class 
currently used in ITNs continues to be widespread in all major malaria vectors 
across malaria endemic countries.  
Burkina Faso is one of the few countries not to have shown an association between 
ITN ownership and a reduction in child mortality. Artemisinin-based combination 
therapy (ACT) and Intermittent Preventive Treatment of Malaria in pregnant 
women using sulfadoxine-pyrimethamine (IPTp-SP) was introduced in 2006, ITNs 
have been distributed free of charge since 2010 every three years and seasonal 
malaria chemoprevention (SMC) in children under five years has been scaled up 
across the country in 2016. Following the mass distribution of more than 30 million 
ITNs in 2010, 2013, 2016 and 2019, more than 97% of households owned at least 
one ITN, although estimates of the proportion of children sleeping under an ITN 
range from <30% in the dry season to >70% in the peak transmission season. 
Despite the high coverage, cases of malaria remain high with 380 cases per 1000 
in 2015, 536 cases per 1000 in 2017 and 528 cases per 1000 in 2018. Reasons for 
the lack of effectiveness of ITNs may include the high levels of insecticide 
resistance in malaria vectors, incomplete coverage of ITNs, poor condition of the 
nets and whether people use them correctly.  
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Here I explored the risk factors for malaria in Burkina Faso, mainly in children and 
pregnant women and for indoor densities of malaria mosquitoes. This thesis 
hypothesised that malaria in Burkina Faso was less common among children and 
pregnant women living in modern housing and with high socio-economic status. 
Two epidemiological study models (cohort study and cross-sectional survey) were 
implemented to help determine major risk factors for Plasmodium falciparum 
infection in an area of persistent and intense malaria transmission in rural Burkina 
Faso, with high ITN coverage and high levels of insecticide resistance, throughout 
different population groups (children, pregnant women and all age population).  
Incidence of P. falciparum infection remains overwhelmingly high in the study area 
with school-age children at greatest risk. Caregivers with high socio-economic 
status (odds ratio, OR =1.05, 95% CI 1.00 - 1.11, p=0.04), having travelled out 
of the study area (OR=1.52, 95% CI 1.45 - 1.52, p<0.001), or being literate 
(OR=1.71, 95% CI 1.26 - 2.32, p=0.001), were at increased risk. Conversely, 
sleeping in a metal-roofed house (OR=0.6, 95% CI 0.4 - 1.0, p=0.03) and having 
an electricity supply in the child’s bedroom (OR=0.4, 95% CI 0.3 - 0.7, p=0.001), 
reduced the risk of house entry by Anopheles gambiae, the dominant malaria 
vectors in the study area.  
During pregnancy there was a reduced risk of P. falciparum infection associated 
with the use of ITNs (Odds ratio, OR=0.31, 95% CI 0.12–0.79, p=0.02), while this 
association was not found in the general population or among children. In pregnant 
women, increasing the dose of IPTp-SP, was associated with the reducing the odds 
of infection by 40% (OR=0.59, 95% CI 0.43–0.81, p<0.001).   
The study findings suggest that malaria control in Burkina Faso and other countries 
in sub-Saharan Africa experiencing persistently high malaria transmission need 
additional interventions to contribute to accelerate the disease burden reduce and 
to achieve the goals of WHO global strategies by 2030. My findings highlight the 
potential of improved housing to reduce malaria transmission as further 
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CHAPTER 1  




Malaria is one of the oldest diseases in the world and has existed since the dawn 
of humanity [1]. Indeed the history of our planet has been shaped by the millions 
of deaths from this disease over the centuries [2, 3]. Malaria is an infectious 
disease cause by the Plasmodium parasite which is transmissible to humans by the 
bite of female Anopheles mosquitoes. Malaria continues to be a public health 
challenge in most developing tropical countries despite the identification of the 
causative parasites, and more than half a century after having effective drugs and 
insecticides at our disposal [4]. Recent reports show that today trends in the 
burden of malaria is not declining, but it’s stable [5], and remains the fifth cause 
of death from infectious diseases worldwide (after respiratory infections, 
HIV/AIDS, diarrhoeal diseases, and tuberculosis) and the second in Africa, after 
HIV/AIDS [6].  
Global malaria situation in the world and sub-Saharan Africa 
Malaria is found in five of the six World Health Organization (WHO) regions, with 
only Europe being malaria free [7]. WHO estimate that at least 3.4 billion people 
in the world continue to be at risk of being infected and developing disease in 92 
countries [5]; Among them, 1.1 billion are often at high risk  with >1 in 1000 
chance of getting malaria each year [5]. The WHO Africa Region is most affected 
by the disease, representing 94% of the total burden in 2019 with an estimated 
219 million cases, followed by the WHO South-East Asia Region (3%) and the WHO 
Eastern Mediterranean Region (2%) [5]. Most of the disease burden in Africa 
occurs in sub-Saharan Africa and in children under five years old (estimated 
bearing more than two thirds of all deaths) and pregnant women [5]. The most 
widespread and actively harmful of malaria parasites is Plasmodium falciparum 
and is the dominant parasite in sub-Saharan Africa [8]. This is one reason why 
there are more infections and deaths from malaria in Africa than elsewhere and 
most burden in children [9, 10]. In fact, in 2018, P. falciparum accounted for 
99.7% of estimated global malaria cases in the WHO African Region, while 
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involving in 50% of cases in the WHO South-East Asia Region, 71% of cases in the 
Eastern Mediterranean and 65% in the Western Pacific and 91% of malaria deaths 
[11, 12]. The good news was that the global distribution of malaria was shrinking 
[13]: Plasmodium falciparum incidence per 1000 individuals at risk and count in 
millions of cases reduced in global sub-Saharan Africa (figure 1.1, A-D), in different 
WHO regions (figure 1.2, A-B), P. falciparum parasites rate spatial distribution in 
children two-ten years old (figure 1.3) and in all age (figure 1.4) [14]. About 25 
countries are on track to eliminate malaria by 2025 and over 60 aim to do this by 
2030 [10, 15]. As COVID-19 continues to challenge the weak health systems in 
sub-Saharan Africa, it’s urgent for malaria endemic countries to keep up the fight 
against malaria. This creates a double challenge for Africa. To achieve the 
ambitious, but attainable, goal of malaria eradication by 2040, malaria-endemic 
countries must work together to achieve the challenging targets set out by WHO 
[10, 15].   
 
Figure 1.1:  World global Malaria incidence rates from 2000–2017.  
Plasmodium falciparum incidence per 1000 individuals (A and B) and count in 
millions of cases (C and D) globally and for sub-Saharan Africa. Source: Weiss D.J. 





Figure 1.2: Regional distribution of Plasmodium falciparum incidence per 





Figure 1.3: Spatial distribution of age-standardised P. falciparum 






Figure 1.4: Spatial distribution of all-age Plasmodium falciparum 
incidence in 2005 (A) and 2017 (B). Source: Weiss D.J. et al., 2019. 
 
In sub-Saharan Africa, the P. falciparum prevalence rate halved in children two to 
10 years old (Figure 1.3),  with a 50% reduction in hyper-endemic areas and a 
75% reduction in holo-endemic areas [4]. In spite of a growing population in 
endemic regions, P. falciparum all age cases declined between 2005 and 2017, 
from 232.3 million (95% uncertainty interval 198.8 – 277.7) to 193.9 million 
(156.6 – 240.2), (Figure 1.4). Three-quarters of this decline was achieved after 
2005. This extraordinary achievement is attributed to the massive deployment of 
insecticide-treated nets (ITNs), accounting for 68% of the reduction, indoor 
residual spraying (IRS) for 13% reduction and artemisinin-based combination 






Figure 1.5: Changing endemicity and effect of interventions 2000–2015. 
Source: Samir Bhatt et al., 2015. Here is represented the predicted time series of 
population-weighted mean PfPR2–10 across endemic Africa. The red line shows the 
actual prediction and the black line a ‘counterfactual’ prediction in a scenario 
without coverage by ITNs, ACTs or IRS. The colored regions indicate the relative 
contribution of each intervention in reducing PfPR2–10 throughout the period.  
In populations at risk from malaria, whilst only 7% of households had access to an 
ITN in 2005, by 2015, 67% had one [4]. The Millennium Development Goals 
(MDGs) target 6c which aimed to halt and begin to reverse the incidence of malaria 






Malaria control stalls? 
Despite enormous progress in malaria control since the turn of the millennium, the 
gains have levelled off with a trend observed over recent years [5]. In 2017, WHO 
warned that the global response to achieve disease control had stalled [7]. From 
the 21 countries on track by WHO to achieve their elimination goals, 11 reported 
increases in indigenous malaria cases since 2015, and five countries reported an 
increase of more than 100 cases in 2016 compared with 2015 [7]. In many parts 
of sub-Saharan Africa there was numerous sites where malaria has changed little 
since the turn of the millennium including Nigeria, Democratic Republic of the 
Congo, Uganda, Mozambique, Niger and Burkina Faso [5, 7, 12, 16, 17]. The latest 
evidence from Burkina Faso between 2000 and 2016 was that malaria was 
increasing in the general population and in the two most vulnerable groups: 
children under five years old and pregnant women (Figure 1.6).  Worryingly, 
malaria was still the main reason for medical consultation (45.0%), hospitalization 
(23.1%) and death (17.9%) in public health centres in Burkina Faso [18-20]. 
Malaria incidence in Burkina Faso is highly seasonal with about 60% of cases 
occurring within the four months from June to September [21]. The malaria 
incidence rate is 7.6 per 1000 child days [22] and Plasmodium infection prevalence 
in children was 57.5% in the country in 2017 [23], this is despite high coverage 
of ITNs, rapid diagnosis and effective treatment with antimalarial. In 2006, the 
country changed the national malaria treatment policy by adopting artemisinin-
based combination therapies and in 2013, seasonal malaria chemoprophylaxis was 
implemented for children under five years old [24, 25]. A total of 8.4 million ITNs 
were deployed in 2010 and a further 10.5 million in 2013 resulting in 
approximately 90% of households owning at least one ITN [26].  More recently, in 
2016, an additional 10.3 million ITNs were deployed, raising the coverage rate of 
households to 97%. Despite this huge investment in ITNs, Burkina Faso is one of 
the few countries not to have shown a significant association between ITN 
ownership and a reduction in child mortality [27, 28].  This is a surprising finding 
since ITNs have been shown to reduce clinical incidence by > 50% in areas of  





Figure 1.6: Malaria incidence in Burkina Faso between 2006 and 2018 in 
general population and in two vulnerable groups: children < 5 years old and 
pregnant women. Source: National Malaria Control Program, Burkina Faso 
Note: Data from 2019 was missing because of repeated and persistent strikes of 
health workers and occasional terrorism attacks.  
 
The mechanics of malaria transmission  
Hackett’s famous quote that ‘malaria is comparable to a game of chess, where 
only few pieces are used to propose an infinite variety of complex situations’ [30] 
captures the essence of malaria [1]. He went on to write that “everything about 
malaria is so moulded and altered by local conditions that it becomes a thousand 
different diseases and epidemiological puzzles” [31]. The four main pieces 
comprising the malaria system are the vector, parasite and human interacting in 
the environment (Figure 1.7), resulting in a huge variety of malaria transmission 
across the world. Globally, distinction is made in areas with high or low malaria 
incidence or malaria free. Some areas experience malaria transmission that lasts 
for several months or throughout the year, and in others it is very brief attributing 
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effective control and elimination requires a tailored package of interventions for 
each specific epidemiological pattern [3]. The drivers of malaria operate at a range 
of spatial scales from coarse to fine. At a global scale, P. falciparum transmission 
is driven by climate and topology that can limit or intensify in the distribution and 
competence of Anopheles vectors [32]; while, at a micro-epidemiological scale in 
endemic areas, numerous factors influence malaria transmission dynamics 
including distance to the nearest mosquito breeding site and house construction 
features [3, 33]. Individual malaria risk may also be associated with human genetic 
factors, socio-economic status or with behavioural factors [34, 35] including those 
relating to occupation [35, 36] and travel [37]. Variations in these factors over a 
small area can result in spatially heterogeneous transmission, resulting in foci or 
hotspots of malaria infection and targeting hotspots may be a highly efficacious 
approach for malaria control [38].  
 
Figure 1.7: Drivers of malaria.  
Environmental factors 
 
At a coarse scale, climate dictates where malaria transmission can occur, in 




Temperature affects the life cycle of the malaria parasite. As the temperature 
decreases, the number of days necessary to complete the development increases 
for a given Plasmodium species [39]. P. vivax and P. falciparum have the shortest 
development cycles and are therefore more common than P. ovale and P. malariae. 
Mosquito larvae also develop more quickly at warmer temperatures [40-42]. When 
it is hot, the time taken to convert a blood meal to eggs shrinks so that the number 
of eggs laid by mosquitoes increases [43].  
Rainfall 
 
The relationship between malaria transmission and rainfall is well established [44] 
and today, rainfall patterns can help predict malaria incidence [45]. The presence 
of water is essential for mosquito development. Aquatic habitats for vectors appear 
during the rainy season and it is for this reason that malaria transmission is highly 
associated with the pattern of rainfall, with most malaria appearing at the end of 
the rains, or shortly after.   
Relative humidity 
 
In general the survival of vectors is greater at higher humidity than lower ones 
[46].. In areas of seasonal malaria transmission, water pools dry up during the dry 
season and the relative humidity drops to levels that raise mosquito mortality. 
Both temperature and relative humidity affect An. gambiae mosquito survival and 
this associated affects the seasonal pattern of observed mosquito abundance [46]. 
Malaria endemicity is also affected by climatic and environmental factors, which 
influence vector proliferation, including rainfall, temperature and vegetation cover. 
Burkina Faso has a tropical Sudanian climate with a long dry season (October to 
April) and a short-wet season (May to September).  The length of the rainy season 
and the total annual rainfall allow three climatic zones to be distinguished from the 
south to the north of the country: i) in the south, there is a Sudanian zone, which 
has a rainfall of between 1,000 and 1,300 mm over five months.  The vegetation 
consists of open forests and forest galleries along the edges of permanent 
watercourses. Malaria transmission is intense and lasts at least five months each 
year; ii) In the centre of the country is a Sudano-Sahelian zone, with rainfall 
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between 600 and 1000 mm, which falls over three to four months each year.  The 
vegetation consists of shrubs and grass and malaria transmission is of moderate 
intensity; iii) in the north is the Sahelian zone, characterized by an annual rainfall 
of between 400 and 600 mm, falling over three to four months.  The Sahelian strip 
is characterized by a tree steppe of balanite and acacia radia with a carpet of 




The most important vectors in sub-Saharan Africa are members of the An. gambiae 
complex, and An. funestus complex [47]. The abundance of adult malaria vectors 
inside people’s houses, where most transmission takes place, are associated with 
several factors [48] such as proximity of aquatic habitats [49], use of indoor vector 
control interventions like ITNs and IRS, and housing quality [48]. The most 
efficient vectors are those like An. gambiae and An. funestus that prefer to feed 
on humans (anthropophagic), rather than animals, and feed indoors (endophilic) 
[50]. Their peak night biting occurs between 23.00 and 05.00 h [51].  
The recent success of malaria control in sub-Saharan Africa has been achieved by 
the massive deployment of ITNs and IRS [4], but these gains are threatened by 
the development of insecticide resistance in vectors [5, 52-54]. Resistance to 
pyrethroids, currently the only class of insecticides used for treating bednets, is 
now known  spread widely across Africa [55].  
Human behaviour 
 
Human behaviour is an important risk factor for malaria. People change the 
landscape increasing or decreasing the risk of malaria. In Africa, rural development 
continues to change the physical landscape, increasing mosquito aquatic habitats 
and biting rates of An. gambiae [56]. Development projects including roads, dams, 
oils pipelines, mining and agricultural development can create aquatic habitats for 
malaria mosquitoes, leading to the increase in the burden of the disease [3, 57-
60]. However, the process of urbanization can though reduce malaria transmission 
mainly because of fewer aquatic habitats, limiting the numbers of adult mosquitoes 
[61]. With increased human densities, malaria exposure per capita also decreases 
[62]. Housing is often of poor quality and the provision of health care and 
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sanitation is often inadequate [63, 64]. Population movement, for economic 
reasons or due to climate change, drought, natural disasters, conflict, 
humanitarian crises and associated deterioration in conditions, might expose 
individuals to increased malaria risk [65]. These conditions can lead to explosive 
growth of mosquito vectors and disease incidence increasing and spreading 
including rural and urban areas.  
Adoption of malaria prevention interventions and health-seeking practices in 
communities govern the effectiveness of interventions such as ITNs, IRS and 
antimalarials and are important determinants of malaria in geographic areas and 
among specific population groups [66]. Low socioeconomic status is associated 
with roughly double the odds of clinical malaria or parasitaemia in children 
compared with higher socioeconomic status, within a locality [67]. Wealth is seen 
to be protective against malaria, and is positively associated with other beneficial 
factors, including better-education, improving housing quality (which reduces 
mosquito entry in house). Malaria and poverty therefore constitute a vicious cycle 
for the poorest households [60, 67].  
Malaria parasites 
 
The high antigenic diversity of P. falciparum allows strains to evade the An. 
gambiae immune system, adapt to mosquito vectors and be an important factor 
driving malaria transmission [68, 69]. Resistance of P. falciparum to artemisinin 
reported in a few countries in South-East Asia   has recently been reported in Africa 
[70].  
Gansane and co-workers in 2021 found a reduction in the efficacy of Artemether-
Lumefantrine at day 28 and Dihydro-Piperaquine at day 42 in Nanoro and Gourcy 
in Burkina Faso, suggesting a change of first-line artemisinin-based combination 
therapy may be warranted in the country [71]. 
. The development of resistance to antimalarials poses one of the greatest threats 
to malaria control.  
Human host factors 
Individuals vary in their susceptibility to malaria. Most malarial disease, and 
particularly severe disease with rapid progression to death, occurs in young 
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children without acquired immunity [72, 73]. However, antibodies to merozoite 
and infected erythrocytes surface antigens increased following infection in early 
childhood [72], so that children living in moderate or in high transmission settings 
develop immunity faster as transmission increases [74]. Severe anaemia, 
hypoglycaemia and cerebral malaria are features of severe malaria more 
commonly seen in children than in adults. Pregnant women are also at risk from 
malaria, because they have weak immunity to malaria infection during their 
pregnancy [75] and are more attractive for Anopheles mosquitoes [76, 77]. Certain 
population groups evolved genetic factors to protect themselves from malaria and 
are only infected by some species of malaria parasite. This is the case for people 
in sub-Saharan Africa whom get infected by falciparum malaria, but not by vivax, 
making falciparum malaria the most prevalent and serious form of malaria in Africa 
[5, 9]. Glucose 6 Phosphate Dehydrogenase deficiency confers an advantage 
against malaria in heterozygous individuals [78]. Sickle haemoglobin is also 
considered to be protective against malaria, whilst malaria is fatal in homozygous 
sickle cell disease [79]. Recently researchers have found that gametocyte carriers, 
are bitten more frequently than those without gametocytes [77, 80, 81].  
Conclusion 
 
The decline of malaria in parts of sub-Saharan Africa is threatened by a number of 
factors including poor coverage of malaria control interventions, risks posed by 
anomalous climate patterns, and the emergence of parasite resistance to 
antimalarial medicines and mosquitoes resistant to insecticides. Overall 
heterogeneous association between climate changes and malaria transmission 
suggest the importance of location-specific approaches for public health 
interventions to impact arising from climate change [82]. Analysis of risk factors 
for malaria will enable development of new vector control tools and approaches, 
as well as decision support tools to support the activities of malaria control 









There has been an unprecedented malaria decline in sub-Saharan Africa between 
2000 and 2015, largely attributable to the roll-out of vector control [4].  However, 
despite all these investments, malaria remains an acute public health problem with 
children and pregnant women most at risk [5]. Worryingly, malaria has not 
declined in some areas, with recent reports  that malaria control has stalled or the 
gains have levelled off in some countries in sub-Saharan Africa [5]. In 2019, 
COVID19 emerged and brings additional challenges to malaria responses 
worldwide. WHO has already sounded the alarm and is working to revive the fight 
for malaria control with the “high burden to high impact” (HBHI) approach [12]. 
Importantly, 11 countries, including Burkina Faso, and nine other countries in sub-
Saharan Africa account for approximately 70% of the world’s malaria burden [5, 
83]. Evidence from Burkina Faso shows that high coverage of ITNs has not 
decreased malaria and all-cause mortality in children under five years old [27]. 
WHO country profile data records from Burkina Faso in 2006 and in 2016 were 
similar [84]. WHO World Malaria Report 2020 recorded similar number of global 
malaria cases in 2018 and in 2019 (7,875,575 and 7,859,000 millions of cases 
respectively) [5]. Also, P. falciparum prevalence remains high in the north-western 
region with up to 75.4 % of children aged five to nine years being infected in a 
community survey conducted in 2013 [23]. The incidence rate of malaria infections 
in pregnant women in Burkina Faso increased from 310 in 2015 to 800 per 1,000 
women-year in 2016 [19]. Since ITNs have been shown to reduce clinical incidence 
by >50% elsewhere in areas of stable malaria [16], the lack of association between 
ITN roll-out and malaria in  Burkina Faso requires further investigation. Recent 
surveys from Burkina Faso have shown higher malaria prevalence in children living 
in traditional houses (70.6%) compared to those living in modern houses (45.5%) 
[85], but it was unclear whether poor housing simply reflects low socioeconomic 
status since the wealth index may not have fully captured differences in 
socioeconomic position [85]. There have been several studies of risks factors for 
malaria in pregnancy in sub-Saharan Africa, where increased risk is associated 
with younger age in pregnancy, primigravidae, first trimester of pregnancy 
infection, non-use of ITNs, lack of education and HIV co-infection [86-89], but few 
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studies, have evaluated environmental, socioeconomic and intervention risk 
factors for malaria in pregnancy. The goal of this research project is to identify risk 
factors for malaria in children and pregnant women in Burkina Faso including 
individual, socioeconomic and environmental risk factors. Identifying risk factors 
for malaria in children and in pregnancy could assist in developing interventions to 
reduce this risk in Burkina Faso and other countries in sub-Saharan Africa.   
 
Research hypothesis  
 
It is hypothesised that malaria in Burkina Faso is less common among children and 




To determine risk factors associated with malaria incidence in children aged five 
to 15 years old and malaria prevalence in pregnant women in rural Burkina Faso. 
Specific objectives 
 
• To determine risk factors for clinical malaria in children  
• To determine risk factors for malaria infection in pregnant women. 
Study outcomes 
 
Epidemiological outcomes   
 
Epidemiological outcomes in children 
 
Incidence of malaria infection detected by microscopy (any level of P. falciparum 
parasitaemia) during active case detection (ACD) or passive case detection (PCD) 
in children cohort survey. 
Epidemiological outcomes in pregnant women 
 
Malaria prevalence in pregnant women defined as the number of pregnant women 
with positive P. falciparum detected by microscopy at each seasonal cross-
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sectional survey, one in high seasonal transmission and one in low seasonal 
transmission. 
Human behaviour outcomes 
Human behaviour outcomes in children 
 
• Proportion of children who slept under a net the previous night as evaluated 
by questionnaire/sleeping place inspection by fieldworkers. 
• Others malaria prevention skills including mosquito coils, insecticide sprays, 
traditional or commercial repellents. 
Human behaviour outcomes in pregnant women 
 
• Estimate time when pregnant women go to bed at night, when she gets out 
of bed in the morning and number of times women get out of bed last night 
as evaluated using a questionnaire administered by a fieldworker. 
• Proportion of pregnant women who slept under a net the previous night as 
evaluated by questionnaire/sleeping place inspection by fieldworker. 
• Number of antenatal clinic (ANC) visits and number of intermittent 
preventive treatment in pregnancy (IPTp) dose coverage by a pregnant 
women. 
• Others malaria prevention technologies used by pregnant women including 
mosquito coils, insecticide sprays, traditional or commercial repellents. 
Environmental risk outcomes in children and pregnant women 
 
• Housing conditions including  open or closed eaves, metal or thatched 
roof, number of rooms, presence of windows, windows  number, size and 
position (next to the door or back to the door), presence of a ceiling, 
screening and house tidiness; household size.  
• Size and proximity of potential aquatic habitats to study households;  
• Presence of solid rubbish or trash next to households; 
• Presence of alternative hosts close to households. 
Socioeconomic risk outcomes in children and pregnant women 
 




• Specific items owned in households of children’s caregivers or pregnant 
women including mobile phone, television, electricity, and modern bed 
of children caregivers or pregnant women.  
• Children’s caregivers or pregnant women are tenants or owners of 
property?  
The research proposal methodology 
 To test my research hypotheses, I carried out four studies: 
1. A cohort study to identify malaria risk factors in children aged five to 15 
years old in the Banfora region in south-west Burkina Faso, where there is brief 
and intense seasonal malaria transmission (chapter 2);  
2. A cross-sectional survey to identify malaria risk factors across all ages in 
Banfora region (chapter 3); 
3.  A cohort study in the same study site to determine risk factors for malaria 
mosquito house entry in study children’s houses (chapter 4); 
4.     A cross-sectional surveys in the dry and wet season to identify malaria risk 








A cohort study to identify risk factors for Plasmodium falciparum infection 
in Burkinabe children: implications for other high burden high impact 
countries 
 
Adapted from:  
Yaro JB, Ouedraogo A, Ouedraogo ZA, Diarra A, Lankouande M, Agboraw E, Worrall 
E, Toe KH, Sanou A, Guelbeogo WM,  Sagnon N, Ranson H, Tiono AB, Lindsay SW, 
Wilson AL (2020).  A cohort study to identify risk factors for Plasmodium falciparum 
infection in Burkinabe children: implications for other high burden high impact 





Progress in controlling malaria has stalled in recent years. Today the malaria 
burden is increasingly concentrated in a few countries, including Burkina Faso, 
where malaria is not declining. A cohort study was conducted to identify risk factors 
for malaria infection in children in southwest Burkina Faso, an area with high 
insecticide-treated net (ITN) coverage and insecticide-resistant vectors. 
Methods  
 
Incidence of Plasmodium falciparum infection was measured in 252 children aged 
5 to 15 years, using active and passive detection, during the 2017 transmission 
season, following clearance of infection. Demographic, socio-economic, 
environmental, and entomological risk factors, including use of ITNs and 
insecticide resistance were monitored.  
Results 
 
During the six-month follow-up period, the overall incidence of P. falciparum 
infection was 2.78 episodes per child (95% CI= 2.66-2.91) by microscopy, and 
3.11 (95% CI= 2.95-3.28) by polymerase chain reaction (PCR). The entomological 
36 
 
inoculation rate (EIR) was 80.4 infective bites per child over the six-month malaria 
transmission season. At baseline, 80.6% of children were reported as sleeping 
under an ITN the previous night, although at the last survey, 23.3% of nets were 
in poor condition and considered no longer protective. No association was found 
between the rate of P. falciparum infection and either EIR (incidence rate ratio 
(IRR): 1.00, 95% CI: 1.00-1.00, p=0.08) or mortality in WHO tube tests when 
vectors were exposed to 0.05% deltamethrin (IRR: 1.05, 95% CI: 0.73-1.50, 
p=0.79). Travel history (IRR: 1.52, 95% CI: 1.45-1.59, p<0.001) and higher 
socio-economic status were associated with an increased risk of P. falciparum 
infection (IRR: 1.05, 95% CI: 1.00-1.11, p=0.04). 
Conclusions  
 
Incidence of P. falciparum infection remains overwhelmingly high in the study area. 
The study findings suggest that because of the exceptionally high levels of malaria 
transmission in the study area, malaria elimination cannot be achieved solely by 




Malaria remains an acute public health problem throughout sub-Saharan Africa 
with an estimated 213 million cases and 380,000 deaths in 2018 [17]. Despite 
unprecedented declines in malaria between 2000 and 2015, of which 68% can be 
attributed to the scale-up of insecticide-treated nets (ITNs) [4], recent years have 
seen stagnating progress in high burden countries [17]. Reasons for this lack of 
progress are unclear, but may include incomplete coverage of ITNs, nets in poor 
condition and malaria vectors resistant to the pyrethroid insecticides used for ITNs. 
Burkina Faso, along with 10 other high-burden countries in Africa, plus India, has 
been designated as a High Burden to High Impact country by the World Health 
Organization (WHO) and Roll Back Malaria Partnership which calls for an aggressive 
new approach to accelerate malaria control [83]. Burkina Faso has the seventh 
highest number of malaria cases globally [17], and has seen a rise in the number 





Despite the known protective efficacy of ITNs, the 2010 ITN universal coverage 
campaign in Burkina Faso did not decrease malaria and all-cause mortality in 
children younger than 5 years old, even with 92% of children reportedly sleeping 
under ITNs [27]. The study site in Burkina Faso has extremely high prevalence 
and intensity of pyrethroid resistance in malaria vectors [91, 92]. For example, 
mosquitoes reared from larvae collected in Tengrela village between 2016 and 
2018, showed only 2% mortality when exposed to the standard diagnostic dose of 
deltamethrin of 0.05% designed to kill all mosquitoes [93]. The public health 
impact of insecticide resistance, however, remains contested [94-97]. Insecticide 
resistance is only one important factor affecting the efficacy of nets, since ITN 
coverage, durability and whether people actually sleep under nets, as well as 
mosquito biting time and behaviour are also important. There is increasing 
evidence that so-called long-lasting insecticidal nets are not effective for 3 years 
[98-100], as claimed, and is the reason the term ITN is used. Coverage and system 
inefficiencies mean that ITNs are unevenly distributed among households and an 
estimated 50% of ITNs are lost from households after 23 months in Africa [101]. 
Social and environmental factors, including access to healthcare, socio-economic 
status (SES) and house construction, found to be protective against malaria in 
other studies [102], may also impact malaria risk in Burkina Faso.  
 
A cohort study of children was conducted to determine risk factors for Plasmodium 
falciparum infection in an area of persistent and intense malaria transmission in 
rural Burkina Faso, with high ITN coverage and high levels of insecticide resistance. 
The study findings may help to identify potential opportunities for improving 
malaria control in Burkina Faso and other countries in sub-Saharan Africa 
experiencing persistently high malaria transmission.  




The study was conducted from June to December 2017 in Banfora Health District, 
Cascades region, southwest Burkina Faso (Figure 2.1), an area of Sudanian 
savannah covering 6,295 km2 and with an estimated population of 407,073 
inhabitants [21]. Subsistence farming and animal husbandry are the main 
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activities. Banfora District has intense seasonal malaria transmission over a six-
month period following seasonal rains from May to November [103]. Plasmodium 
falciparum accounts for 90% of cases [21]. The main malaria vector is Anopheles 
gambiae sensu stricto (s.s.), but Anopheles coluzzii is also found [103]. A universal 
coverage (defined as one ITN for every two persons at risk of malaria) campaign 
in 2016 distributed ITNs with permethrin or deltamethrin (Sumitomo Chemical, 
Vestergaard and BASF) and therefore no new ITNs were distributed by the study. 
No indoor residual spraying (IRS) was conducted. Since 2014, children under 5 
years of age in the study area receive seasonal malaria chemoprevention (SMC) 
during the transmission season [104]. 
 
Figure 2.1:  Map of the 10 study villages 
A) location of Burkina Faso; B) location of study site in Burkina Faso; C) location 
of study villages in study site. 
 
Recruitment of study cohort 
 
Ten villages were randomly selected from a list of villages in the study area 
following a two-stage process. Firstly, an area spanning the catchment areas of 
five health centres was chosen. Each health centre had a catchment radius of 
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approximately 10 km. Secondly, two villages at least 3 km apart were chosen at 
convenience from each catchment area, giving a total of 10 villages. Thirty children 
were randomly selected from each village using the Health and Demographic 
Surveillance System enumeration list. Children were eligible to participate if they 
were aged 5-15 years, likely to remain resident in the village for the duration of 
the study and the caregiver provided informed consent (assent of child if aged 12-
15 years). Older children were selected as they have the highest malaria incidence, 
relatively low immunity and contribute substantially to transmission [105], while 
children under 5 years were excluded due to roll-out of SMC. Children were not 
eligible if they were participating in a malaria clinical trial, or had a contra-
indication to the artemisinin-combination therapy (ACT), artemether-lumefantrin 
(AL). At enrolment in June 2017, 300 children provided a blood film. Irrespective 
of their malaria parasite status, all children received a curative dose of AL (Wellona 
Pharma Private Limited, Nana Varachha, Surat, India) to clear any existing 
parasitaemia. Children were revisited 21 days later, at which time two blood slides 
and a blood spot were taken and examined to ensure parasite clearance. Those 
with a negative parasite status confirmed by polymerase chain reaction (PCR) were 
enrolled in the study. Children re-infected in the 21-day period were re-treated 
with AL and were eligible for enrolment in the study after 28 days once parasite 
clearance was confirmed using PCR.  
 
Symptomatic and asymptomatic Plasmodium infections were recorded using both 
active and passive detection. Study children were visited at home every two weeks 
by fieldworkers during the peak transmission season, from July-December 2017. 
At each visit, fieldworkers measured a child’s axillary temperature and prepared 
two blood films and a filter paper blood spot. Children with an axillary temperature 
≥37.5°C or history of fever in the previous 48 hours were advised to visit the local 
health centre and, if they were a malaria case, treated with AL, following National 
Malaria Control Programme (NMCP) guidelines [25]. If a child was absent at the 
time of the visit, the fieldworker made one more attempt to locate them the 
following day, after which the child was recorded as being absent. Caregivers were 
encouraged by the study team at enrolment and at fortnightly visits to take their 
child to the nearest government health centre should the child have a fever or feel 
unwell. Travel and treatment costs for sick children were reimbursed by the study. 
Study nurses were posted in the five health centres close to the study villages and 
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performed rapid diagnostic tests for malaria (SD BIOLINE Malaria Ag P.f/Pan, 
Abbott Laboratories, Illinois, USA) in study children presenting with an axillary 
temperature ≥37.5°C or history of fever within the previous 48 hours, and 
prepared two blood films and a filter paper blood spot. Children diagnosed with 
clinical malaria received AL [25]. Clinical data were recorded on dedicated study 
logs and transcribed by fieldworkers who visited each nurse weekly.  
 
Detailed descriptions of the microscopy and PCR and are provided in Appendix 2. 
In brief, thick blood films were stained with Giemsa (Figure 2.2) and examined 
under 1,000-fold magnification by experienced microscopists at the Centre 
National de Recherche et de Formation sur le Paludisme (CNRFP) in Banfora. 
Parasite counts were recorded per high power field and 100 fields counted before 
a slide was declared negative. Two blood slides from each subject were read 
separately by two microscopists. Discrepancies in positive and negative reads and 
parasite counts differing by more than 10-fold between the two reads were 
resolved by the supervisor.  
 





for 5 min 















Filter paper blood samples were analysed for the presence of 18s rRNA gene using 
PCR [107]. Blood was collected on Whatman filter Papers (Whatman 3 mm, GE 
Healthcare, Pittsburg, USA) and labelled with patients’ study numbers, air-dried, 
and individually placed into plastic bag marked containing a desiccant to protect 
against humidity. The bags were stored at room temperature until DNA extraction. 
Parasite DNA was extracted using Chelex methods [106].  
 
The prepared blood spots were analysed at the CNRFP molecular biology laboratory 
to confirm or refute the microscopy results. DNA extraction was done using the 
QIAamp DNA Mini Kit protocol based on the principle of precipitation and column 
purification of DNA. Nested PCR was used for amplification of Plasmodium sp. DNA. 
Nested PCR consists of performing two successive amplifications. The DNA 
fragments obtained by PCR were revealed directly by agarose gel electrophoresis 
using ethidium bromide (BET). Their identification is facilitated by the use of 
molecular weight markers (Figure 2.3). 
 
The electrophoresis results are interpreted as follows: 
Line S: standard molecular weight marker (50-bp).   
Line 1: diagnostic band for P. vivax (120 bp).  
Line 2: diagnostic band for P. malariae (144 bp).  
Line 3: diagnostic band for P. falciparum (205 bp).  














Figure 2.3: Example of agarose gel separation (Snounou et al., 1993). 
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Figure 2.4:  Study flowchart 
 
Risk factors  
 
At enrolment, socio-demographic characteristics of the child (age, gender, religion, 
ethnicity) and their caregiver (education, occupation) were recorded. 
Questionnaires recorded the presence or absence of large domestic animals 
(cattle, goats, sheep, donkeys, horses) within 5 m of each study child’s house and 
the materials used to construct the building in which the study child slept, including 
presence of a metal roof, eaves and door and window screening. The head of 
household completed a questionnaire on their asset ownership, house construction 
and other variables, following standard procedures used in the Burkina Faso 
Malaria Indicator Survey (MIS) [108]. Houses of study children were geolocated 




Use of an ITN the previous night by each study child and use of spatial or topical 
repellents were recorded at enrolment and each active visit. Survivorship and 
integrity of each study child’s ITN was measured in July, October and December. 
Each net was recorded as being in use (i.e., hanging over the study child’s sleeping 
space), in storage, being washed, or lost. Loss was categorized as: i) net given 
away voluntarily; ii) net stolen; or, iii) net destroyed, discarded or used for 
alternative purposes. Fabric integrity of the net was assessed by counting the 
number of holes and their size according to WHO guidance [109]. A weighted sum 
of hole counts, the proportionate hole index (pHI), was calculated with a pHI of 0-
64 categorized as good, 65-642 as acceptable and 643+ as too torn and non-
protective [110]. To measure ITN bio-efficacy, 26 bed nets were sampled (at least 
2 randomly selected nets per village, except for Sitiena village where 1 net was 
tested) in October 2017 and stored at +4°C. ITNs taken for testing were replaced 
with new ones. WHO cone bioassays were performed using the pyrethroid-
susceptible Kisumu strain of An. gambiae sensu lato (s.l.) at the CNRFP insectaries 
in Banfora using the WHO efficacy requirement of ≥80% mortality [111].  
 
Mosquitoes were sampled with CDC light traps, positioned with the light 1 m above 
the ground at the foot end of the bed of each study child sleeping under an ITN 
from 19.00 to 06.00, every four weeks from July to December 2017. In addition, 
each child’s net was systematically searched for mosquitoes between 06.00 and 
07.00 every four weeks using a torch. Mosquitoes were identified morphologically 
using established keys and female An. gambiae s.l. typed to species using PCR. 
The presence of sporozoites in An. gambiae s.l. was determined using an enzyme-
linked immunosorbent assay. Larval surveys to determine the proximity of 
anopheline larval habitats to study children’s houses were carried out in the vicinity 
of all 10 villages during September 2017. All types of larval habitats were surveyed 
including irrigated fields, puddles, muddy foot or hoof prints, streams and ponds.   
 
Phenotypic insecticide resistance was measured using WHO tube tests as per 
standard procedures [112]. Assays were performed with An. gambiae s.l. 
mosquitoes reared from immatures collected in seven study villages (larvae were 






Data management and statistical analysis  
 
Data were collected on android personal digital assistants programmed using 
KoboCollect and included drop-down boxes and consistency checks to reduce data 
entry errors. Following cleaning, the dataset was locked and saved in Microsoft 
Access. An analytical plan was developed prior to data analysis. 
 
The primary outcome was the incidence rate of microscopically confirmed P. 
falciparum infection during the transmission season, detected using active and 
passive case detection. PCR-confirmed P. falciparum incidence rate was a 
secondary outcome. After ACT treatment, further infections were censored for 28 
days since infections during this time were most likely due to recrudescent 
parasites. Time at risk was also censored for time that study children spent away 
from their compound should they be found to be absent at the two-weekly home 
visits. The entomological inoculation rate (EIR) or estimated number of infectious 
bites per study child during the transmission season was calculated using the 
formula EIR=MaSd where Ma is the human biting rate, estimated from the 
arithmetic mean number of female An. gambiae s.l. caught per light trap night 
across the six-month transmission season, where S is the proportion of female An. 
gambiae s.l. found to be sporozoite positive by village and d is the number of days 
in the transmission season (n). Cone bioassay results for the netting pieces from 
each sampled net were pooled by village and by net type. QGIS Geographic 
Information System (QGIS Development Team (2019), Open Source Geospatial 
Foundation Project) was used to determine distances between the child’s home 
and aquatic habitats. Distance to the nearest health facility was determined based 
on the shortest distance to travel by road. Principal component analysis was used 
to calculate a SES factor score based on asset ownership and household 
characteristics. SES factor scores (ranging from -1.8 to 3.2) were ranked and 
households divided into five equal wealth quintiles (1 poorest, through to 5, least 
poor).  
 
Mean values were compared using a t-test and proportions compared using Chi-
squared tests. Poisson regression models were used to identify risk factors 
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associated with P. falciparum infection incidence rate, adjusting for clustering by 
village. Risk factors assessed were: child’s age, gender, ethnic group, religion, 
caregiver’s education and occupation, wealth quintile and SES factor score, use of 
ITNs and other personal protection, ITN integrity, number of people sleeping in 
the room with the study child, housing materials (roof, eaves, wall and floor 
material, door and window screening), presence of cows, horses, sheep or goats 
within 5 m of the child’s home, Euclidean distance to the nearest aquatic habitat 
with larval anophelines, distance by road to the nearest health centre, EIR at 
village level, and percentage mortality of An. gambiae s.l. mosquitoes from the 
village when exposed to 0.05% deltamethrin in a WHO tube test. A multivariate 
regression model was developed using a forward stepwise approach. Statistical 
analysis was carried out in Stata 15 (Statacorp, Texas, USA).   
 
Assuming two P. falciparum infections per child during the transmission season, 
an intraclass correlation coefficient of 0.1 (design effect of 3.4), and a loss to 
follow-up of 10%, the study had greater than 90% power to detect effect sizes of 
>50% at the 5% level of significance, assuming 50% prevalence of the risk factor 
of interest in the population using the formula for comparison of two rates [113]. 
The study is reported following STROBE guidelines [114]. 
Results 
 
Of 300 randomly selected children, 252 children aged 5 to 15 years old were 
enrolled in the cohort after confirmation of parasite clearance by PCR (Fig. 2.2). 
Of these 252 children, 228 were clear of infection at day 21 post-ACT, while an 
additional 24 children were enrolled following receipt of a second course of ACT 
due to re-infection. Three children withdrew from the study due to migration. No 
deaths were recorded among the cohort during the study period. 
 
The mean age of cohort participants was 9.9 years, 52.0% of whom were male 
(Table 2.1); 38.9% of children were Gouin, 21.8% Karaboro, 11.5% Mossi, 9.1% 
Turka, 6.3% Fulani, and 4.4% Senoufo. Caregivers were predominantly illiterate 
(79.0%) and farmers (95.2%). Most sleeping rooms of the children had metal 
roofs (75.8%), brick walls (57.9%) and cement floors (70.2%). Over half the 
46 
 
children’s sleeping rooms had open eaves (54.8%) and the vast majority did not 
have window screening (96.0%).  
 
Table 2.1:  Baseline characteristics of the study cohort 
Characteristic  Number (%) 
N=252 
Age at enrolment 5 years to <8 years 76 (30.2%) 
≥8 years  176 (69.8%) 
Age (mean/standard deviation)  9.93 (2.8) 
Gender Male 131 (52.0%) 
Female 121 (48.0%) 
Ethnicity Gouin 98 (38.9%) 
Karaboro 55 (21.8%) 
Mossi 29 (11.5%) 
Turka 23 (9.1%) 
Fulani 16 (6.3%)  
Senoufo 11 (4.4%) 
Others 20 (7.9%) 
Reported bed net use  Used bed net usually 215 (85.3%) 
Used an ITN the previous night 203 (80.6%) 
Caregiver’s education level Illiterate 199 (79.0%) 
Primary school 45 (17.9%) 
Secondary school or above 8 (3.2%) 
Caregiver’s occupation Not working/retired 6 (2.4%) 
Farmer 240 (95.2%) 
Commercial activities / government officer 6 (2.4%) 
Eave status of child’s 
sleeping room   
Closed 102 (40.5%) 
Open 138 (54.8%) 
Roof material of child’s 
sleeping room 
Metal 191 (75.8%) 
Thatch 34 (13.5%) 
Other roof type 18 (7.1%) 
Wall material of child’s 
sleeping room 
Mud 65 (25.8%) 
Brick  146 (57.9%) 
Cement (plastered or painted) 32 (12.7%) 
Floor material of child’s 
sleeping room 
Cement 177 (70.2%) 
Dirt floor 65 (25.8%) 
Tiles 1 (0.4%) 
Window screening of child’s 
sleeping room 
Absent 242 (96.0%) 
Present 1 (0.4%) 
 
 
During the follow-up period, 249 of the 252 children experienced at least one P. 
falciparum infection, as detected by microscopy; 31 children (12.3%) had one P. 
falciparum infection, 139 (55.2%) children experienced two P. falciparum 
infections, 75 (29.8%) experienced three P. falciparum infections, and 4 (1.6%) 
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experienced four P. falciparum infections. A total of 550 P. falciparum infections 
were identified using microscopy while 608 infections were identified using PCR. 
Of the 550 P. falciparum infections confirmed using microscopy, 528 (96.0%) were 
detected using active case detection and 22 (4.0%) detected using passive case 
detection. Infections detected passively had a higher geometric mean P. falciparum 
density (19,875/mL, 95% CI = 7,896-31,854) compared to those detected 
through active surveillance (3,744/mL, 95% CI = 2,691-4,797, p<0.001). The P. 
falciparum infection incidence rate was 2.78 episodes per child during the six-
month transmission season (95% CI= 2.66-2.91) by microscopy, and 3.11 
episodes (95% CI = 2.95-3.28) by PCR. Among children suffering from at least 
one infection, the median time to first infection detected by microscopy was 27 
days (range 14 to 123 days).  
 
At baseline, 80.6% of caregivers reported that the study child slept under an ITN 
the previous night. Reported ITN use the previous night at the baseline survey was 
greater than 82% across the four lowest SES quintiles compared to the least poor 
children (quintile 5= 53.2%, p<0.001). Most study children’s bed nets were either 
Permanet 2.0 (52.0%) or Olyset net (16.7%), with 85.5% provided by the NMCP 
and 4.0% purchased on the open market. Sleeping place inspections in July, 
October and December found 87.8% of children had a bed net hanging over their 
sleeping place (638 out of 727 observations). The most common reason for not 
having a net hanging was loss of the net (59/89 observations, 66.3%), while 
15.7% (14/89 observations) of nets were stored and 2.2% (2/89 observations) 
being washed. The proportions lost, stored or being washed did not differ across 
the three surveys. Of the nets that were reported as being lost, 76.3% (45/59 
observations) were destroyed, 22.0% (13/59 observations) stolen and 1.7% (1/59 
observations) given to friends or family. It was common for children to share a 
bed net with siblings and 61.4% of children slept with three or more children. At 
the last survey in December, 62.2% (155/249) of ITNs were in good condition, 
14.5% (36/249) were damaged and 23.3% (58/249) badly torn and non-
protective. Net condition did not differ significantly by survey round, although 
there was a tendency towards net deterioration over the study period. Cone testing 
of a random sample of 26 children’s bed nets gave a mean knockdown at 1 hour 
of 76.5% (95% CI= 61.9-91.1%) and mortality after 24 hours of 42.2% (95% CI= 
18.8-65.6%) for Olyset nets (9 nets, permethrin-treated) and mean knockdown of 
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85.2% (95% CI= 77.9-92.4%) and 24-hour mortality of 39.9% (95% CI= 27.7-
52.0%) for Permanet (17 nets, deltamethrin-treated). 
 
A total of 20,929 mosquitoes were caught from 1,151 trap collections with 16,270 
of these being An. gambiae s.l.. Highest densities of An. gambiae s.l. occurred in 
August (Figure 2.3). Tengrela village had the highest density of An. gambiae s.l. 
across the season, reaching a peak of 137 An. gambiae s.l. per trap /night in 
August. Of the 7,615 identified to species, 4,101 (53.9%) were An. gambiae s.s. 
and 2,590 (34.0%) An. coluzzii; 3.3% of the An. gambiae s.l. were sporozoite 
positive. The overall EIR in the study area was 80.4 infective bites/child over the 
six-month transmission season. The village-level EIR ranged from 40.8 in 
Timperba to 191.9 in Tondoura. Monthly systematic searches of study children’s 
bed nets in the early morning did not collect any mosquitoes. Anopheles gambiae 
s.l. were resistant to 0.05% deltamethrin in WHO tube tests with a mean corrected 
mortality of 52.3% (95% CI= 26.4-78.2%), with values ranging from 27.2% 
mortality in Toumousseni to 93.0% in Yendere.     
 
 
Figure 2.3:  Mean number of Anopheles gambiae s.l. per trap night in 
sleeping rooms of study children during the transmission season 
 
The mean number of water bodies with anopheline larvae within 500 m of study 
houses was 8.7 (95% CI = 7.0-10.3). The average distance by road from the study 
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house to the nearest clinic was 3.6 km (95% CI = 3.2-4.0), although for the 
villages of Toundoura and Gouera, which did not have a clinic nearby, the distance 
was 7.5 km and 9.4 km, respectively.  
 
Correlations between variables were explored and several relationships were found 
where the correlation was greater than 0.3, which is considered the lower limit for 
weak associations [238]. There was a weak positive association between floor and 
wall materials (r=0.3718), between eaves and roof (r=0.3229), occupation and 
education (r=0.3497), SES and eaves (r=0.3803) and SES and electricity supply 
(r=0.3012), while there was a weak (negative) association between roof and floor 
material (r=-0.4138). Correlations suggest that houses with cement or tiled floors 
also had cement walls; houses with cement walls were more likely to have a metal 
roof; open eaves were more common in thatched-roofed houses than those with 
metal roofs; farmers were likely to be illiterate; and richer households were more 
likely to have electricity. Since these correlations are weak, we do not consider 
them to have led to exclusion of any important associations in the final model. 
 
Univariate Poisson regression analysis identified two variables associated with 
incidence of P. falciparum infection in the study children and both remained 
significant in a multivariate model (Table 2.2). Although a small number of children 
travelled from the study area, this was associated with a 52% increase in the 
incidence of P. falciparum infection compared to children that did not travel 
(incidence rate ratio (IRR): 1.52, 95% CI: 1.45-1.59, p<0.001). The least poor 
children were found to have a higher incidence of P. falciparum infection. A 1 unit 
increase in the SES factor score was associated with a 5% increase in infection 




An extremely high incidence of P. falciparum infection was observed, with only 
three of the 252 cohort children remaining free from infection during the six-month 
follow-up period and 86.5% of children experiencing two or more infections. This 
high incidence of infection, despite regular retreatment with an effective anti-
malarial if a child was infected, indicates the high force of infection in the study 
area and is supported by an estimated EIR of 80.4 infective bites per child during 
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the transmission season. Similarly, high levels of P. falciparum infection and 
malaria morbidity have been reported from other recent studies in Burkina Faso in 
areas of high ITN coverage [22, 23, 115]. 
 
The assessment of socio-demographic, entomological and environmental risk 
factors for P. falciparum infection did not elucidate any strong associations. It is 
postulated that this is because the force of infection is so overwhelming in the 
study area, meaning that all the children were at extremely high risk of infection. 
Nevertheless, there was an indication of increased malaria risk in the few children 
that travelled overnight during the study period. Whether staying with family or 
for farming reasons, these children may be at higher risk of P. falciparum infection 
because they lack or have limited access to malaria prevention including ITNs, and 
diagnosis and treatment [116]. Overnight travel history was a risk factor for 
malaria in Uganda in a recent cohort study, with those not using ITNs at 
particularly high risk [117]. The finding of an association between higher SES 
factor score and a higher incidence of P. falciparum infection was unexpected since 
it is widely reported that the least poor children are typically at lower malaria risk 
than the most poor children [102]. The same pattern was also observed when SES 
quintiles were included in the model. The SES factor score was used in the 
multivariable model instead of the study quintiles since, unlike quintiles which 
allocate children into categories, the factor score better reflects the range of values 
in the dataset. The finding that the least poor children have a higher P. falciparum 
infection risk is not explained by a greater number of passively detected infections 
in these children. Passive cases contributed only 4% of all cases identified and 
there were no differences in this proportion across wealth quintiles. Plasmodium 
falciparum infection rates may be higher in the least poor children due to lower 
ITN use than the most poor children. Only 53.2% of the least poor children were 
reported to use an ITN the previous night compared to over 82.6% of children in 
the lowest quintile (most poor).  
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Table 2.2:  Risk factors for Plasmodium infection incidence among children aged 5-15 years in Banfora region of 
Burkina Faso 




Time at risk 
(years) 
Rate Univariate analysis Multivariate analysis 
IRR (95% CI) P value IRR (95% CI) P value 
Age (years) 5-7 76 164 31.09 5.28 - -   
8-15 176 386 71.40 5.41 1.02 (0.94-1.12) 0.59   
Gender Male 131 288 52.93 5.44 - -   
Female 121 262 49.56 5.29 0.97 (0.90 - 1.05) 0.46   
Ethnic group Other ethnicity 236 519 95.82 5.42 - -   
Fulani 16 31 6.66 4.65 0.86 (0.65-1.13) 0.28   
Caregiver’s education Illiterate 199 443 80.45 5.51 - -   
Literate 53 107 22.04 4.86 0.88 (0.76-1.02) 0.09   
Caregiver’s occupation Farmer 240 523 97.39 5.37 - -   
Non farmer 12 27 5.09 5.30 0.99 (0.83 - 1.18) 0.89   
Religion Muslims 170 375 68.97 5.44 - -   
Christians 33 67 13.93 4.81 0.88 (0.77 - 1.02) 0.09   
Animists 49 108 19.58 5.51 1.01 (0.87 - 1.18) 0.85   
SES quintile Poorest 46 102 20.16 5.06 
1.04 (0.99-1.09) 0.14 
  
Poor 44 95 18.47 5.14   
Middle 44 98 18.21 5.38   
Rich 46 103 19.34 5.33   
Richest 47 106 17.79 5.96   
SES factor score 1 unit increase - - - - 1.06 (1.01-1.11) 0.03 1.05 (1.00–
1.11)* 
0.04 
Travel history during 
the study period 
No 246 537 100.93 5.32 -    
Yes 6 13 1.55 8.39 1.58 (1.31-1.90) <0.001 1.52 (1.45–
1.59)$ 
<0.001 
Slept under bed net 
previous night 
Yes  203 448 83.55 5.36 - -   
 No 49 102 18.93 5.39 1.00 (0.78-1.29) 0.97   
≤6 55 124 23.10 5.37 -    
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Number of people 
sleeping in the child 
room (including child) 
6<no.≤12 118 265 46.32 5.72 1.07 (0.94-1.21) 0.33   
>12 79 161 33.06 4.87 0.91 (0.79-1.04) 0.16   
Bed net integrity (at 
final survey in 
December) 
Good (pHI: 0-64) 155 331 62.63 5.28 -    
Damaged (pHI: 65-
642)  
36 81 15.71 5.16 0.98 (0.83-1.15) 0.76   
Too torn (pHI: 643+) 58 134 23.52 5.70 1.08 (0.97-1.20) 0.18   
Used other personal 
protective measures 
No 184 407 74.64 5.45 - -   
Yes 58 125 24.53 5.10 0.93 (0.81-1.08) 0.36   
Housing: roof of child’s 
sleeping room 
Metal 191 420 77.60 5.41 -    
Non metal 52 114 21.85 5.22 0.96 (0.85-1.09) 0.57   
Housing: floor of the 
child’s sleeping room 
Cement/tiles  178 388 72.91 5.32 - -   
Dirt  65 146 26.54 5.50 1.03 (0.94-1.13) 0.48   
Housing: wall of the 
child’s sleeping room 
Mud 65 151 26.54 5.69 - -   
Brick 146 309 59.15 5.22 0.92 (0.83-1.02) 0.12   
Cement  32 74 13.77 5.37 0.94 (0.83-1.08) 0.39   
Housing: eaves of the 
child’s sleeping room 
Open  138 299 56.57 5.29 -    
Closed  102 229 41.60 5.51 1.04 (0.91-1.20) 0.57   
Cows, horses, sheep or 
goats within 5m of 
child’s home  
Present  169 371 67.80 5.47 -    
Absent 80 174 33.51 5.19 0.95 (0.83-1.09) 0.46   
Euclidean distance to 
the nearest positive 
aquatic habitat 
<=300 m 127 266 51.76 5.14 - -   
>300 m    125 284 50.72 5.60 1.09 (1.00-1.19) 0.06   
Distance by road to 
nearest health centre  
<=2 km 119 252 49.65 5.08 - -   
> 2 km 133 298 52.83 5.64 1.11 (1.00-1.24) 0.06   
EIR (village-level) - - - -  1.00 (0.99-1.00) 0.08   
% Mortality in WHO 
tube test with 0.05% 
deltamethrin diagnostic 
dose 
- - - - - 1.05 (0.73-1.50) 0.79   




No association was found between P. falciparum infection risk and either of the 
two entomological variables hypothesized to impact on the primary outcome, 
namely EIR and insecticide resistance. The lack of association with EIR and vector 
density is counter-intuitive given it has been demonstrated in several other studies 
[118, 119], but could arise if vector densities in all villages were sufficiently high 
to maintain high transmission, or due to outdoor biting. Although levels of 
insecticide resistance varied between villages, the rate of P. falciparum infection 
was not greater in villages with higher levels of resistance. This finding may be 
partly due to the relatively small number of villages surveyed for insecticide 
resistance, and the resulting lack of statistical power, although no evidence of an 
association between malaria and insecticide resistance has been found in large 
area studies in the Sudan and Kenya [97]. Despite the high levels of pyrethroid 
resistance in the study area, no malaria vectors were found under the children’s 
ITN after 1,156 searches. This would imply that the nets are still providing some 
level of personal protection since a study in The Gambia found malaria mosquitoes 
under 48.3% of untreated bed nets following 1,584 net searches [120]. Another 
study conducted in Kenya in an area of pyrethroid resistance found live An. 
gambiae s.l. in holed ITNs, with significantly higher numbers in nets with holes 
greater than 50 sq cm in size [121]. Although not measured in this cohort, early 
evening malaria vector biting is found in the study area [122]. This is a time when 
it is common to find communities active in the peridomestic environment, for 
example cooking, eating or socializing. In the study site an estimated 85% of 
exposure to malaria vector bites can be prevented by use of ITNs from 22.00 to 
05.00 but early evening biting outdoors and sporozoite rates of 3.3%, mean that 
residents are still exposed to ~32 infectious bites per person per year even with 
high ITN compliance [122]. Early evening biting outdoors when people are active 
in the peridomestic environment is common across Africa [123], and highlights the 
need for vector control tools that can protect outdoors, such as insecticide-treated 
‘eave ribbons’, attractive targeted sugar baits or larval source management [124-
127]. 
 
ITN use was high with 80.6% of caregivers reporting that the study child slept 
under an ITN the previous night at the baseline survey. This is in line with other 
surveys including the 2017-8 MIS survey, which reported that 76.0% children 
under 5 years slept under an ITN the previous night [27]. The finding of lower 
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reported ITN use in the least poor children (quintile 5) was unexpected. Other 
studies indicate higher ITN use among the least poor, including the 2018 Burkina 
Faso MIS survey in all ages which shows the least poor (quintile 5) have 1.4-1.6 
times the odds of using an ITN the previous night compared to the most poor 
(quintile 1). It will be important to explore the reasons for the apparent lower ITN 
use among the least poor children in future studies. Data on ITN ownership or 
access was not collected as part of this study and so it is not known whether this 
is the cause of lower ITN use among the least poor children. Studies across sub-
Saharan Africa indicate that the net-use gap is primarily driven by intra-household 
access [128]. Despite the overall high reported bed net use in the study population 
and considering that the NMCP campaign only took place the year before the study 
started, there was cause for concern about the durability of the ITNs since only 
62.2% of the children’s ITNs were in good condition at the final survey. Although 
a longitudinal survey of the ITNs was not conducted, the finding is supported by 
studies from other countries. For example, in Tanzania a randomized double-blind 
prospective evaluation of the lifespan of three ITN products found that the 
functional survival (ITNs in serviceable condition) was 2 years for Olyset™ and 2.5 
years for Permanet® ITNs [99], the two types of ITN delivered by the Burkina Faso 
NMCP. Bio-efficacy of the sample of children’s ITNs evaluated showed low 24-hour 
mortality of 42.2% for Olyset™ nets and 39.9% for Permanet®, substantially below 
the ≥80% mortality threshold set by WHO. Thus, there is a great deal of 
uncertainty about net use and the protective efficacy of ITNs in Burkina Faso. The 
analysis shows that there was no difference in malaria risk between ITN users and 
non-users, nor that children sleeping under badly torn nets were more likely to 
have P. falciparum infections than those that slept under good nets.  
 
The study has several limitations. Firstly, and most importantly, the study was 
probably underpowered to detect small risk factors. The sample size calculation 
assumed 50% prevalence of risk factors in the study population, while the study 
children were, in reality, relatively homogeneous with regard to risk factors shown 
to be important in other studies, for example, house construction. Secondly, while 
caregivers reported high compliance with ITN use, assessing ITN use is notoriously 
difficult, and this may have impacted on the ability to identify this as an important 
risk factor. Indeed, social desirability bias and other forms of error mean that 
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surveys are likely to substantially overestimate use [129], and objective and 
unobtrusive tools to measure ITN compliance are not currently available.  
 
Burkina Faso is one of ten sub-Saharan Africa countries designated as a High 
Burden High Impact country with a response plan, including increased political will, 
strategic use of data to deploy tools for maximum impact and a multi-sectoral 
approach. While this study generates useful data on malaria burden in Banfora 
District, it is clear that additional tools will be needed to reduce this burden. Dual-
active ITNs (pyrethroid plus piperonyl butoxide (PBO) or pyrethroid plus 
chlofenapyr) are now being deployed in the study area. PBO-pyrethroid ITNs have 
been shown to be more effective in reducing malaria than pyrethroid-only ITNs in 
areas of pyrethroid-resistant vectors [130, 131], and monitoring of the 
effectiveness of these dual active ITNs is ongoing in Burkina Faso. Indoor residual 
spraying (IRS) should also be considered as it has been shown to be effective in 
reducing malaria in other high-burden countries. In an area of Uganda with an EIR 
of 176 infective bites/year, three rounds of IRS with the carbamate insecticide, 
bendiocarb, every six months reduced malaria incidence from 3.3 episodes to 0.6 
episodes per person year [132]. Even this effective combination of interventions 
is, however, insufficient to eliminate malaria, so further interventions are required. 
SMC is currently being used in 12 sub-Sahelian countries, including Burkina Faso, 
in children up to 5 years of age, with a protective efficacy of over 50% against 
parasitaemia in Burkina Faso [104, 133]. A recent trial in Senegal found similarly 
high reductions in malaria when SMC was used in children aged under 5 years and 
in children aged 5 to 9 years [134]. Expanding the age range eligible for SMC 
could, therefore, be effective in reducing malaria further in Burkina Faso. Burkina 
Faso is also the site of pilot testing of gene drive mosquitoes, which if proven to 
be efficacious, feasible and acceptable, could be a potential option for malaria 




The study found overwhelmingly high levels of malaria transmission in Banfora 
district, in southwest Burkina Faso, and the risk factor survey did not identify any 
risk factors for further investigation to reduce the malaria burden. The findings 
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have implications for achievement of the ambitious goals set out in the WHO Global 
Technical Strategy [10]. Malaria elimination in this area of intense seasonal 




ACT=artemisinin combination therapy, AL= artemether-lumefantrine, 
CI=confidence interval, CNRFP= Centre National de Recherche et de Formation sur 
le Paludisme, EIR=entomological inoculation rate, IRR=incidence rate ratio, 
IRS=indoor residual spraying, ITN=insecticide-treated net, NMCP=National 
Malaria Control Programme, PBO= piperonyl butoxide, PCR=polymerase chain 
reaction, pHI= proportionate hole index, SD=standard deviation, SES=socio-
economic status, SMC=seasonal malaria chemoprevention, WHO=World Health 
Organization 
Ethics approval and consent to participate 
 
The caregivers of study participants provided informed consent (or assent of child 
if aged 12-15 years) to participate in the study. Study documents were approved 
by the Burkina Faso Ministry of Health Research Ethics Committee (Deliberation 
No 2016-12-137), CNRFP Institutional Bioethics Committee 
(No2016/000007/MS/SG/CNRFP/CIB), Durham University Department of 
Biosciences Ethics Committee (SBBS/EC/MIRA) and Liverpool School of Tropical 
Medicine Ethical Committee (Protocol number: 16/047). The study was conducted 
in compliance with principles set out by the International Conference on 
Harmonization Good Clinical Practice, the Declaration of Helsinki and the 
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Risk of falciparum malaria infection in an area of intense transmission in 





Burkina Faso has one of the highest malaria burdens in sub-Saharan Africa despite 
the massive deployment of insecticide-treated nets (ITNs). We used a cross-
sectional survey to identify risk factors for malaria infection in rural Burkina Faso 
that might be used to identify and target malaria control measures.  
Methods 
A cross-sectional survey of 1,199 children and adults (stratified into three age 
groups, 2 to <10 years, 10 to <30 years, ≥30 years old) was conducted in 10 
villages during the peak malaria transmission season in south-west Burkina Faso. 
Plasmodium falciparum infection was diagnosed by microscopy and PCR and data 
collected on age, gender, ethnicity, socioeconomic status, house construction, 
presence of animals, use of personal protection and travel history. Binary logistic 
regression was used to identify risk factors for malaria infection.  
Results 
Overall P. falciparum prevalence detected by microscopy was 32.8%; with 41.9% 
of children aged 2 to <10 years old, 40.6% in 10 to <30 years old and 16.1% of 
those > 30 years old infected. Prevalence of symptomatic malaria was 2.7% in the 
entire study population. 3.3% of the study population had high density P. 
falciparum parasitaemia (>5,000 parasites/µL). Children aged between 5 and 15 
years were at highest risk of P. falciparum infection. Children aged 5 to <10 years 
old were at 3.8 times the odds (95% CI= 2.4–6.0, p<0.001) and children aged 10 
to 15 years old at 4.3 times the odds (95% CI= 2.6 – 7.1, p<0.001) of P. 
falciparum infection compared to children aged less than 5 years old.  Literacy was 
associated with increased risk of P. falciparum infection (OR=1.71, 95% CI= 1.26 
– 2.32, p<0.001). There was a weak association between use of an electric fan 
59 
 
(OR=0.55, 95% CI= 0.31 – 0.99, p=0.05) and female gender (OR=0.77, 95% 
CI=0.58-1.02, 0.07) and decreased risk of P. falciparum infection. 
Conclusion 
Malaria infections were high in all age strata, although highest in children aged five 
to 15 years, despite universal coverage with ITNs and prompt and effective 
treatment with antimalarials. Although ITNs provide some protection, additional 
interventions are required to reduce the burden of malaria in this area of intense 
transmission. Extension of the eligibility criteria for Seasonal Malaria 




Impressive reductions in malaria have occurred throughout sub-Saharan Africa 
from 2000-2015 [4]. Progress, however, has not been geographically uniform. In 
many high-burden countries, parasite prevalence rates and mortality from malaria 
remain obstinately high despite high coverage with insecticide-treated nets (ITNs), 
the main preventative measure recommended by the World Health Organisation 
(WHO) [17].  
Burkina Faso is one of the ten countries in the world with the highest burden of 
malaria and has been designated as a High Burden High Impact country by WHO 
with calls for a more aggressive approach to malaria control [83]. Despite having 
national ITN distribution campaigns in 2010 and 2013, the 2014 malaria indicator 
survey (MIS) found 61% of children aged <5 years old were positive for malaria 
parasites [135]. In this highly endemic area, the burden of clinical malaria is 
highest in infants and young children, with modelling showing that 60-70% of 
cases are in under five year olds in south-west Burkina Faso [136]. Furthermore, 
data from the National Malaria Control Programme shows that malaria cases have 
risen from 7,814,634 cases in 2014 [137]  to 11,463,808 cases in 2018 [19]. This 
is surprising since ITN use has been shown to reduce clinical incidence by >50% 
in areas of stable malaria [95]. The reasons for this control failure may be due to 
the rise in resistance of vectors to pyrethroid insecticides used to treat ITNs [92], 
low net usage or lack of net durability or some other factors. A cross-sectional 
survey was therefore carried out to determine the prevalence of Plasmodium 
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falciparum infection in different age groups and identify risk factors in Banfora 
Health District in south-west Burkina Faso. This information could be important for 
developing future malaria control strategies that could be adopted to bring down 
the burden of malaria.   
Methods 
 
Study site  
 
The study was conducted in Banfora Health District, an area of Sudanian savannah 
in the Cascades region, in south-west Burkina Faso (lying between 10°40’ to 
10°04’13’’ North latitude and 5°01’21’’ to 4°46’18’’ West longitude). Human 
settlements are situated across broad valleys inundated with slow-moving rivers 
and streams. There were 713,059 habitants in 2018 [138] from three major ethnic 
groups: Gouin, Karaboro and Turka. This is an area of intense seasonal malaria 
transmission with peaks during the rainy season, from May to November [21], with 
most cases occurring in September [103].  Farming and animal husbandry are the 
main activities in rural areas. Plasmodium falciparum accounts for 90% of cases 
[21] and the main malaria vectors are Anopheles gambiae sensu stricto, An. 
arabiensis, and, to a lesser extent, An. coluzzii [103]. The National Malaria Control 
Programme (NMCP) undertook an ITN universal coverage campaign (distribution 
of one ITN for two persons) in 2010, 2013 and 2016 using nets either treated with 
permethrin or deltamethrin from BASF, Sumitomo Chemical and Vestergaard. No 
additional nets were distributed by the study team. Indoor residual spraying was 
not conducted during the study or the preceding 12 months. Since 2014, children 
under five years old receive seasonal malaria chemoprevention (SMC) on four 
occasions every month during the transmission season as per WHO 
recommendations [139]. 
Study design and procedures 
 
A random sample of 10 villages were selected from a list of villages in the study 
area using a two-stage process.  Five health centres in the study area were chosen 
with each health centre having a catchment radius of approximately 10 km. The 
catchment areas of the five chosen health centres were contiguous and 2 villages 
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randomly selected from each catchment area, giving a total of 10 villages, at least 
3 km apart.  
An age-stratified cross-sectional survey of both children and adults in three age 
groups (2 to <10 years, 10 to <30 years, ≥30 years) was carried out to determine 
the prevalence of P. falciparum by microscopy and PCR. The survey aimed to 
sample a total of 1,200 individuals, 400 from each of the three age strata. 150 
study subjects (50 in each age strata) were randomly selected from the Health 
and Demographic Surveillance System (HDSS) lists of the 10 study villages and 
entered the screening process. Each study subject was selected from a different 
household. The 40 first subjects per age strata and per village which met the 
inclusion and exclusion criteria were enrolled. Participants were eligible to 
participate if they met the age criteria and provided informed consent but were 
excluded if they were currently participating in a trial of a malaria vaccine or drug, 
under chemoprophylaxis (except for SMC) or currently participating in a related 
cohort study. The survey was carried out shortly after the peak of malaria 
transmission in 2017, from October to November, when parasite prevalence would 
be expected to be highest. Fieldworkers visited the study subject at home to obtain 
written informed consent to participate in the study. After consenting, information 
was collected on potential malaria risk factors, following a standard questionnaire 
used in malaria indicator surveys [140]. During the survey, respondents, or their 
caregivers, gave information on age, gender, socio-economic status, house 
construction (wall, floor and roof material, eave closure), presence of electricity or 
functioning fan, presence of animals within 5 m of the household, use of personal 
protective measures (ITNs, topical and spatial repellents) and travel history in the 
previous two weeks. Participants were also asked about any fevers within the 
previous two weeks and treatment seeking for fever, including whether a blood 
test was performed, and whether antimalarial treatment was given. 
During the clinical survey, a finger-prick blood sample was taken from each 
participant and the axillary temperature measured using an electronic 
thermometer. Participants with a temperature of ≥37.5°c were considered to be 
febrile and history of fever within the previous 48 h was recorded. Two blood slides 
were made, and filter paper blood spots taken for polymerase chain reaction (PCR). 
A malaria rapid diagnostic test (RDT) (SD BIOLINE Malaria Ag P.f/Pan screening 
test Abbott, Geonggi-do, Republic of Korea) was performed for point-of-care 
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diagnosis and those with positive RDTs were offered treatment with artemisinin 
combination therapy according to national guidelines [25].  Thick blood films were 
stained with Giemsa and examined under 1000-fold magnification by experienced 
microscopists centrally at Centre National de Recherche et de Formation sur le 
Paludisme (CNRFP) in Banfora. Parasite counts were recorded per high power field 
and 100 fields counted before a slide was declared negative. Parasite density was 
estimated assuming that one parasite per high power field equals 500 parasites/μl. 
Two blood slides from each subject were read separately by two microscopists. 
Discrepancies in positive and negative reads and parasite counts differing by more 
than 10-fold between the two reads were resolved by the supervisor. Filter paper 
blood samples were analysed for the presence of 18s rRNA gene using PCR. [141] 
Human landing catches were carried out outdoors twice a month during the 2017 
transmission season in each village. Four households were sampled on one night 
every month, with a different group of households selected the following month to 
maximise spatial coverage. Volunteers collected mosquitoes landing on their legs 
between 19.00 h to 06.00 h. Mosquitoes were typed to species using established 
morphological keys [122].  Phenotypic insecticide resistance was measured using 
WHO tube tests as per standard procedures [112]. Assays were performed with 
An. gambiae s.l. mosquitoes reared from immatures collected in seven study 
villages (larvae were not found in the other three villages during the period of the 
survey). 
Data handling and record keeping 
 
Data were collected on personal digital assistants (PDAs) provided to fieldworkers 
and programmed with an electronic data capture system, KoboCollect. Each form 
on the PDA was piloted ten times prior to roll out in the field. Data forms had drop-
down boxes and consistency checks to avoid data entry errors. PDAs were 
uploaded by fieldworkers weekly to a central computer.  
Sample size considerations 
 
A random sample of 400 individuals from each of the three age groups (2 to <10 
years, 10 to <30 years, ≥30 years) were selected from 10 villages giving a total 
sample size of 1200 individuals.  Assuming a true parasite prevalence ranging 
between 40 to 60% across the three age groups [142], the study was able to 
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measure the point prevalence of P. falciparum infection by microscopy with a 5% 
precision at the confidence level of 95% [113].  
 
Statistical Analysis   
 
The primary outcome was P. falciparum infection confirmed by microscopy (any 
level of parasite density). Secondary outcomes were: i) prevalence of symptomatic 
malaria defined as axillary body temperature ≥ 37.5°C (or history of fever within 
the previous 48 h) with microscopically confirmed P. falciparum infection, ii) 
prevalence of high-density P. falciparum infection (>5,000 parasites/µL) detected 
by microscopy, iii) prevalence of P. falciparum infection detected using PCR and 
iv) prevalence of sub-microscopic parasitaemia defined as microscopy negative but 
PCR positive.  
 
Principal component analysis was used to calculate the socio-economic status 
(SES) factor score (based on asset ownership and household characteristics). SES 
factor scores were ranked and households divided into 5 equal wealth quintiles (1 
being the poorest, through to 5, least poor). Mean values were compared using a 
t-test and proportions compared using chi squared tests. Parasite prevalence was 
estimated as the proportion of subjects infected divided by the number of subjects 
tested. The entomological inoculation rate (EIR) or estimated number of infectious 
bites per study participant during the transmission season was calculated using 
the formula EIR=MaSd where Ma is the human biting rate, estimated from the 
arithmetic mean number of female An. gambiae s.l. caught per human landing 
catches across the six-month transmission season, where S is the proportion of 
female An. gambiae s.l. found to be sporozoite positive by village and d is the 
number of days in the transmission season. All confidence intervals (CIs) were 
two-sided computed using the exact method [113]. Logistic regression was used 
to investigate the association between malaria infection and risk factors. A 
multivariate model was constructed using a forwards stepwise process [113] and 
models compared using a likelihood ratio test. Age and gender was retained in all 
multivariable models a priori to control for any potential confounding effects. All 




Ethical approval for this study was provided by the Burkina Faso Ministry of Health 
Research Ethics Committee (Deliberation No 2016-12-137), CNRFP Institutional 
Bioethics Committee (No2016/000007/MS/SG/CNRFP/CIB), Durham University 
Department of Biosciences Ethics Committee (SBBS/EC/MIRA) and Liverpool 
School of Tropical Medicine Ethical Committee (Protocol number: 16/047). The 
study was conducted in compliance with principles set out by the International 
Conference on Harmonization Good Clinical Practice, the Declaration of Helsinki 
and the regulatory requirements of Burkina Faso.  
Results 
 
Participant and household characteristics 
 
A total of 1,199 individuals were surveyed, 399 (33.3%) aged 2 to < 10 years, 
397 (33.1%) aged 10 to <30 years and 403 (33.6%) aged ≥30 years (Table 3.1). 
The mean age of the study population was 23.7 years, ranging from 2.1 to 89.9 
years old. 55.0% of the study population were female (660/1199), with lower 
proportions of females in the 2 to < 10 age strata (47.9%) compared to older age 
strata (53.9% in 10 to <30 years age strata and 63.3% in ≥30 years age strata, 
p<0.001). The most common ethnic groups were Gouin and Turka (51.9%), 
Karaboro (18.8%), and other ethnic groups including Mossi, Senoufo, Lobi and 
Fulani (29.3%). The respondents were Muslim (35.4%), Animists (20.3%) and 
Christians (14.3%). Most study subjects were illiterate (70.5%) and farmers 
(54.8%), whereas 43.5% of participants were not active either because they were 
too young or because they were too old to work. 1142 (95.2%) of respondents 
reported having access to a bednet, with 1,087 (90.7%) saying they slept under 
a bednet the previous night of the survey. 9.2% of the population reported using 
a topical repellent in the last week, whether commercial or traditional. Only 6.2% 
of the study population reported using insecticide aerosols, mosquito coils or other 
spatial repellents. The study population was sedentary and only 1.8% reported a 















> 30  
years, 
n=403 
Age (mean / SD) 23.7 (19.1) 5.9 (2.3) 18.0 
(5.7) 
46.9 (12.8) 











Karaboro (n/%) 226 (18.8) 73 (18.3) 72 (18.1) 81 (20.1) 











Christian 172 (14.3) 60 (15.0) 58 (14.6) 54 13.4) 
Animist 243 (20.3) 84 (21.1) 69 (17.4) 90 (22.3) 
Education  











Farming 657 (54.8) 40 (10.0) 245 
(61.7) 
372 (92.3) 
Commercial and office workers 20 (1.7) 1 (0.3) 6 (1.5) 13 (3.2) 










History of travel in the previous 2 
weeks 
22 (1.8) 9 (2.3) 5 (1.3) 8 (2.0) 
Received SMC in previous month 169 (42.4)    
Eave construction of the sleeping 
room of the subject (212 missing) 
 





  Open 198 (16.5) 41 (10.3) 74 (18.6) 83 (20.6) 
Roof construction of the sleeping 
room of the subject (212 missing) 
 










Sleeping room of subject has a 
functioning lightbulb installed (213 
missing) 





Sleeping room of subject has a 
functioning fan 
74 (6.2) 34 (8.5) 16 (4.0) 24 (6.0) 
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Animals tethered within 5 metres of 
this part of the house (212 missing) 
65 (5.4) 27 (6.8) 19 (4.8) 19 (4.7) 
Use of topical repellent in last week 110 (9.2) 38 (9.5) 32 (8.1) 40 (9.9) 
Use of spatial repellent in the last 
week (212 missing) 




Overall P. falciparum prevalence detected by microscopy was 32.8% in the study 
area (Table 3.2). 41.9% of children aged 2 to <10 years were infected with P. 
falciparum, compared to 40.6% of those aged 10 to <30 years and 16.1% of those 
aged ≥30 years (p<0.001). Further splitting the age groups, P. falciparum 
prevalence was highest among children aged 5 to <10 years old (53.7%) and 10 
to < 15 years old (56.7%) compared to other age strata, with these two age groups 
responsible for 55.0% of the parasite burden in the population (216/393 P.f 
positive participants) (Figure 3.1). Children aged 5 to <10 years old were at 3.8 
times the odds (95% CI= 2.4–6.0, p<0.001) and those aged 10 to 15 years old at 
4.3 times the odds (95% CI= 2.6 – 7.1, p<0.001) of P. falciparum infection 
compared to children aged less than 5 years old.  Prevalence of symptomatic P. 
falciparum malaria (those with fever or reported fever within 48 h with 
microscopically confirmed parasitaemia) was 2.7% in the entire study population, 
with no significant differences across the three age strata. 9.0% of children aged 
5 to <10 years had high density P.f infections (>5,000 parasites/µL), compared to 
only 1.0% of those aged 10 to <30 years and none of those aged ≥30 years.  The 
P. falciparum gametocyte geometric mean density was higher in children aged 5 
to <10 years (49.4, 95% CI=29.3 – 83.1) compared to those aged 10 to <30 
years (21.6, 95% CI=12.7 – 36.8) or those aged ≥30 years (17.6, 95% CI=12.5 




Table 3.2: Malariometric characteristics of cross-sectional survey 
participants 
Variable  Overall 
N= 1199 




> 30 years 
N= 403 
Plasmodium infection 
P. falciparum n (%) 393 (32.8) 167 (41.9) 161 (40.6) 65 (16.1) 
P. malariae n (%) 9 (0.8) 7 (1.8) 2 (0.5) 0 (0) 
Mixed infection (P. falciparum + 
P. malariae) 
n (%) 
20 (1.7) 14 (3.5) 5 (1.3) 1 (0.2) 
P. ovale n (%) 0 0 0 0 
P. vivax n(%) 0 0 0 0 
P. falciparum high density (>5,000 
parasites/μL) prevalence, detected 
by microscopy  
n (%) 
40 (3.3)* 36 (9.0) 4 (1.0) 0 
Geometric mean of P. falciparum 







(913.7 – 1488.0) 
389.9 




Gametocyte prevalence P.f (any 
density)  
n (%) 
57 (4.8) 29 (7.3) 14 (3.5) 14 (3.5) 
Geometric mean P.f gametocytes 





(22.8 – 43.0) 
49.4 
(29.3 – 83.1) 
21.6 
(12.7 – 36.8) 
17.6 
(12.5 – 24.7) 
Fever   
(body temperature ≥ 37.5°C or 
history of fever in the previous 48h)  
n (%) 
80 (6.7) 22 (5.5) 30 (7.6) 28 (6.9) 
Prevalence of symptomatic P. 
falciparum malaria (fever + 
microscopy positive)  
n (%) 
32 (2.7) 12 (3.0) 15 (3.8) 5 (1.2) 
Prevalence of asymptomatic P. 
falciparum infection  
n (%) 
361 (30.1) 155 (38.8) 146 (36.8) 60 (14.9) 
* 2/40 were mixed P.f/P.m infections 
 
Of the 422 participants positive for Plasmodium parasites by microscopy, 393 
(93.1%) were positive for P. falciparum, with only 2.1% found to have P. malariae 
and 4.7% mixed P. falciparum and P. malariae infection.  
The EIR in the study area was 188 bites/human subject/season transmission 
ranging from 0 in Sitiena village to 336 in Dangouindougou village. 
23.4% of respondents (280/1199) were found to be PCR positive for Plasmodium 
parasites which was lower than the proportion detected by microscopy. This is 
likely to be due to lack of amplification during the PCR reaction and therefore we 
do not present PCR results further here. We don’t know why the PCR results were 
lower than microscopy. This was a surprising result and the laboratory was 
confident they performed their analysis following their internal protocol with 
success and quality control was also successfully performed. Because PCR is more 
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sensitive, we assumed to do not use PCR results through these chapter 3 data 
analysis process and we kept microscopy data results to complete the analysis as 
microscopy is a standard diagnosis method. 
 
Figure 3.1: Prevalence of P. falciparum infection by age group in study 
population. Error bars are 95% confidence intervals. 
 
Risk factors for malaria infection 
 
Correlations between variables were explored and a weak negative association 
found between religion and ethnicity (r=-0.4412), while a weak positive 
association was found between eaves and socio-economic status (r=0.3283). The 
correlations suggest that Fulani were most likely to be muslims, while richer 
households were more likely to have open eaves. The latter result was 
unexpected since we would normally expect richer households to have closed 
eaves.  
 
In the univariate analysis, literacy (OR=2.26, 95% CI= 1.75 – 2.92, p<0.001) and 
increasing EIR (OR=1.00, 95% CI=1.00-1.00, p=0.03) were associated with 
increased risk of P. falciparum infection (Table 3). Decreased risk of P. falciparum 
infection was associated with increasing age (1 year increase in age, OR=0.97, 
95% CI=0.96-0.97, p<0.001), female gender (OR=0.71, 95% CI=0.56-0.91, 
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p=0.006) and the use of an electric fan in the sleeping bedroom (OR=0.56, 95% 
CI= 0.32-0.99, p=0.05). Farming was associated with a lower risk of malaria 
compared to those with no occupation/retired (OR=0.49, 95% CI=0.39-0.63). No 
association was found between risk of P. falciparum infection and ethnicity, 
religion, socio-economic status, travel history during the previous 2 weeks, use of 
a bednet the previous night, roof material, eave status (open or closed), presence 
of an electric light in the sleeping room, use of topical or spatial repellent, having 
animals tethered within 5 m of the house and percentage mortality of An. gambiae 
s.l. when exposed to 0.05% deltamethrin in WHO tube tests.  
In the multivariate analysis (Table 3.3) literacy (OR=1.71, 95% CI= 1.26 – 2.32, 
p<0.001) was associated with an increased risk of malaria infection, even after 
adjusting for age. Age ≥ 30 years (OR=0.27, 95% CI=0.18-0.40, p<0.001) was 
significantly associated with a decreased risk of P. falciparum infection. There was 
some evidence of an association between sleeping in a room with electric fan 
(OR=0.55, 95% CI= 0.31 – 0.99, p=0.05) and female gender (OR=0.77, 95% 
CI=0.58-1.02, 0.07) and decreased risk of P. falciparum infection.  
We looked for any association between variables and malaria infection risk using 
corelation table assessment. A table of variables association with other risk factors 
has been built to check any additional strong association. Table 2 have been added 
in appendix 3. There was a strong association between distance for all larval 





















1 year increase  0.97 (0.96 - 0.97) <0.001   
2 to < 10 167/399 
(42.5) 
1  1  
10 to < 30 161/397 
(41.0) 
0.95 (0.71 – 1.26) 0.71 0.88 (0.63 – 1.22) 0.44 
≥ 30 65/403 
(16.5) 




1  1  
Female 194/660 
(29.4) 






1    
Karaboro 65/226 
(28.8) 









1  1  
Literate 161/353 
(45.6) 
2.26 (1.75 - 2.92) <0.001 1.71 (1.26 – 2.32) 0.001 
Occupation 
None / retired 217/522 
(41.6) 





0.49 (0.39 – 0.63) <0.001   
Commercial and 
Office worker 




1    
Christian 56/172 
(32.6) 
1.01 (0.71 – 1.43) 0.95   
Animist 84/243 
(34.6) 
1.08 (0.80 – 1.46) 0.62   





1    
Quintile 2 (low) 81/238 
(34.0) 















0.89 (0.61 – 1.31) 0.56   
History of travel in the previous 2 weeks 
No 389/1177 
(33.1) 
1    
Yes 4/22 (18.2) 0.45 (0.15 – 1.34) 0.15   
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Slept under a bednet the previous night 
No 44/111 
(39.6) 
1    
Yes 348/1087 
(32.0) 
0.72 (0.48 – 1.07) 0.10   
Eave construction of the sleeping room of the subject  
  Closed 258/789 
(32.7) 
1    
  Open 59/198 
(29.8) 
0.87 (0.62 – 1.23) 0.44   
Roof construction of the sleeping room of the subject  
  Metal 229/689 
(33.2) 
1    
  Thatch/mud 88/298 
(29.5) 
0.84 (0.63 – 1.13) 0.25   
Sleeping room of subject has a functioning lightbulb installed 
No 67/223 
(30.0) 
1    
Yes 250/763 
(32.8) 
1.13 (0.82 – 1.57) 0.44   
Sleeping room of subject has a functioning fan 
No 301/913 
(33.0) 
1    
Yes 16/74 (21.6) 0.56 (0.32 – 0.99) 0.05 0.55 (0.31 – 0.99) 0.05 
Animals tethered within 5 metres of the house 
No 298/922 
(32.3) 
1    
Yes 19/65 (29.2) 0.86 (0.50 – 1.50) 0.61   
Use of topical repellent in last week  
None 355/1089 
(32.6) 
1    
Yes 38/110 
(34.5) 
1.09 (0.72 – 1.65) 0.68   
Use of spatial repellent in the last week  
None 290/913 
(31.8) 
1    
Yes 27/74 (36.5) 1.23 (0.75 – 2.02) 0.40   
EIR (village-
level) 
 1.00 (1.00 – 1.00) 0.03   
% mortality in 








This study describes the prevalence of P. falciparum infection in an area of high 
and stable malaria transmission [143] with universal ITN coverage since 2010 
[144]. This is an area of high malaria transmission where the EIR was 188 
infectious bites per human subject over the 6 month transmission season and 
where children aged 5-15 years have an average of 2.8 episodes of P. falciparum 
infection during the 6 months of the peak transmission season [145]. The study is 
unusual since most malariometric surveys often focus on the high-risk groups of 
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children and pregnant women. The overall prevalence of P. falciparum infection, 
detected by microscopy, was 32.8% in all age groups at the end of the malaria 
transmission season. P. falciparum prevalence was, however, highest in children 
aged 5 to <10 years old (53.7%) and 10 to < 15 years old (56.7%) suggesting 
these ages are an important reservoir of infection in the community. High infection 
prevalence in 5-15 year olds may be a result of insufficient and unequal access to 
ITNs as children grow older and sleep together rather than in the mothers’ bed. 
Anthropological research in the same study area suggests that ITN distributions 
occur at times of year when family members often moved out of the study area, 
resulting in insufficient ITNs being provided protection [146]. Studies from other 
parts of sub-Saharan Africa also report a lower use of ITNs among school-aged 
children compared to children under 5 years old [147-149] and a sleeping space 
survey in Uganda found that heads of household sometimes receive priority over 
children when households have too few nets to cover all members [150]. Age and 
gender trend in ITN use in sub-Saharan study identify school age children as group 
of community member which less use ITN with elder aged 50 and more [151]. 
Another study reported that in malaria endemic countries school-age children are 
the lest protected with ITN even they are the greatest group of infections reservoir 
[152]. Also, recent evidence from Uganda reports highest non-adherence of nets 
use in school-age children, specifically from poorer homes [153].   School-age 
children, particularly boys may also be more likely to sleep outside, thus increasing 
their risk of infection [154].   P. falciparum prevalence was 23.2% in children aged 
below 5 years. This compares favourably to the prevalence reported in the 2014 
MIS report of 53.3% [108] for the Cascades Region, suggesting that SMC has 
reduced malaria burden in this group. Early randomised controlled trials of SMC in 
Burkina Faso demonstrated a protective efficacy of 70% against clinical malaria 
compared to ITNs alone [155], and quasi-experimental studies of the operational 
roll-out of SMC show between 50-60% protective efficacy against parasite 
prevalence [133]. As expected, malaria parasite prevalence and parasite density 
both decreased in the older age groups, illustrating the impact of acquired 
immunity [73].  
 
The burden of clinical malaria was relatively low (2.7%) in the study community 
during this cross-sectional survey and distributed in all age group (3.0% in children 
aged 2 to <10 years; 3.8% in 10 to <30 years old and 1.2% in 30 years old and 
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more). This finding suggests the highest prevalence of P. falciparum infections was 
asymptomatic and presents challenges of malaria control since these individuals 
will not seek care and therefore infections will not be cleared [156].  Few 
individuals 40 (3.3%) in the survey had high parasite densities (>5000 
parasites/µl), and 90.0% of them occurred in children aged 2-10 years old. This 
result was expected since the burden of malaria is typically higher in the younger 
age group [23, 157-159]. Overall the P. falciparum gametocyte prevalence was 
low (4.8%), with highest prevalence in children aged 2-10 years old. This finding 
is much lower to a previous study from Burkina Faso which showed 34.5% 
prevalence of gametocytes in children aged three to 15 years old [160] and 21.4% 
all age  [161]. Our data recorded microscopy results while others reported qPCR 
and quantitative-nucleic acid sequence-based amplification (QT-NASBA) analysis 
results. Also, we may suspect the impact of ACT use. Microscopy results 
underestimate real gametocytes prevalence. 
 
Literate study participants were found to have 1.7 times the odds of P. falciparum 
infection compared to illiterate participants. This association was unexpected and 
was present even after adjusting for age (children were more likely to be literate 
than older study participants due to the introduction of compulsory schooling from 
ages 6-16 since 2007) [162].  Sleeping in a room with an electric fan was not 
common in the study population (6.2%), but we found some evidence of an 
association with use of a fan and reduced P. falciparum infection. Ceiling fans or 
smaller fans may make the sleeping room more comfortable at night, encouraging 
the use of bednets, as has been found in a study in Ghana [163]. Fans, if they are 
sufficiently powerful, may also discourage landing and feeding of malaria 
mosquitoes. Female gender was associated with 0.77 times the odds of P. 
falciparum infection compared to males. In the study area, as found in other 
studies in SSA, [164] it is common for men to sleep outside at night due to high 
temperatures with low access to bednets [165]. This is likely to increase infection 
risk for males compared to females.  
 
We show a high burden of malaria infection despite three ITN universal coverage 
campaigns in 2010, 2013 and 2016 and malaria case management with effective 
artemisinin combination therapies. What are the implications of our findings for 
malaria control in the Cascades region of Burkina Faso? It is well documented that 
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the burden of malaria shifts to older children as malaria declines [166]. Senegal, 
another country in the Sahel region with seasonal malaria transmission, has 
started to implement SMC in children aged up to ten years following the results of 
clinical trials which showed high protective efficacies against malaria in aged up to 
ten years [167]. Therefore, this may be an option for Burkina Faso. 
Implementation of SMC can also have benefits for other age groups. For example, 
one of the Senegalese trials demonstrated that by implementing SMC to reduce 
the reservoir of infection, one can reduce the burden of malaria in all age groups, 
and showed a 26% reduction in incidence of malaria in adults and children too old 
to receive SMC [167]. Infection risk was highest in the 5-15 year olds who may 
have insufficient and unequal access to ITNs compared to younger children and 
those above the age of 15 years. Distribution of additional ITNs could help to 
increase access for this at-risk group, perhaps using school distributions as a keep-
up strategy [168]. Efforts should be made to discourage outdoor sleeping without 
ITNs, where possible. It may be possible to increase indoor sleeping under ITNs 
by increasing the thermal comfort of rural African houses using for example, 
relatively inexpensive solar powered fans [163] or installing two screened windows 
on opposite walls of the house to encourage cross-ventilation [169]. In the study 
site, during the hot season, men socialised and slept outside [146] and so indoor 
sleeping may not be well accepted. Provision of additional ITNs, that could be used 
outside, during for example funerals when outdoor sleeping is part of local culture 
[154] may therefore be an option.  
 
Study limitations 
Unfortunately, we did not obtain PCR results and so were not able to evaluate sub-
microscopic infections. Microscopy results underestimate P. falciparum real 
prevalence in our study findings. There is a need for increase laboratory training 
and supervision to avoid errors in future studies. We did not observe a relationship 
between P. falciparum infection and bednet use. However, assessment of bednet 
use through questionnaires is subject to social desirability bias and we lack 







P. falciparum infection in the Cascades Region of Banfora remains high despite 
universal coverage with ITNs and access to diagnosis and treatment. Our study 
findings imply that current national strategies for malaria control in Burkina Faso 
are not sufficient to eliminate the disease. The high prevalence of P. falciparum 
infection in children aged 5 to 15 years suggests that an extension of the age 






Risk factors associated with house entry of malaria vectors in an area of 
Burkina Faso with high, persistent malaria transmission and high 
insecticide resistance  
 
Adapted from: Yaro JB, Ouedraogo A, Ouedraogo ZA, Diarra A, Lankouande M, 
Agboraw E, Worrall E, Toe KH, Sanou A, Guelbeogo WM,  Sagnon N, Ranson H, 
Tiono AB, Lindsay SW, Wilson AL (2020). A cohort study to identify risk factors for 
Plasmodium falciparum infection in Burkinabe children: implications for other high 





In rural Burkina Faso, the malaria vector Anopheles gambiae s.l. primarily feeds 
indoors at night. Identification of factors which influence mosquito house entry 
could lead to development of novel malaria vector control interventions. A study 
was therefore carried out to identify risk factors associated with house entry of An. 
gambiae s.l. in south-west Burkina Faso, an area of high insecticide resistance.  
 
Methods  
Mosquitoes were sampled monthly during the malaria transmission season using 
CDC light traps in 252 houses from 10 villages, each house sleeping at least one 
child aged five to 15 years old. Putative risk factors for house entry of An. gambiae 
s.l. were measured, including socio-economic status, caregiver’s education and 
occupation, number of people sleeping in the same room as the child, use of anti-
mosquito measures, house construction and fittings, proximity of mosquito aquatic 
habitats and presence of animals near the house. Mosquito counts were compared 
using a generalised linear mixed-effect model with negative binomial and log link 
function, adjusting for repeated collections.  
 
Results 
20,929 mosquitoes were caught, of which 16,270 (77.7%) were An. gambiae s.l. 
Of the 6,691 An. gambiae s.l. identified to species, 4,101 (61.3%) were An. 
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gambiae and 2,590 (38.7%) An. coluzzii. Having an electricity supply (incidence 
rate ratio, IRR = 0.4, 95% CI = 0.3–0.7, p = 0.001) and a metal-roofed house 
(IRR, = 0.6, 95% CI = 0.4–1.0, p = 0.034) were associated with fewer malaria 
vectors inside the home.   
 
Conclusion  
This study demonstrated that there were fewer An. gambiae s.l. in homes with 
electricity and a metal roof compared to those that did not. Brightly-lit, well-built 
houses with metal roofs may reduce entry of malaria mosquitoes compared to 
dimly-lit, poorly-built thatched roofed houses. 
Introduction 
 
Despite large reductions in the malaria burden across sub-Saharan Africa from 
2000-2015 [4], some countries continue to experience extremely high malaria 
transmission [5]. In Africa, malaria transmission is highly efficient because of the 
wide distribution of Anopheles gambiae s.l., an effective malaria vector that readily 
feeds readily on people indoors at night, where about 79% of malaria transmission 
typically occurs [123]. The indoor density of malaria mosquitoes is dependent on 
numerous environmental and household factors, including the abundance and 
proximity of aquatic habitats of malaria mosquitoes [48, 170], presence of large 
domesticated animals who may serve as alternative hosts [171], typology of 
houses [169, 172], use of anti-mosquito measures in the house [48], the number 
of residents [173] and variability in the attractiveness of individual people [120] 
(Figure 4.1).  
Burkina Faso is an area of intense seasonal malaria transmission, and cases are 
increasing [20, 174] despite high coverage of vector control tools, including three 
national insecticide-treated net (ITN) mass distribution campaigns in 2010, 2013 
and 2016 [27]. Resistance to pyrethroids, the main insecticide class used for 
treating ITNs, is high in An. gambiae s.l., and in the study area near Banfora town 
exposure to ITNs has no impact on the lifelong survival of malaria vectors [93]. 
New tools are urgently needed to reduce the burden of malaria in Burkina Faso 
and other countries in sub-Saharan Africa.  
Several studies have demonstrated that malaria mosquito house entry can be 
reduced through simple changes to house design such as closing eaves and 
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screening windows and doors [175]. The use of personal protective measures such 
as ITNs and spatial repellents may also reduce transmission [95, 176]. There is a 
lack of evidence, of whether such methods will reduce house entry of malaria 
vectors in settings of high insecticide resistance, such as the study site in south-
west Burkina Faso. A risk factor survey was conducted to identify variables 
associated with indoor density of An. gambiae s.l. during the malaria transmission 
season in an area of intense malaria transmission in Burkina Faso. Findings from 
this study might identify potential opportunities for improving malaria control in 
Burkina Faso and other countries in sub-Saharan Africa experiencing persistently 
high malaria transmission. 
 
Figure 4.1: Environmental and household factors affecting the abundance 





The study was conducted in Banfora Health District, in the Cascades Region, south-
west Burkina Faso (Figure 4.2). This is an area of Sudanian savannah covering 
6,295 km2 with an estimated population of 407,073 inhabitants [174]. Malaria 
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transmission is intense and seasonal, occurring mainly during the rainy season, 
from May to November [21]. Plasmodium falciparum accounts for 90% of cases 
[177]. The main malaria vectors are An. gambiae s.s. and An. coluzzii [177]. In 
2016, approximately 1 year before this study took place, a universal coverage 
campaign distributed ITNs with permethrin or deltamethrin (Sumitomo Chemical, 
Vestergaard and BASF) at a rate of one net for every two people at risk. No 
additional ITNs were distributed by the study. No indoor residual spraying was 
conducted. Typically, single room houses each housing a family are organised into 
compounds, consisting of on average 4 houses, led by a compound head. 
 
Figure 4.2: Map of study area 
Study design 
 
The study was nested in a cohort study of risk factors for P. falciparum infection in 
children aged five to 15 years [145]. This study reports on the household and 
environmental risk factors associated with the density of An. gambiae s.l. in the 
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children’s sleeping room over six months of high malaria transmission from July to 
December 2017.  
Recruitment of study cohort  
 
Sampling and recruitment of the study cohort is described elsewhere [145]. In 
brief, a random sample of 10 villages were selected from a list of villages in the 
study area using a two-stage process. Firstly, five health centres in the study area 
were selected, each with a catchment radius of 10 km. Secondly, two villages, at 
least 3 km apart, were selected from each catchment area. An enumerated list of 
children in the study villages was obtained from the Banfora Demographic and 
Health Surveillance System. From each village, a random sample of 30 children 
aged five to 15 years were chosen. Each child was selected from a separate house, 
and, where possible, a separate compound. Children were included in the study if 
they were of the appropriate age, were likely to remain resident in the village over 
the duration of the transmission season and the caregiver provided informed 
consent to participate in the study. 252 children who were successfully cleared of 
P. falciparum infection were included in the cohort study and this current study 
reports on the entomological surveillance from the children’s sleeping rooms. 
Entomological surveillance  
 
CDC light traps (John Hock, Gainsville, USA) were used to estimate indoor 
mosquito densities in the study child’s sleeping room. These traps were placed 
with the bulb 1500 mm above the floor, approximately 500 mm from the foot end 
of a bed with an ITN occupied by the study child. Houses were sampled from 19.00 
h to 06.00 h every four weeks. Typically, houses were sampled once a month, but 
in some cases two collections were performed. Two villages (Nofesso and 
Ouangolodougou) were inaccessible for two weeks at the start of the study period 
due to flooding. Mosquitoes were taken to the laboratory in cool boxes, killed by 
freezing at −20°C, and identified morphologically using established keys [178]. 
The presence of circumsporozoites protein (CSP) in An. gambiae s.l. were identified 
using an enzyme-linked immunosorbent assay [179] and An. gambiae s.l. females 




Risk factor assessment 
 
In June, a questionnaire was administered to the caregiver of the study child to 
collect information on ethnicity, education level and occupation of caregivers, ITN 
use during the previous night, use of other protective measures (e.g. insecticide 
knockdown spray, mosquito coils, traditional spatial repellent), number of people 
sleeping in the room with the child, roof, wall and floor construction of the child’s 
sleeping room, whether the eaves (the gap between the top of the wall) were open 
or closed, presence of mosquito screening and electricity supply. Information was 
also collected from the head of the child’s household on asset ownership and 
household characteristics, following standard procedures used in the Burkina Faso 
Malaria Indicator Survey [108]. The number and type of large domestic animals 
(cattle, goats, sheep, pig, dog, donkeys or horses) tethered within 5 m of the 
house was recorded by a fieldworker. The house was geo-located using a handheld 
global positioning system (GARMIN eTrex 20). Larval surveys were carried out in 
each village in September, during the peak of the transmission season. All water 
bodies within 1 km from a village were mapped, including irrigated fields, streams 
and ponds, puddles, and foot or hoof prints. The presence of anopheline larvae 
was recorded with a dipper.  
 
Data management and statistical analysis  
 
Data were collected on Android personal digital assistants programmed using the 
KoboCollect system and included drop down boxes and consistency checks to 
reduce data entry errors. Following cleaning, the dataset was locked and saved in 
Microsoft Access. The primary outcome was the number of An. gambiae s.l. 
collected in each child’s sleeping room per night. QGIS Geographic Information 
System (QGIS Development Team (2019), Open Source Geospatial Foundation 
Project) was used to determine distances between the child’s home and aquatic 
habitats. Principal component analysis (PCA) was used to calculate the socio-
economic status (SES) factor score of the head of the child’s household. SES factor 
scores were ranked, and households divided into five equal wealth quintiles, from 
1, the poorest, to 5, the least poor. The entomological inoculation rate (EIR) or 
estimated number of infectious bites per study child during the transmission 
season was calculated using the formula EIR=MaSd where Ma is the human biting 
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rate, estimated from the arithmetic mean number of female An. gambiae s.l. 
caught per light trap night across the six-month transmission season, where S is 
the proportion of female An. gambiae s.l. found to be CSP positive by village and 
d is the number of days in the transmission season (n). Mean values were 
compared using a t-test and proportions compared using chi-squared tests. A 
generalised linear mixed-effect model with a negative binomial distribution, to 
account for overdispersion, and log link function was used to identify risk factors 
associated with the mean number of An. gambiae s.l. per catch night per house 
each month. Risk factors were selected a priori based on importance for malaria 
vector house entry. These were SES quintile, ITN use, use of other protective 
measures, number of people sleeping in the room with the child, roof, floor and 
wall material in the sleeping room, eaves (open or closed), electricity supply, 
presence of large domesticated animals within 5 m of the house and proximity of 
habitats positive for anopheline larvae. A random effect for study child ID number 
was used to account for repeated measures on the same house and village was 
included as a fixed effect. Following univariate analysis, each risk factor with P<0.1 
was incorporated into a multivariate model which was refined through a process 
of backwards stepwise elimination using a likelihood ratio test. Interactions were 
tested between a subset of variables that were thought to be biologically relevant 
to explore. Means and 95% confidence intervals were calculated. Statistical 
analysis was carried out in Stata 15 (Statacorp, Texas, USA). The study is reported 
following STROBE guidelines [114]. 
Results 
 
As reported elsewhere [145], a total of 20,929 mosquitoes were caught from 1,151 
trap collections in the 252 study houses, with 16,270 of these being An. gambiae 
s.l. (77.7%). Of the 6,691 An. gambiae s.l. identified to species (excluding 924 
lost and non-identified samples), 4,101 were An. gambiae s.s. (61.3%) and 2,590 
An. coluzzii (38.7%). 3.3% of An. gambiae s.l. were CSP positive and the overall 
EIR in the study area was 80.4 infective bites/child over the six-month 
transmission season. The village-level EIR ranged from 40.8 in Timperba to 191.9 
in Tondoura. 
The ethnic composition of the study population was Gouin (38.9%), Karaboro 
(21.8%), Mossi (11.5%), Turka (9.1%), Fulani (6.3%), Senoufo (4.4%) and other 
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ethnic groups (7.9%) (Table 4.1). Caregivers were predominantly illiterate 
(79.0%) and farmers (95.2%). 80.6% of caregivers reported that their child slept 
under an ITN the previous night, while 15.9% reported using mosquito coils and 
6.4% insecticide knockdown spray. Children’s sleeping rooms were constructed 
with predominantly brick walls (57.9%), cement or tiled floors (70.6%), metal 
roofs (75.8%) and open eaves (54.8%). Window screening was rare (0.4%). 
67.1% of households had large domestic animals (cattle, goats, sheep, dogs, pig, 
donkeys or horses) within 5 m of the house. 50.4% of child’s households were 
located within 300 m of an aquatic habitat containing anophelines.  
Sleeping spaces in metal roofed houses were more likely to have walls and floors 
made of finished materials, open eaves, be less crowded and have an electricity 
supply than thatch roof sleeping spaces. 81.7% of sleeping spaces with a metal 
roof had a cement or tiled floor compared to 42.3% of those with a thatch roof 
(p<0.001). Metal roof sleeping spaces were also more likely to have brick or 
cement walls (77.0%) compared to thatch roof sleeping spaces (55.8%, p<0.001). 
Sleeping spaces with a metal roof were also more likely to have open eaves 
(66.0%) and an electricity supply (51.8%) than sleeping spaces with a thatch roof 
(23.1% and 28.8% respectively, p<0.001 and p=0.003). 26.2% of sleeping spaces 
with a metal roof had more than 12 people sleeping in them compared to 38.5% 
of sleeping spaces with a thatch roof (p<0.001). There was no association between 
metal roof sleeping spaces and distance from the nearest anopheline larvae 
positive habitat.  
Assessment of linear correlation between electricity or roof type and the other 
variables included in the model did not identify any correlations, including with 
SES. As such, we consider that these variables were acting on mosquito house 
entry independently. That said, we cannot account for unmeasured risk factors or 
poorly measured risk factors. In this regard, we are aware of the limitations of 
measuring SES, for example. We have removed the statement in the discussion 
regarding the potential for electricity to be a proxy for SES.  
Univariate analysis of putative risk factors showed that there was an association 
between An. gambiae s.l. abundance and roof and floor materials, electricity 
supply, and proximity of positive larval habitats (Table 4.2). There was a 40% 
reduction in the rate of An. gambiae s.l. if the child slept in a room with a metal 
roof (IRR = 0.6, 95% CI 0.4 – 0.9, p = 0.026), increasing to a 60% reduction if  
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Table 4.1: Characteristics of the study participants and their houses 
Characteristic  Number (%) 
N=252 
Socio-demographic characteristics 
Ethnicity Gouin 98 (38.9%) 
Karaboro 55 (21.8%) 
Mossi 29 (11.5%) 
Turka 23 (9.1%) 
Fulani 16 (6.3%) 
Senoufo 11 (4.4%) 
Others 20 (7.9%) 
Caregivers education level Illiterate 199 (79.0%) 
Primary school 45 (17.9%) 
Secondary school or above 8 (3.2%) 
Caregivers occupation Farmer  240 (95.2%) 
Non-farmer 12 (4.8%) 
Number of people 
sleeping in the child 
room (including child) 
≤6 55 (21.8%) 
7-12 118 (46.8%) 
>12 79 (31.3%) 
Use of personal protective measures 
Reported ITN use Used ITN usually 215 (85.3%) 
Used an ITN the previous night 203 (80.6%) 
Use of other personal 
protection methods 
Coils  40 (15.9%) 
Insecticide spray 16 (6.4%) 
Traditional repellent (non-topical) 2 (0.8%) 
None 184 (73.0%) 
House construction 
Roof material of child’s sleeping 
room 
Metal 191 (75.8%) 
Non-metal (Thatch/mud) 52 (20.6%) 
Wall material of child’s sleeping 
room 
Mud 65 (25.8%) 
Brick  146 (57.9%) 
Cement blocks (plastered or painted) 32 (12.7%) 
Floor material of child’s 
sleeping room 
Cement/tile 178 (70.6%) 
Mud 65 (25.8%) 
Eave status of child’s sleeping 
room   
Closed 102 (40.5%) 
Open 138 (54.8%) 
Window screening of child’s 
sleeping room 
Absent 242 (96.0%) 
Present 1 (0.4%) 
Electricity supply in the child’s 
sleeping room 
Present  115 (45.6%) 
Absent 111 (44.0%) 
Missing  26 (10.3%) 
Environmental factors 
Presence of large domestic 
animals within 5 m of the 
household 
Present 169 (67.1%) 
Absent 80 (31.7%) 
Proximity to anopheline 
positive larval habitats 
<300 m 127 (50.4%) 




there was an electricity supply in the sleeping room of the child (IRR = 0.4, 95% 
CI 0.3 – 0.7, p = 0.001). A mud floor was associated with 1.5 times the rate of 
An. gambiae s.l. compared to a cement or tiled floor (IRR = 1.5, 95% CI 1.0 – 2.4, 
p=0.043). There was 50% increase in the rate of An. gambiae s.l. when the child’s 
house was >300 m from a larval habitat containing anopheline mosquitoes (IRR = 
1.5, 95% CI 1.0 – 2.3, p = 0.032). 
In the final multivariate model, having an electricity supply in the child’s sleeping 
room (IRR = 0.4, 95% CI 0.3 – 0.7 p < 0.001) and a metal roof (IRR = 0.6, 95% 
CI 0.4 – 1.0, p = 0.034) were associated with fewer malaria vectors indoors (Table 
4.2). Inclusion of eave status did not improve the model fit or alter the IRR 





Our findings demonstrate highly intense transmission of malaria in the study area 
with a person sleeping without an ITN experiencing a seasonal EIR varying from 
40.8 infectious bites per person in Timperba village to 191.9 in Toundoura village 
[145]. Malaria vector abundance rises in July after the start of the rains in May, 
reaching a peak in August, before declining to low levels in November and 
December.  
Having a supply of electricity in the sleeping room of the child and a metal roof 
were both associated with fewer An. gambiae s.l. malaria vectors entering houses. 
Fewer An. gambiae s.l. found in houses with electricity may be due to the use of 
electric lights or fans and this hypothesis requires further investigation. The 
relationship between electrification and malaria is not well established and there 
are only a few, low quality studies on this topic, with most indicating a higher risk 
of malaria given electrification [182-184]. Electrification was associated with a 
two-fold increase in the odds of clinical malaria in a case control study in Burkina 
Faso [185]. An increase in malaria may results from mosquitoes being attracted 
to light. For example, the CDC light trap is thought to be attractive at distances of 
5 m [186], and may increase indoor catches of mosquitoes if the light is seen from 
outside the house [187]. Qualitative studies suggest that outdoor lighting and 
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ownership of televisions may also increase in malaria risk due to the extension of 
the period of outdoor activity [154, 188, 189]. Alternatively, there is evidence that 
lighting is protective against mosquitoes. The disappearance of malaria in England 
was associated with improvements in housing including better lighting, improved 
ventilation, drier and more spacious rooms, better ceiled and plastered and less 
crowded bedrooms [190]. Responses of mosquitoes to light is likely to be more
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Mean mosquito density 
per month (95% CI) 
Univariate analysis Multivariate analysis 
IRR (95% CI) P value IRR (95% CI) P value 
Socio-economic status of child’s household 
Poorest 23.0 (10.0 – 36.1) 1    
Poor 14.1 (6.8 – 21.3) 0.8 (0.4 – 1.4) 
0.4 
  
Middle 11.8 (7.7 – 15.9) 0.9 (0.5 – 1.7)   
Rich 11.5 (7.3 – 15.8) 0.7 (0.4 – 1.4)   
Richest 12.4 (5.6 – 19.1) 0.7 (0.3 – 1.5)   
ITN use the previous night 
No 7.1 (4.5 – 9.8) 1    
Yes 15.8 (11.7 – 19.8) 1.2 (0.6 – 2.3) 0.6   
Use of other personal protection measures (insecticide knockdown spray, mosquito coils, traditional spatial repellent) 
No 15.8 (11.4 – 20.2) 1    
Yes 9.6 (6.3 – 13.0) 0.9 (0.6 – 1.6) 0.8   
Number of people sleeping in the same room as the study child 
≤6 13.5 (9.6 – 17.4) 1    
7-12 17.1 (10.3 – 23.8) 1.1 (0.7-1.9) 0.7   
>12 10.4 (7.5 – 13.3) 0.8 (0.4 – 1.3) 0.3   
Roof material of child’s sleeping space 
Non-metal 14.3 (8.1 – 20.6) 1  1  
Metal 14.4 (10.3 – 18.4) 0.6 (0.4 – 0.9) 0.03 0.6 (0.4 – 1.0)$ 0.03 
Floor material of child’s sleeping space 
Cement/tile 13.3 (9.1 – 17.5) 1    
Mud 17.4 (11.4 – 23.3) 1.6 (1.0 – 2.4) 0.04   
Wall material of child’s sleeping space 
Mud 17.4 (11.3 – 23.4) 1    
Brick 13.6 (8.5 – 18.6) 1.0 (0.6 – 1.6) 1.0   
Cement 11.6 (7.0 – 16.1)  0.8 (0.4 – 1.7) 0.6   
Eaves of child’s sleeping space 
Open 13.8 (9.8 – 17.7) 1    
Closed 14.9 (9.6 – 20.3) 1.0 (0.6 – 1.6) 0.9   
Electricity supply of child’s sleeping space 
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No 17.9 (11.1 – 24.7) 1  1  
Yes 11.8 (8.9 – 14.8) 0.4 (0.3 – 0.7) 0.001 0.4 (0.3 – 0.7)& 0.001 
Presence of large domestic animals near the house  
Yes 14.9 (10.1 – 19.7) 1    
No 12.7 (9.3 – 16.0) 1.1 (0.8 – 1.7) 0.6   
Distance to positive larval habitat 
<300m 9.5 (7.3 – 11.8) 1    
>300m 18.6 (12.4 – 24.9) 1.5 (1.0 – 2.3) 0.03   
IRR: incidence rate ratio, CI: confidence interval, *adjusted for repeated measures and village as fixed effect, $adjusted for electricity supply, 
repeated measures and village as fixed effect, &adjusted for roof material, repeated measures and village as fixed effect
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nuanced, depending not only on the intensity and frequency of the light, but on 
the time of day a mosquito perceives the light. For example, An. gambiae s.s. 
exposed to white light for 10 min at the start of the night interrupted feeding 
activity for two to four hours [191]. The use of electric fans is also likely to reduce 
collections of mosquitoes by light traps since the powerful air current generated 
by a fan will prevent or greatly disturb mosquito flight. There may also be other 
explanations for our finding that are more straightforward. Firstly, the use of 
electricity, as suggested by Yamamoto and co-workers, may lead to a shift away 
from use biomass fuels and creation of smoke that would repel malaria vectors 
from entering the house [185]. Secondly, the use of electricity may simply be a 
proxy for higher socio-economic status and a more mosquito-proof house, along 
the lines suggested by James in 1920 [190]. Clearly further research is needed to 
clarify what is contradictory evidence.  
Finding fewer mosquitoes in houses with metal roofs compared with thatched roofs 
has been reported in several studies, including a Tanzanian study where metal 
roofed houses had 33% less An. arabiensis than thatched-roof houses [192, 193], 
and a Ugandan study where there were 38-43% fewer An. gambiae s.l. in metal-
roofed houses [194]. Results are, however, contradictory in other studies. In The 
Gambia metal-roofed houses were not associated with fewer mosquitoes [171], 
and in an experimental study, metal roofed houses with closed eaves and mud 
walls had similar numbers of mosquitoes as thatched-roofed houses with open 
eaves and mud walls [169]. Whether a metal-roofed house has more or less 
mosquitoes than a thatched-roof house ultimately depends on how porous the 
house is to mosquitoes and the extent of ventilation [195]. In general, since metal-
roofed houses are hotter before midnight than thatched-roofed houses, metal-
roofed houses will generate more carbon dioxide from people sleeping in the 
houses, and therefore attract more mosquitoes, than cooler thatched-roofed 
houses [169, 196]. However, metal-roofed houses are often better built, with 
fewer mosquito entry points, than thatched-roofed houses. In such cases, metal-
roofs may simply be a marker for a better quality home that is less porous to 
mosquitoes. 
The lower An. gambiae s.l. density in metal-roofed houses compared to thatch 
houses in this study appeared to be operating independently of eave status, since, 
thatched roofs were more likely to have closed eaves and an interaction between 
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eave status and roof type was not significant. A final consideration is that there is 
evidence that the high temperatures experienced in metal roof houses in the hot 
humid tropics, increases the mortality of malaria vectors resting indoors during 
the day [195]. Thus, the reduction in mosquitoes found in metal-roofed houses 
may be partly due to the higher temperatures experienced indoors.  
 
The study has several limitations. Firstly, both electricity supply and metal-roofed 
houses are associated with high SES. Adjusting the final model for SES quintile did 
not impact on the results. Despite this, the SES quintile is a crude measure and 
there may be other features of wealth that reduce malaria mosquito numbers in 
houses with electricity supply and metal roofs. Second, ITN use the previous night 
was assessed by asking the caregiver which may be prone to social desirability 
bias [129]. The use of an ITN will usually vary over the transmission season, but 
we only measured use during the baseline survey. This may have impacted on our 
ability to identify an association between ITN usage and indoor density of malaria 
vectors.   
The cohort study in which this entomological study was nested did not identify 
strong risk factors for P. falciparum infection, with only overnight travel and higher 
SES factor score being associated with higher rates of P. falciparum infection 
[145]. It is difficult to reconcile the entomological and epidemiological findings and 
further studies are needed. It is perhaps unsurprising that the risk factors for 
malaria vector density and P. falciparum infection in children differed, since higher 
indoor vector density does not automatically imply higher infection risk. The indoor 
density of malaria vectors may be less important in this study area due to the 
observation of increasing outdoor biting with some studies suggesting ~54% of 
An. gambiae s.l. host seeking outdoors [122]. Research also suggests that the 
study communities spend more time outside in the peri-domestic environment 
during peak biting times than previously thought [146]. 
What are the implications of the study findings for vector control and future 
research? Increased access to electricity in sub-Saharan Africa raises questions 
about the impact on vector behaviour (e.g. whether lights attract mosquitoes or 
leads to mosquito avoidance behaviour), human behaviour (e.g. alteration of time 
to bed or use of fans) and malaria risk which are complex and yet to be understood. 
Further research on this topic is needed. The risk factor study also highlights the 
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potential of improved housing to reduce malaria transmission and supports the 
results of systematic and multi-country research studies on this topic [85, 102]. 
Housing improvements tend to be implemented as a package and, in line with this, 
our study found that metal roof sleeping spaces were more likely to have floors 
and walls made of finished materials, be less crowded and have an electricity 
supply than thatch roof sleeping spaces. Improving house construction should be 
a focus for malaria reduction [197], with increasing evidence in support of 
screened, self-closing doors, closed eaves, raising buildings off the ground, 
screened windows on either side of building for ventilation and solid roofs [175]. 
As well as contributing to the development agenda, there is also evidence that 
improved housing can reduce risk of other major causes of death in children 
including diarrhoea, growth failure and anaemia [198]. While other vector control 
tools such as dual-active ITNs are now being deployed in the study area, the study 
results highlight the importance of non-insecticidal interventions such as house 




This study in south-west Burkina Faso demonstrates reduced indoor density of 
malaria vectors in houses with electricity and a metal roof. Further research is 
needed to unpack the implications of electrification and metal roof housing on 
malaria risk; however, this study adds to the growing evidence base supporting 
the use of housing improvement against malaria. 
 
Ethics approval and consent to participate 
 
Permission to enter the communities was sought from village leaders. The 
caregivers of study participants provided informed consent (or assent of child if 
aged 12-15 years) to participate in the cohort study and for collection of 
mosquitoes from the child’s sleeping room. Study documents were approved by 
the Burkina Faso Ministry of Health Research Ethics Committee (Deliberation No 
2016-12-137), CNRFP Institutional Bioethics Committee 
(No2016/000007/MS/SG/CNRFP/CIB), Durham University Department of 
Biosciences Ethics Committee (SBBS/EC/MIRA) and Liverpool School of Tropical 
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Medicine Ethical Committee (Protocol number: 16/047). The study was conducted 
in compliance with principles set out by the International Conference on 
Harmonization Good Clinical Practice, the Declaration of Helsinki and the 
regulatory requirements of Burkina Faso 
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Risk factors for Plasmodium falciparum infection in pregnant women in 
Burkina Faso: a community-based malaria cross-sectional survey 
 
Adapted from: Yaro JB, Ouedraogo A, Diarra A, Sombie S, Ouedraogo ZA, 
Ouedraogo NI, Drakeley C, Sirima SB, Tiono AB, Lindsay SW, Wilson AL (2020). 
Risk factors for Plasmodium falciparum infection in pregnant women in Burkina 
Faso: a community-based malaria cross-sectional survey. Malaria Journal, 




Malaria in pregnancy remains a public health problem in sub-Saharan Africa. 
Identifying risk factors for malaria in pregnancy could assist in developing 
interventions to reduce the risk of malaria in Burkina Faso and other countries in 
the region. 
Methods  
Two cross-sectional surveys were carried out to measure Plasmodium falciparum 
infection using microscopy in pregnant women in Saponé Health District, central 
Burkina Faso. Data were collected on individual, household and environmental 
variables and their association with P. falciparum infection assessed using 
multivariate analysis.  
Results  
A total of 356 pregnant women were enrolled in the surveys, 174 during the dry 
season and 182 during the wet season.  The mean number of doses of 
sulphadoxine pyrimethamine for Intermittent Preventive Treatment in pregnancy 
(IPTp-SP) was 0.4 doses during the first trimester, 1.1 doses at the second and 
2.3 doses at the third. Each dose is composed by three tablets of 500mg of 
sulfadoxine and 25 mg of pyrimethamine. Overall prevalence of P. falciparum 
infection by microscopy was 15.7%, with 17.8% in the dry season and 13.7% in 
the wet season. 88.2% of pregnant women reported sleeping under an insecticide-
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treated net on the previous night. P. falciparum infection risk in pregnancy was 
reduced in those women who reported using an ITN (Odds ratio, OR=0.31, 95% 
CI 0.12-0.79, p=0.02) and an increasing number of IPTp-SP doses during 
pregnancy, with each additional dose reducing the odds by 40% (OR=0.59, 95% 
CI 0.43–0.81, p<0.001).   
Conclusion 
The prevalence of P. falciparum infection among pregnant women remains high in 
study area although use of IPTp-SP and ITNs were found to reduce the odds of 
infection. Despite this, compliance with IPTp remains far from that recommended 
by the National Malaria Control Programme and World Health Organization. 
Behaviour change communication should be improved to encourage compliance 




Malaria in pregnancy remains a major public health problem in sub-Saharan Africa 
[5], despite the decline in malaria transmission observed throughout the region 
from 2004-2015 [4]. Burkina Faso is a high burden country and is not experiencing 
yet declines in malaria and all-cause mortality in children despite high coverage of 
insecticide-treated nets (ITNs) and prompt and effective treatment with 
antimalarials [27].  
Pregnant women are at high risk from malaria because of their lowered immunity 
during pregnancy [17, 75]. They are also at increased risk of transmission since 
they are more attractive to Anopheles gambiae, the most important African malaria 
vector [76], and may leave the safety of their ITNs more often than their non-
pregnant counterparts [199]. Infection with Plasmodium falciparum can lead to 
poor outcomes for the mother, the foetus and child, resulting in maternal anaemia, 
low birth weight, preterm delivery and perinatal mortality [200-203]. Pregnant 
women, especially those pregnant for the first time (primigravidae), are at 
increased risk of more frequent and more severe malaria infections [86, 87, 89, 
204]. The World Health Organization (WHO) recommends the use of ITNs 
(distributed free-of-charge at Antenatal Clinic (ANC) visits), intermittent 
preventive treatment in pregnancy (IPTp) with sulphadoxine pyrimethamine (SP) 
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and prompt access to diagnosis and effective case management, to prevent and 
manage malaria risk in pregnancy [139]. According to national guidelines in 
Burkina Faso, pregnant women are advised to receive at least three doses of IPTp-
SP starting from the second trimester, with a minimum interval of one month 
between doses [25].   
The incidence of malaria infections in pregnant women in Burkina Faso in 2014 
was 39.2 per 1,000 women-months, and was more than twice as great in 
primigravids at 88.6 per 1,000 women-months than multigravids [89]. In 2014, 
another study in the country found that malaria infection was five-fold greater in 
primigravids than in multigravids [87]. There have been many studies of risk 
factors for malaria in pregnancy in sub-Saharan Africa, where increased risk was 
reported to be associated with younger age in pregnancy, primigravidae, first 
trimester of pregnancy infection, non-use of ITNs, lack of education and HIV co-
infection [86-89].  Few, however, have evaluated socioeconomic and 
environmental risk factors for malaria in pregnancy. For example, recently a 
number of studies have shown that malaria in children is associated with poor 
housing [102, 145, 205, 206], but it is not known whether this is also true for 
pregnant women.  The goal of the present study was to identify risk factors for P. 
falciparum infection in pregnancy in Burkina Faso, including potential 
socioeconomic and environmental risk factors. Identifying risk factors for malaria 
in pregnancy could assist in developing interventions to reduce this risk in Burkina 





Putative risk factors for P. falciparum infection were measured during two cross-
sectional surveys, one in the dry season and one in the wet season.  
Study site 
 
The study was conducted in Saponé Health District, situated in the central region 
of Burkina Faso, 30 Km south-west of Ouagadougou, the capital of Burkina Faso 
(Figure 5.1). In the study area, malaria transmission is intense and highly seasonal 
[115], with the peak of malaria transmission occurring at the end of the rainy 
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season (June to October) and markedly reduced transmission during the dry 
season (December to May) [136]. The main vectors are Anopheles gambiae s.s., 
An. arabiensis and An. funestus, and P. falciparum accounts for more than 95% of 
all malaria infections [115, 136, 207]. This is a rural area of open Sudanian 
savannah, where farming is dominant and the major crops grown are sorghum and 
millet. Houses in the study area are typically constructed with mud walls and floors, 
with thatched or metal roofs [23].  
Surveys 
 
Two cross-sectional surveys were carried out. One at the beginning of the dry 
season in December 2018 and the second one at the end of the rainy season from 
September to October 2019. Pregnant women were enrolled through a 
Demographic Health Surveillance System (DHSS), with home visits in 21 villages 
in the study area. All women of child-bearing age in the study area were identified 
and visited at home for pregnancy screening. This approach was adopted, rather 
than screening at the ANC because ANC attendance is relatively low in the study 
area, with only 35% of women attending the ANC at least three times [174]. 
Women thought to be pregnant were referred to the health facilities for a 
pregnancy test or, if willing to provide urine for a dipstick pregnancy test, 
fieldworkers performed the test at the woman’s home. Women identify as 
pregnant, but who had not visited their ANC, were referred to the local health 
facilities. At the ANC, the study protocol and procedures were explained by trained 
staff to the potential participants in French or the main local language of Moore. 
Pregnant women were enrolled if aged between 15-40 years, provided written 
informed consent and agreed with the study procedures, including taking of blood. 
Pregnant women with a known history of SP allergy or any other medical condition 
that in the opinion of a study physician may be a threat to her or the foetus were 








Clinical data collection 
 
All study participants completed a questionnaire at enrolment, where demographic 
data, medical and obstetrical history including previous ANC visits, IPTp doses and 
use of antimalarials or any other medication within 14 days prior to study 
enrolment were recorded. For each participant, thick and thin bloods films were 
performed from finger prick. Smears were air-dried, thin blood films were fixed 
with methanol and both stained with Giemsa 3%. Slides were then read using light 
microscope at ×100 (oil immersion objective). One hundred high-power fields 
(HPF) were examined, and the number of malaria parasites of each species and 
stage recorded. The number of parasites per microliter of blood was calculated 
assuming 20 white blood cells per high power field and a fixed white cell count of 
8000/μl. Each slide was read by two different lab technicians and if the difference 
between the two readers was more than 30%, the slide was reexamined by a third 
reader blinded to the results of the first two readers. The final result was the 
average of the two closest parasite counts. A slide was considered as negative if 
no parasite was found after 100 high-power fields (HPF) were examined. 
In case of fever (axillary temperature ≥37.5°C or reported fever in the last 24 h) 
or other symptoms/signs of clinical malaria, a rapid malaria diagnostic test (RDT) 
(SD BIOLINE Malaria Ag P.f/Pan, Abbott Laboratories, Illinois, USA) was 
performed. Subjects presenting with clinical malaria ( Fever+ RDT positive) were 
referred to the nearest health facility and treated according to national guidelines 
[25]. Clinical assessment was performed at home unless there was a specified need 
to check more about the health status of the volunteer. If this was the case, the 
woman was referred to the health facility to have deep clinical examination. 
Risk factor data collection 
 
Study participants were visited at home by fieldworkers who recorded information 
about the household, including whether the woman had slept under an ITN the 
previous night. If the answer was no, the reason why the woman did not use an 
ITN was recorded. Women sleeping under an ITN were asked about the bed net 
source and how many times they left their ITN during the night. ITN fabric integrity 
was also assessed by fieldworker observation and classified as entire/complete, 
with any hole, or torn. Women were asked to estimate the time they went to bed 
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and the time they get out of bed in the morning. Social and economic risk factors 
for malaria were recorded, including ethnicity, education level and occupation, 
ownership of a radio or mobile phone, estimated distance to the nearest health 
facility, and use of other protective measures, including mosquito coils, insecticide 
sprays, traditional spatial repellent or commercial topical repellents.  
 
House construction (metal or thatched roof, presence of open eaves, electricity 
supply( in sleeping room), household size (number of persons) and the presence 
of clothes hanging in the sleeping room were recorded. The presence or absence 
of big domestic animals (donkey, horses, sheep, cows, goats, dogs) and rubbish 




The sample size was estimated based on the sample size for frequency of the 
disease in a population (https://www.openepi.com/SampleSize/SSCohort.htm). 
To determine malaria parasite prevalence, we assumed a population prevalence of 
2.5% in the study area based on previous data of the frequency of malaria in 
pregnant women in the study area recorded in 2017 [19]. We assumed a 2% 
precision, with 5% level of significance and 95% confidence limits. Considering 
housing type as major risk factor (improved housing reduces risk of malaria 
prevalence by~50%, Odds ratio = 2) [85] and 10% non-response, a sample size 
of 175 pregnant women was considered necessary for each cross-sectional survey. 
 
Data management and statistical analysis   
 
Data were collected on Android personal digital assistants programmed using Open 
Data Kit (https://getodk.org/) and included drop down boxes and consistency 
checks to reduce data entry errors. Following cleaning, the dataset was locked and 
saved in Microsoft Access and analysed with Stata 15 (Statacorp, Texas, USA). 
The primary outcome measure was the prevalence of microscopically confirmed P. 
falciparum infection in pregnant women during each cross-sectional survey. 
Logistic regression was used to investigate the association between predictor 
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variables and the primary outcome, adjusting for clustering by village. The 
multivariable model was constructed using a forwards stepwise process and 
models were compared using a Wald test.  
Results 
 
A total of 356 pregnant women were enrolled in the surveys, 182 during the wet 
season and 174 during the dry season (Table 1). The mean age of the study 
participants was 26.9 years, ranging from 15 to 40 years old, and was similar in 
both surveys. Of these women, 78 (21.9%) were in their first pregnancy, 74 
(20.8%) in their second and 204 (57.3%) in their third pregnancy or more. Most 
women were enrolled in their second and third trimester of pregnancy (37.1% and 
30.3% of women where gestational age was recorded). Fewer were enrolled at 
their first trimester: only 5/78 (6.4%) of primigravidae, 11/74 (14.9%) of 
secundigravidae and 20/204 (9.8%) of multigravidae were enrolled in their first 
trimester of pregnancy. 59.0% of women were illiterate and most were farmers 
(69.9%) or traders (22.1%).  73.1% of primigravidae were literate compared to 
only 42.5% of those on their second pregnancy and 27.6% of women with two or 
more pregnancies. 97.5% of study participants were from the Mossi ethnic group. 
Most women lived in households with three or fewer people 57.9% (206/356). 
Only 46.3% of women reported having an electricity supply in the sleeping room. 
Most houses were constructed with metal roofs (95.5%) with 64.6% of houses 
having hanging clothes inside. Large domesticated animals were common near the 














Total n (%) 
N=356 
Age 
<20 11 (6.3%) 23 (12.6%) 34 (9.6%) 
20-30 101 (58.1%) 90 (49.5%) 191 (53.7%) 
30-45 62 (35.6%) 69 (37.9%) 131 (36.8%) 
Education 
Illiterate 107 (61.5%) 103 (56.6%) 210 (59.0%) 
Literate 65 (37.4%) 79 (43.4%) 144 (40.4%) 
Occupation 
Farmers 115 (66.1%) 134 (73.6%) 249 (69.9%) 
Traders 46 (26.4%) 33 (18.1%) 79 (22.1%) 
Other 11 (6.3%) 12 (6.6%) 23 (6.5%) 
Gravidity 
Primigravida 31 (17.8%) 47 (25.8%) 78 (21.9%) 
secundigravida 42 (24.1%) 32 (17.6%) 74 (20.8%) 
multigravida 101 (58.1%) 103 (56.6%) 204 (57.3%) 
Gestation 
1st trimester 19 (10.9%) 17 (9.3%) 36 (10.1%) 
2nd trimester 75 (43.1%) 57 (31.3%) 132 (37.1%) 
3rd trimester  61 (35.1%) 47 (25.8%) 108 (30.3%) 
Ethnic group 
Mossi 169 (97.1%) 178 (97.8%) 347 (97.5%) 
Fulani 4 (2.3%) 2 (1.1%) 6 (1.7%) 
Other 1 (0.6%) 2 (1.1%) 3 (0.8%) 
Roof material of 
sleeping room 
Metal 165 (94.8%) 175 (96.2%) 340 (95.5%) 
Non-metal 
(Thatch/mud) 
7 (4.0%) 6 (3.3%) 13 (3.7%) 
Eave status of 
sleeping room   
Closed * 30 (16.5%) - 
Open * 149 (81.9%) - 
Electricity supply in 
the sleeping room 
No  91 (52.3%) 87 (47.8%) 178 (50.0%) 
Yes 72 (41.4%) 93 (51.1%) 165 (46.3%) 
Presence of large 
domestic animals 
within 5 m of the 
household 
No  31 (17.8%) 37 (20.3%) 68 (19.1%) 
Yes 138 (79.3%) 143 (78.6%) 281 (78.9%) 
Presence of solid 
waste within 5 m of 
the household 
No 
90 (51.7%) 98 (53.8%) 188 (52.8%) 
Yes 79 (45.4%) 84 (46.2%) 163 (45.8%) 
Household size 
<1-3 92 (52.9%) 114 (62.6%) 206 (57.9%) 
4-5 68 (39.1%) 55 (30.2%) 123 (34.6%) 
≥6 8 (4.6%) 13 (7.1%) 21 (5.9%) 
Distance to health 
facility 
<3Km 100 (57.5%) 98 (53.9%) 198 (55.6%) 
3-5Km 42 (24.1%) 65 (35.7%) 107 (30.1%) 
>5Km 28 (16.1%) 19 (10.4%) 47 (13.2%) 
Hanging clothes in 
the sleeping room 
No  28 (16.1%) 92 (50.5%) 120 (33.7%) 
Yes  140 (80.5%) 90 (49.5%) 230 (64.6%) 
* missing data 
 
The overall prevalence of P. falciparum infection by microscopy was 15.7% 
(56/356), with 17.8% (31/174) during the dry seasonal survey and 13.7% 
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(25/182) in the wet season survey (p=0.3). The overall geometric mean of 
parasites density (GMPD) of infected pregnant women was 777.3/µl (95% CI= 
496.0-1218.2) (Table 2). GMPD was higher in the wet season (876.2/µl (95% CI= 
367.0– 2092.0)) than in the dry season (705.7/µl (95% CI= 444.8–1119.5)). 
GMPD was higher in women in their first pregnancy (1375.5/µl (95% CI= 720.5–
2626.1)) compare to those in their second pregnancy or more ((474.0/µl (95% 
CI= 260.1– 863.8)). GMPD was higher in women aged under 20 years old than 
older women, with a GMPD of 3374.7/µl (95% CI= 946.1- 12036.9) among women 
aged under 20 years, 633.5/µl (95% CI= 368.0-1090.7) among women aged 20-
30 and 552.0/µl (95% CI= 204.8-1487.5) among women aged 30 years or more.  
P. falciparum gametocytes carriage was found rare, 6/356 (1.7%) in the survey. 
Women had on average received 1.7 doses of IPTp-SP (95% CI= 1.5-1.8) with 
increasing number of doses according to the trimester of pregnancy (0.4, 1.1 and 
2.3 doses at first, second and third trimester of pregnancy, respectively). 
Secundigravidae were more likely to report taking no IPTp (25.7%) than 
primigravidae (7.7%) or multigravidae women (11.3%) (p=0.003). Women aged 
20-30 years were more likely to report taking no IPTp-SP (17.8%) than women 
aged under 20 (8.8%) or women aged over 30 years (8.4%) (p=0.003). There 
was no difference in the proportion of literate and illiterate pregnant women 
reporting not taking IPTp-SP in this study (p=0.8).  
A total of 95.1% of women reported using an ITN in the rainy season survey, 
compared to 81.5% in the dry season survey (p<0.001). 95.2% of women 
reported that the National Malaria Control Program provided their ITNs. The mean 
age of the ITN was 7.9 months (ranged 1 to 48 months) and 89.9% of them were 
reported to be un-holed. On average women self-reported an estimated time to 
bed of 20.21 h during the dry season and 20.13 h during the rainy season, and 
leave the bed at 05.29 h during the dry season and 5:39 h during the wet season. 
Only 4.5% of pregnant women reporting that they did not leave their ITN until the 
morning. However, 47.2% of them exited their ITN once or twice a night, and 
42.7% exited their ITN three or more times a night. Mosquito coils were used by 
19.4% of participants, 5.9% other types of spatial repellent (traditional repellents 
such as herbs or insecticide sprays) and 9.6% topical commercial repellents.   
Multivariable analysis showed that P. falciparum infection risk in pregnancy was 
reduced among pregnant women who used ITNs (Odds ratio, OR=0.31, 95% CI 
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0.12–0.79, p=0.02) and with use of IPTp-SP, with each additional dose reducing 
the odds by 40% (OR=0.59, 95% CI 0.43 – 0.81, p=0.001) (Table 5.3).   
Correlation of variables with others risk factors have been checked and the 
summary of the results has been completed in the corelation table 4 in appendix 
3 section. Age and gravidity are strongly associated with a reduction in the risk of 
malaria infection risk while IPTp doses and the gestation are strongly associated 
with an increased risk of malaria. 
 
Discussion 
This study aimed to identify risk factors for malaria infection in pregnant women 
living in an area of intense and stable seasonal malaria transmission in Burkina 
[115, 161, 208] with increased pyrethroid resistance in malaria vectors [92] and 
to identify risk factors for malaria infection. The overall prevalence of P. falciparum 
infection during both surveys was 15.7%. The parasite rates in this study are 
similar to those recorded in other studies in Burkina Faso (e.g. 18.1% [87]) and 
other high burden countries in sub-Saharan Africa e.g. 20.1% in Kenya [209] and 
21.6% in Ghana [210]. These results suggest that P. falciparum malaria infection 
is common in pregnant women in the community and the burden of P. falciparum 
infection in pregnancy remains high despite use of standard malaria control 
interventions. The overall geometric mean of parasites density in the study area 
was 777.3/µl (95% CI 496.0 – 1218.2). Fana and co-workers from Nigeria, another 
high burden country, recorded a similar mean parasite density of 800/µl [88]. The 
high parasite densities found in pregnant women results from their decreased 
immune competence [75, 211]. As expected, the parasite density was higher in 
primigravidae and secundigravidae compared to those women multigravide and in 
younger women compared to older women, since younger women are more likely 
to be primigravid. There was no significant difference in P. falciparum prevalence 
between the wet season (13.7%) and dry season (17.8%). This may be because 
we conducted the dry season survey in the early stages of the dry season when 
infections from the end of the rains may be present. Parasite density was, however, 
higher in the wet season compared to dry season, showing that even in this high 
burden area, malaria is seasonal in pregnancy [115].  P. falciparum gametocytes 
carriage in pregnancy in this study was lower (1.7%) and was detected by 
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microscopy. Lower parasites density may result in lower gametocytes identification 
by microscopy. Evidence of the dynamics of Plasmodium falciparum gametocyte 
carriage in pregnant women under IPT-SP in Benin matched with lower prevalence 




Table 5.2: Malariometric characteristics and use of personal protection according to season  
Variables Dry season N=174  Wet season N=182  
Primigravidity Secundigravidity Multigravidity Total Primigravidity Secundigravidity Multigravidity Total 
n=31 n=42 n=101  n=47 n=32 n=103  
P. falciparum infection  
Parasitaemia (any 
level) 
7 (22.6%) 10 (23.8%) 14 (13.9%) 31 
(17.8%) 




4 (12.9%) 2 (4.8%) 4 (4.0%) 10 
(5.7%) 




1435.7 (412.7 - 
4995.2) 
738.7 (276.0 - 
1976.8) 






2925.3 (421.0 - 
20325.6) 
Low number of 
observations 





Use of personal protective measures  
Access to ITN 23 (74.2%) 37 (88.1%) 93 (93.0%) 153 
(88.4%) 
41 (87.2%) 32 (100%) 99 (96.1%) 172 
(94.5%) 
Used an ITN the 
previous night 
21 (67.7%) 35 (83.3%) 85 (85.0%) 141 
(81.5%) 
42 (89.4%) 31 (96.9%) 100 (97.1%) 173 
(95.1%) 
Mosquito coils  8 (25.8%) 9 (21.4%) 24 (24.0%) 41 
(23.7%) 




1 (3.2%) 0 5 (5.0%) 6 
(3.5%) 




3 (9.7%) 5 (11.9%) 9 (9.0%) 17 
(9.8%) 
8 (17.0%) 1 (3.1%) 8 (7.8%) 17 
(9.4%) 
0 dose of IPTp-SP 
use during 
pregnancy 
6 (19.4%) 15 (35.7%) 16 (15.8%) 37 
(21.3%) 
0 4 (12.5%) 7 (6.8%) 11 
(6.0%) 
1 dose of IPTp-SP 
use during 
pregnancy 
9 (29.0%) 8 (19.0%) 35 (34.7%) 52 
(29.9%) 
11 (23.4%) 8 (25.0%) 28 (27.2%) 47 
(25.8%) 
2 doses of IPTp-SP 
use during 
pregnancy 
7 (22.6%) 4 (9.5%) 23 (22.8%) 34 
(19.5%) 




3 or more doses of 
IPTp-SP use during 
pregnancy 
5 (16.1%) 8 (19.0%) 12 (11.9%) 25 
(14.4%) 
20 (42.6%) 6 (18.8%) 21 (20.4%) 47 
(25.8%) 
Mean IPTp dose 
(SD) 
1.4 (1.0-1.8) 1.3 (0.8-1.7) 1.4 (1.2-1.6) 1.4 
(1.2-
1.6) 
2.2 (1.9-2.5) 1.8 (1.3-2.3) 1.8 (1.6-2.1) 1.9 
(1.8-
2.1) 
Use of antimalarial 
drug two weeks 
before the survey  
3 (10.7%) 6 (15.0%) 18 (18.4%) 27 
(16.3%) 


















Table 5.3: Risk factors for P. falciparum infection in pregnant women in Saponé Health District 
 Factors P. falciparum 
infection positivity  
n/N (%) 
 N=356  







95% CI p-value  
Pregnancy characteristics 
Gestation 1st trimester   10/48 (20.8%)  1 
     
2nd trimester 34/132 (25.8%) 1.32 0.90 - 1.94 0.16    
3rd trimester  7/108 (6.5%) 0.26 0.12-0.58 0.001    
Gravidity Primigravidae 14/78 (17.9%) 1      
Secundigravidae 12/74 (16.2%) 0.88 0.48 – 1.64 0.70    
Multigravidae 30/204 (14.7%) 0.79 0.41 – 1.50 0.47 
   
Socio-demographic characteristics 
Mean age (years)  - 0.98 0.94-1.02     
Education No formal education 24/210 (11.4%) 1 
     
Literate 31/144 (21.5%) 2.13 1.29 - 3.52 0.003       
Occupation Farmers  34/249 (13.7%) 1 
     
Traders 15/79 (19.0%) 1.48 0.75 - 2.93 0.26       
Other 6/23 (26.1%) 2.23 0.72 – 6.90 0.16       
Use of personal protective measures 
ITN use the previous 
night 
No 12/41 (29.3%) 1     1     
Yes 43/314 (13.7%) 0.38 0.18 - 0.81 0.01 0.31 0.12 – 0.79 0.02 
Number of IPTp-SP doses  - 0.57 0.41 – 0.80 0.001 0.59 0.43 – 0.81 0.001 
Number of IPTp-SP doses 0 13/48 (27.1%) 1           
1 or more 43/307 (14.0%) 0.44 0.17 – 1.15 0.09 
   
Mosquito coils No 46/286 (16.1%) 1      
Yes  9 /69 (13.0%) 0.78 0.48 - 1.29 0.33       
Other spatial repellent No 54/335 (16.1%) 1 
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Yes 2/21 (9.5%) 0.55 0.09 – 3.53 0.53       
Commercial repellent 
(topical) 
No 51/320 (15.9%) 1      
Yes 4/34 (11.8%) 0.70 0.24 – 2.04 0.52    
Distance to nearest 
health centre 
<3km 26/198 (13.1%) 1      
3-5km 19/107 (17.8%) 1.43 0.73 – 2.78 0.30    
>5km 10/47 (21.3%) 1.79 0.66 – 4.83 0.25    
Use of antimalarial drug 
during the last two week 
before the survey 
No 48/302 (15.9%) 1      
Yes 5/46 (10.9%) 0.65 0.32 – 1.31 0.23    
House characteristics and construction 
Household size <4 31/206 (15.0%) 1        
4≤no.<6 20/123 (16.3%) 1.10 0.58 - 2.07 0.78    
≥6 4/21 (19.0%) 1.33 0.36 - 4.91 0.67    
Roof material of sleeping 
room 
Metal 52/340 (15.3%) 1 
     
Thatch or mud 3/13 (23.1%) 1.66 0.62 - 4.42 0.31       
Electricity supply in 
sleeping room 
No 33/178 (18.5%) 1      
Yes 21/165 (12.7%) 0.64 0.37 – 1.11 0.11    
Clothes hanging in 
sleeping room 
No 16/120 (13.3%) 1      




   
      
Own a radio No 24/127 (18.9%) 1      
Yes 31/224 (13.8%) 0.74 0.42 – 1.30 0.29    
Own a mobile phone No 8/56 (14.3%) 1      
Yes 47/295 (15.9%) 1.14 0.62 – 2.09 0.68    
Environmental factors 
     
      
Season enrolled Dry season 31/174 (17.8%) 1      
Rainy season 25/182 (13.7%) 0.73 0.41 - 1.31 0.30    
Presence of large 
domestic animals within 
5 m of the household 
No 10/68 (14.7%) 1      
Yes 45/281 (16.0%) 1.11 0.48 – 2.55 0.81    
Presence of solid waste 
within 5 m of the 
household 
No 30/188 (16.0%) 1 
     
Yes 24/163 (14.7%) 0.91 0.50 – 1.64 0.75    
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between the wet season (13.7%) and dry season (17.8%). This may be because 
we conducted the dry season survey in the early stages of the dry season when 
infections from the end of the rains may be present. Parasite density was, 
however, higher in the wet season compared to dry season, showing that even in 
this high burden area, malaria is seasonal in pregnancy [115].  P. falciparum 
gametocytes carriage in pregnancy in this study was lower (1.7%) and was 
detected by microscopy. Lower parasites density may result in lower gametocytes 
identification by microscopy. Evidence of the dynamics of Plasmodium falciparum 
gametocyte carriage in pregnant women under IPT-SP in Benin matched with 
lower prevalence of gametocytes [212].  
Overall, 91.3% of pregnant women owned an ITN, with 88.2% reporting using an 
ITN the night before the survey. This is similar to other surveys from Burkina Faso; 
in the Banfora Region, 80.6 % of surveyed children reported sleeping under an 
ITN the previous night [145]. The high reported ITN use is encouraging, although 
accurately determining net use is challenging and reporting can be susceptible to 
response bias [129, 213, 214].  
The study found that IPTp-SP and ITNs are highly effective interventions for 
preventing malaria infection during pregnancy. For each additional dose of IPTp 
reported as being received by women, the odds of malaria infection fell by 40%. 
Relatively few women, however, took three or more doses of IPTp-SP (20.2%) 
which is recommended by the NMCP and WHO [5, 25]. We also found lower use 
of IPTp-SP among women aged 20-30 compared to other age groups and among 
secundigravidae compared to other women. This suggests that women in their 
second pregnancy may be more compliant with ANC attendance and malaria 
prevention than women in their first pregnancy or later pregnancies. This finding 
contrasts with another study in Burkina Faso that found compliance with IPTp-SP 
in adolescent women to be more problematic due to structural constraints (e.g. 
social position and household labour requirements) and needs (e.g. anonymity in 
the health encounter) [215]. Numbers of secundigravidae women were relatively 
small and so this finding requires further exploration.  
ITNs associated with 69% reduction in the odds of P. falciparum infection, which 
is higher than other studies have found [216]. This indicates that ITNs are 
protective against malaria in pregnancy despite high levels of insecticide 
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resistance present in Burkina Faso [92, 217-220]. This contrasts with findings 
from a cohort study in children aged 5-15 years in south-west Burkina Faso  which 
showed no difference in malaria risk between ITN users and non-users [145], and 
in all age in a community-wide survey in Banfora region (Yaro, J.B. et al., 
Unpublished).  
Women reported going to bed at 20.21 h during the dry season and 20.13 h during 
the rainy season. This finding contrasts with a study by Guglielmo and co-workers 
who reported that 100% of females in south-west Burkina Faso (sample of 211 
and 695 females observed in two villages) were outdoors until 22.00 h, after which 
point women started to move indoors to bed [146]. It may be that pregnant 
women tend to go to bed earlier and so those using ITNs are more likely to be 
protected from vectors biting during the early evening which has been observed 
in Burkina Faso [146]. Increased malaria risk in Human including pregnant women 
who go to bed later has been observed in other studies in sub-Saharan Africa 
[154, 188, 221]. 
Our study has a number of limitations. Firstly, the sample size was probably not 
large enough to identify minor risk factors in this study and future investigations 
may help improve the sample power. Secondly, ITN ownership and use was self-
reported and subject to social desirability bias and we lack objective tools for 
measuring bednet use in this study. Microscopy technology used for Plasmodium 
falciparum diagnosis may underestimate the real community prevalence of 
parasite level. Future bio-molecular technology may be useful for undetectable 
asexual and sexual parasite fractions [3, 222]. 
What are the implications of this research for control of malaria in pregnancy in 
Burkina Faso? Behaviour change communication is necessary to ensure high ANC 
attendance and compliance with IPTp-SP and ITN use.  Messages need to be 
tailored to the different vulnerable groups of women. For example, we found lower 
IPTp-SP compliance among women aged 20-30 than the other age groups. As it 
this common in sub-Saharan Africa, pregnant women are often unaware that they 
are pregnant and so do not attend or are unwilling to attend an ANC in the early 
stages of pregnancy. An association between early ANC attendance and a higher 
average number of IPTp-SP doses has been demonstrated in several studies [223-
225]. One option to increase IPTp-SP coverage is community delivery by 
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community health workers, rather than ANC. This delivery route has been shown 
in a clinical trial in Burkina Faso to increase IPTp-SP compliance from 2.1 to 2.8 
doses in the community delivery study arm with no apparent decrease in ANC 
attendance [226]. Also, evidence of a community-based multicentre cluster-
randomized controlled trial from The Gambia, Burkina Faso and Benin reported a 
lower risk of placenta malaria, anaemia at delivery, and low birth weight 
associated with increasing number of IPTp-SP doses given during pregnancy and 
recommend this as a priority of strategies for malaria control in pregnancy [227]. 
Conclusion  
 
The prevalence of P. falciparum infection among pregnant women remained high 
despite wide deployment of ITNs, access to IPTp-SP and prompt and effective 
treatment with ACTs. Nonetheless, women who took IPTp-SP and use ITNs during 
their pregnancy were at much reduced risk of being infected by malaria. These 
findings suggest that IPTp-SP and ITNs use are effective at reducing malaria 
infection in pregnant women living in malaria high burden countries, but that 
research is needed to increase uptake of IPTp-SP use.  
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Overview and summary of findings 
 
The goal of this thesis was to determine risk factors associated with malaria 
infection and transmission in rural Burkina Faso, a high burden, persistent malaria 
infection and high insecticide resistance area, in children, all ages and pregnant 
women. Identification of the drivers which impede disease control may help guide 
malaria control strategies in Burkina Faso as well as sub-Saharan African 
countries.    
 
Chapter 1 summarises the background and literature review on malaria burden 
in the world, in sub-Saharan Africa and Burkina Faso. It was about the 
mechanisms of disease transmission including all major factors involve the 
physiopathology: environment factors with temperature, rainfall, humidity, 
vectors and human behaviours; malaria parasites and the high antigenic diversity 
of Plasmodium falciparum; human host factors affecting an individual’s 
susceptibility to malaria. This chapter also displays the research hypothesis and 
the study outcomes after the study methodology for data collection, analysis and 
scope.  
Despite enormous progress in malaria control since the turn of the millennium, 
substantial worries persist in malaria cases in the WHO Region of Africa [5]. The 
World Malaria Report in 2020 recorded that the gains achieved between 2000 and 
2015 have levelled off over recent years. The global trends in malaria incidence 
rate (cases per 1000 population at risk) stalled from 2015 to 2019 [5]. From the 
same report, 29 countries accounted for 95% of malaria cases globally in the 
world, with Nigeria (27%), the Democratic Republic of the Congo (12%), Uganda 
(5%), Mozambique (4%) and Burkina Faso (3%) accounted for about 51% of all 
cases globally [5]. The eleven countries including Burkina Faso are on track to 
keep focus on the first wave of the approach to high impact malaria control 
following World Health Organization and Roll Back Malaria partnership to end 
malaria guiding principles [83]. The latest evidence from Burkina Faso is that 
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malaria was increasing in the general population and in the two most vulnerable 
groups: children less than five years old and pregnant women (Figure 1.6) from 
2000 to 2018. There were 7,859,000 malaria cases reported 2019, slightly fewer 
than 7,875,575 cases in 2018. However, the accuracy of the statistics collected in 
2019 have been challenged because of the long and persistent strikes of health 
workers and from occasional terrorism, so that sometimes record data in 2019 
was a repeat data of 2018. Has malaria control in Burkina Faso stalled? 
Worryingly, malaria was still the main reason for medical consultation (41.3%), 
hospitalization (21.4%) and death (16.4%) in public health centres in Burkina 
Faso in 2018 [174]. Malaria incidence in Burkina Faso is highly seasonal with about 
60% of cases occurring within the 4 months from June to September [21]. The 
malaria incidence rate is 7.6 per 1000 child days [22] and Plasmodium infection 
prevalence in children was 57.5% in the country in 2017 [23]. A total of 8.4 million 
ITNs were deployed in 2010 and a further 10.5 million in 2013 resulting in 
approximately 90% of households owning at least one ITN [26]. More recently, 
deployment of an additional 10.3 million ITN in 2016 and 12 million in 2019 raised 
the global coverage rate of households to 85% (https://www.afro.who.int/fr/news/lutte-
contre-le-paludisme-au-burkina-faso-campagne-de-distribution-de-12-millions-de-milda-aux). 
Despite this huge investment in ITN coverage, Burkina Faso is still one of the few 
countries not to have shown a significant association between ITN ownership and 
a reduction in child mortality [27, 28]. This situation is surprising since elsewhere, 
ITN use have been shown to reduce clinical incidence by > 50% in areas of stable 
malaria [29].  
To elucidate the numerous factors that influence malaria transmission dynamics 
in this study area, this thesis challenges was to look for effective control packages 
of interventions for this specific epidemiological pattern that could help for malaria 
control in Burkina Faso and all others endemic sub-Saharan countries. 
 
Chapter 2 summarises the malaria incidence of P. falciparum in children aged five 
to 15 years old, the entomological inoculation rate (EIR), the use of ITNs, the main 
malaria vector (Anopheles gambiae) resistance to insecticide, the ITNs used 




In fact, in this study area, malaria infection incidence remains overwhelmingly 
high. During the six-month follow-up period, covering the high malaria 
transmission season in the study site, the overall incidence of P. falciparum 
infection, was 2.78 episodes per child (95% CI= 2.66-2.91) by microscopy, and 
3.11 (95% CI= 2.95-3.28) by PCR. The entomological inoculation rate (EIR) was 
80.4 infective bites per child over the six-month malaria transmission season. 
However, a high level of 80.6% of children were reported as sleeping under an 
ITN the previous night, although at the last survey, 23.3% of their nets were in 
poor condition and considered no longer protective. We do not find an association 
between the rate of P. falciparum infection and either EIR (Incidence Rate Ratio, 
IRR: 1.00, 95% CI: 1.00 –1.00, p=0.08) or mortality in WHO tube tests when 
vectors were exposed to 0.05% deltamethrin (IRR: 1.05, 95% CI: 0.73–1.50, 
p=0.79). The significant association was only found with the travel history of child 
out of the study area during the survey (IRR: 1.52, 95% CI: 1.45–1.59, p<0.001) 
and the increasing socio-economic status of the child caregivers were associated 
with an increased risk of P. falciparum infection (IRR: 1.05, 95% CI: 1.00–1.11, 
p=0.04). These study findings suggest that because of the exceptionally high 
levels of malaria transmission in the study area, malaria elimination cannot be 
achieved solely by mass deployment of ITNs and additional control measures are 
needed. 
 
Chapter 3 aimed to identify the prevalence of P. falciparum infection in all age 
strata in the study community-based screening and the risk factors for P. 
falciparum infection in rural Burkina Faso that might be used to identify and target 
malaria control measures in this area of high burden, persistent malaria infection 
and high insecticide resistance as well in all high burden malaria countries in sub-
Saharan. 
In this survey findings, malaria infections were high in all age strata, although 
highest in children aged 5 to 15 years, despite universal coverage with ITNs and 
prompt and effective treatment with antimalarials. The overall P. falciparum 
prevalence detected by microscopy was 32.8%, with 41.9% of children aged 2 to 
<10 years old, 40.6% in 10 to <30 years old and 16.1% of those > 30 years old 
infected. Symptomatic malaria cases were found represented 2.7% in the entire 
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study population and 3.3% had high density P. falciparum parasitaemia (>5,000 
parasites/µL). Children aged between 5 and 15 years were the group at highest 
risk of P. falciparum infection in the community. Those aged 5 to <10 years old 
were at 3.8 times the odds (95% CI= 2.4–6.0, p<0.001) and those aged 10 to 15 
years old at 4.3 times the odds (95% CI= 2.6 – 7.1, p<0.001) of P. falciparum 
infection compared to children aged less than 5 years old.  Literacy was associated 
with increased risk of P. falciparum infection (OR=1.71, 95% CI= 1.26 – 2.32, 
p<0.001). However, there was a weak association between use of an electric fan 
(OR=0.55, 95% CI= 0.31 – 0.99, p=0.05) and female gender (OR=0.77, 95% 
CI=0.58-1.02, 0.07) and decreased risk of P. falciparum infection. 1142 (95.2%) 
of respondents reported having access to a bednet, with 1,087 (90.7%) saying 
they slept under a bednet the previous night of the survey. 9.2% of the population 
reported using a topical repellent in the last week, whether commercial or 
traditional. Only 6.2% of the study population reported using insecticide aerosols, 
mosquito coils or other spatial repellents.  
Our study findings imply that current national strategies for malaria control in 
Burkina Faso are not sufficient to eliminate the disease. The high prevalence of 
P. falciparum infection in children aged 5 to 15 years suggests that an extension 
of the age group eligible for SMC may be able to reduce malaria burden 
substantially.  
 
Chapter 4 aimed to identify the risk factors associated with house entry of An. 
gambiae s.l. in rural Burkina Faso, an area of high burden, persistent malaria 
infection and high insecticide resistance. This study demonstrated that there were 
fewer An. gambiae s.l. in homes with electricity (incidence rate ratio, IRR = 0.4, 
95% CI = 0.3–0.7, p = 0.001) and houses with metal roofs (IRR, = 0.6, 95% CI 
= 0.4–1.0, p = 0.034) than those that did not. In fact, there are some implications 
of the study findings for vector control and future research. The increased access 
to electricity in sub-Saharan Africa raises questions about the impact on vector 
behaviours (e.g. whether lights attract mosquitoes or leads to mosquito avoidance 
behaviour), human behaviour (e.g. alteration of time to bed or use of fans) and 
malaria risk which are complex and yet to be understood. The risk factor study 
also highlights the potential of improved housing to reduce malaria transmission 
and supports the results of systematic and multi-country research studies on this 
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topic. Well-lit and well-built houses with metal roofs may reduce entry of malaria 
mosquitoes compared to poorly lit, poorly built and thatched roofed houses. While 
other vector control tools such as dual-active ITNs are now being deployed in the 
study area, the study results highlight the importance of non-insecticidal 
interventions such as house improvement to increase long-term resilience against 
malaria and for insecticide resistance management.  
 
Chapter 5 was aimed to assess the prevalence of P. falciparum in pregnancy in 
both the wet and dry seasons, the compliance of pregnant women to intermittent 
preventive treatment in pregnancy (IPTp), the use of ITNs in pregnancy, pregnant 
women behaviour at night time and the risk associated with P. falciparum infection 
for pregnant women in Burkina Faso, an area of high burden, persistent malaria 
infection and high insecticide resistance. Overall compliance with IPTp was two 
mean doses during the survey with increasing doses during pregnancy (0.4, 1.1 
and 2.3 doses respectively at first, second and third trimester of pregnancy). The 
overall prevalence of P. falciparum infection by microscopy was 56/356 (15.7%), 
with 31/174 (17.8%) and 25/182 (13.7%) respectively in dry and wet season. 
Primigravidae and secundigravidae have carried 54.8% of P. falciparum infection 
in dry season and 36.0% in wet season. In the previous night of the survey, 88.5% 
of pregnant women reported they slept under an insecticide-treated net (ITN). 
During the night, 47.2% of pregnant women reported getting out of their ITN one 
or two times, while 42.7% did it more than two time a night. P. falciparum 
infection risk in pregnancy was reduced in those women who reported using an 
ITN (Odds ratio, OR=0.31, 95% CI 0.12-0.79, p=0.02) and an increasing number 
of IPTp-SP doses during pregnancy, with each additional dose reducing the odds 
by 40% (OR=0.59, 95% CI 0.43–0.81, p<0.001).   
This study findings highlight persistent high prevalence of P. falciparum infection 
among pregnant women in study area although use of IPTp-SP and ITNs were 
found to reduce the odds of infection. Despite this, compliance with IPTp remains 
far from that recommended by the National Malaria Control Programme and WHO. 
Behaviour change communication should be improved to encourage compliance 







Table 6.1: Summary of significant risk factors for P. falciparum infection 
in this study. Where RR= risk ratio and OR= odds ratio. 















children aged 5 
to 15 years old 
SES factor score  
1 unit increase 
RR : 1.05 1.00 - 1.11 0.04 
Travel history during the 
study period 
RR : 1.52 1.45 - 1.52 <0.001 
Malaria 










OR : 1.71 
 
1.26 - 2.32 
 
0.001 
sleeping room of subject 
have a functioning fan 
OR : 0.55 0.31 - 0.99 0.05 





five to 15 years 
old 
Metal roof materials of child 
sleeping room 
RR : 0.6 0.4 - 1.0 0.03 
Electricity supply for child 
sleeping room 









15 to 40 years 
old 
ITN use OR : 0.31 0.12 – 0.79 0.02 
Use of IPTp-SP doses  
1 dose increased 
OR : 0.59 0.43 – 0.81 0.001 
 
Table 6.1 summarizes significant risk factors associated with malaria infection and 
transmission in the study.  
The assessment of socio-demographic, entomological and environmental risk 
factors for P. falciparum infection did not elucidate any strong associations. This 
may be because of the huge force of infection in the study area which meant that 
all the children were at extremely high and persistent risk of infection. The finding 
of higher SES factor score was associated with higher incidence of P. falciparum 
infection was unexpected since it is widely reported that the least poor children 
are typically at lower malaria risk than the most poor children [67]. Quintiles were 
used to allocate children into categories, while the factor score was better reflected 
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the range of values in the dataset has been used in the multivariable model. P. 
falciparum infection rates may be higher in the least poor children due to lower 
ITN use than the most poor children. For example, only 53.2% of the least poor 
children were reported to use an ITN the previous night compared to over 82.6% 
of children in the lowest quintile (most poor).  Nevertheless, ITN use was only 
associated with protection against malaria infection in pregnant women. Additional 
ITN is attributed free of charge to pregnant women during their ANC visits by the 
Ministry of Health. This second attribution of ITN is usually considered by pregnant 
women as their own comparatively to the national campaign one which was 
considered for the whole family. During the ANC visits, health workers sensitized 
pregnant women to use their ITN. This innovative strategy of additional free of 
charge ITN in pregnancy maybe introduce in children by planning for a school net 
additional programme through primary schools net distribution associated with 
health workers and teachers actions of children sensitization for these ITN use. 
Similar evidence has been implemented with proven for feasibility and effective 
strategy of household ITN high coverage in Tanzania [228]. 
However, the increased access to electricity highlight the questions about the 
impact on vector behaviour (e.g. whether lights attract mosquitoes or leads to 
mosquito avoidance behaviour), human behaviour (e.g. alteration of time to bed 
or use of fans) and malaria risk which are complex and yet involved confounders 
and need to be understand. Our study found that child sleeping in houses with 
metal roofs reduce mosquito house entry. However, metal roof houses are more 
likely to have floors and walls made of finished materials and have electricity 
supply with sometime electric fan supply than thatched-roofed houses. Although, 
higher SES is associated with owning or living in improve housing conditions with 
better commodities supply (well house construct with metal roof materials, 
electricity supply, electric fan supply, television owner, etc). Future research is 
needed clear state about benefits of electricity in improving housing conditions 
regarding the risk of malaria infection and transmission.   
Study limitations 
 
This study has several limitations. Firstly, and most importantly, the study 
methodologies (cohort study and cross-sectional surveys) used to assess risk 
factors were subject to bias and confounders that could reduce the quality of study 
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results during the surveys [229-231]. Risk factors assessed in our study did not 
mean causality and the reported associations highlight the possible interaction 
between factors assessed and malaria vectors or P. falciparum infection. The 
associations reported may be influenced by both the dependent variable (malaria 
infection) and independent variables (risk factors assessed). I’d try to reduce 
confounders by randomly selected subject in cohort study in children (chapter 
two) and in the community-wide cross-sectional study (chapter three). Selection 
bias with the study participants’ selection has been fairly good enough managed 
in chapter two, chapter three and chapter four, where study participants’ were 
randomly selected after study villages’ random selection from demographic and 
health surveillance system (DHSS) of Banfora Health District. In chapter 5, we 
also selected our study participants’ based on the DHSS from Sapone Health 
District, however, pregnant women recruitment was community-based and the 
sample may not be representative of the larger community because pregnant 
women were not randomly selected regarding their women age or parity, 
gestational age nor household locations. All the studies suffered from recall bias, 
where the age of the ITNs may be imprecise. While caregivers reported high 
compliance with ITN use in their children, assessing ITN use is notoriously difficult 
to assess and this may have impacted on our ability to identify this as an important 
risk factor in all age in community or more specifically in children. Indeed, social 
desirability bias and other forms of error mean that surveys are likely to 
substantially overestimate use [130], and we lack objective and unobtrusive tools 
to measure ITN compliance.  
Secondly, the cohort study in chapter two was probably underpowered to detect 
small risk factors in children. The sample size calculation assumed 50% prevalence 
of risk factors in the study population aged five to 15 years old in cohort study, 
while the study children were, in reality relatively homogeneous with regards to 
risk factors shown to be important in other studies, for example, housing 
construction. Risk for mosquitoes’ house entry study was a nested study in the 
cohort study in children. The sample size was probably not large enough to identify 
minor risk factors. The risk in pregnant women study was deduced from a research 
protocol on pregnant women. Our study was a cross sectional and the sample size 
was not sufficiently large to detect all the small risk factors, but sufficient to carry 
out the survey.  
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Thirdly, I was unable to collect the real information about ITN used by study 
participants in all studies. Information’s used to assess ITN ownership and use 
was collected by fieldworkers based on the questionnaire. This may subject to 
social desirability bias with lack objective tools for measuring bednet use in this 
work [129, 232, 233].  However, ITN use assessment was associated with P. 
falciparum infection reduce in only pregnant women target group. Do the 
additional ITN provided to pregnant women during their ANC visits may have 
impacted on our ability to identify it was an important risk factor. Future 
exploration for better understanding is needed.  
Fourthly, we did not obtain PCR results for parasites real estimates and so were 
not able to evaluate sub-microscopic infections in the community-wide in chapter 
three. We miss to assess the community-wide disease level and rising up the need 
for increase laboratory training and supervision to avoid errors in future studies, 
at community all age level.  
 
Future direction and wider applicability of this research 
 
Burkina Faso is one of eleven sub-Saharan African countries designated as a High 
Burden High Impact country with a response plan including increased political will, 
strategic use of data to deploy tools for maximum impact and a multi-sectoral 
approach [83]. While this study generates useful data on malaria burden in 
Banfora District, it is clear that additional tools will be needed to reduce the disease 
burden. Dual-active ITNs (pyrethroid plus piperonyl butoxide or pyrethroid plus 
chlofenapyr) are now being deployed in the study area. PBO-pyrethroid ITNs have 
been shown to be more effective in reducing malaria than pyrethroid only ITNs in 
areas of pyrethroid-resistant vectors [130], and monitoring of the effectiveness of 
these dual active ITNs is ongoing in Burkina Faso [234]. IRS should also be 
considered as it has been shown to be effective in reducing malaria in other high 
burden countries [235]. In an area of Uganda with an EIR of 176 infective 
bites/year, three rounds of IRS with the carbamate insecticide, bendiocarb, every 
six months reduced malaria incidence from 3.3 episodes to 0.6 episodes per 
person year [132]. But even this effective combination of interventions is 
insufficient to eliminate malaria so further interventions are required. SMC is 
currently being used in 12 sub-Sahelian countries including Burkina Faso in 
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children up to five years of age, with a protective efficacy of over 50% against 
parasitaemia in Burkina Faso [133, 236]. A recent trial in Senegal found similarly 
high reductions in malaria when SMC was used in children aged under five years 
and in children aged five to nine years [134]. Expanding the age range eligible for 
SMC up to 15 years old could therefore be effective in reducing malaria further in 
Burkina Faso. Burkina Faso is also the site of pilot testing of gene drive mosquitoes 
which, if effective and acceptable, could constitute another option for malaria 
control in Burkina Faso [237]. 
 
Recommendations for malaria control in Burkina Faso forward into policy 
and practice for others high burden, persistent malaria infection and high 
insecticide resistance sub-Saharan Africa 
 
The study found predominantly high and persistent levels of malaria transmission 
in Burkina Faso despite the large coverage of ITN, and the risk factor survey did 
not identify much risk factors for further investigation to reduce the malaria 
burden in this high burden country. This lack of impact of ITN may be due to the 
intense level of transmission of malaria during the high transmission season. The 
lack of association with EIR and vector density was also surprising, but could arise 
if vector densities in all villages were sufficiently high to maintain high 
transmission, or due to outdoor biting associated human extended night time 
activities. Despite the high levels of pyrethroid resistance in the study area, no 
malaria vectors were found under the children’s ITN after more than 1000 
searches [145]. This would imply that the nets are still providing some level of 
personal protection.  
The findings have implications for achievement of the ambitious goals set out in 
the WHO Global Technical Strategy. Malaria control in this area of intense seasonal 
transmission and subject of increased insecticide resistance cannot be achieved 
solely by massive ITN deployment. Additional strategy of intervention are needed 
though the use of additional interventions including dual-active ITNs and IRS with 
non-pyrethroid insecticides, extension of SMC in children under five years to 
school-age children, those aged five to 15 years old, promotion of ITN use in 
school-age children and pregnancy and specifically communication for IPTp-SP use 
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in pregnancy, and housing condition improvement such as well constructed house 
with metal roof, windows screen and electricity supply as well electric fan. 
SMC use could be extended to children aged 5 to 15 year old, to help reduce 
malaria burden in community. This school-age children should be a new group age 
of interest in the community regarding malaria control. 
Conclusion 
 
The study found overwhelmingly high levels of malaria transmission in study area 
highlighting Burkina Faso as high burden of high and persistent insecticide 
resistance area despite the best available treatment, particularly for P. falciparum 
malaria, artemisinin-based combination therapy (ACT) and sulfadoxine-
pyrimethamine (SP) for intermittent preventive treatment in pregnancy since 
2006, the massive ITN deployments since 2010 and the use of seasonal malaria 
chemoprevention in children since 2016. School-age children age five to 15 years 
old are more at risk (three to four times increase) compare to other age group in 
the community. Higher SES children, those who travelled out of the study area 
during the survey and people literates were more at risk for P. falciparum infection. 
There was evidence of lack of impact of ITN universal coverage in children in 
Burkina Faso and insecticide resistance spreading throughout study sites in 
Banfora. However, well-lit house with metal roof materials, electricity supply, as 
well electric fan are associated with fewer mosquitoes’ in houses. Also, IPTp-SP 
and ITNs use are effective at reducing malaria infection in pregnant women living 
in malaria high burden countries, even research is needed to increase uptake of 
IPTp-SP use.  Our findings have implications for achievement of the ambitious 
goals set out in the WHO Global Technical Strategy for malaria 2016 – 2030 [10] 
will not be achieved with solely massive ITN deployments and other additional 
strategy is needed. Even risk factors assessment doesn’t mean causality, major 
risk associations highlight potential contribution for malaria control. Evidences that 
additional interventions to contribute to accelerate malaria control in Burkina and 
other high burden countries may be oriented on research questions which need to 
answer as well ITN real use, SMC extension in school-age children impact on P. 
falciparum prevalence in community, electricity real benefit in the context of 
country development, house contribution with the types of structured house which 
would be effectiveness for malaria control in Burkina Faso and other high burden 
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countries in sub-Saharan Africa. Because education of young people was strongly 
associated with malaria infection risk, Burkina Faso Government may take account 
people education in the disease control strategies to impact significantly 
mosquitoes’ abundance and the infection risk reduce. The onset of Coronavirus 
disease (COVID-19) pandemic bring new challenges for fragile health systems and 
strong, adequate and preventive actions should be implemented to deal with the 
emergency and avoid a setback in the fight against malaria. Robust political 
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Appendix 1.  









Artemether - lumefantrine 
indication Sulfadoxine, a sulphur 
medicine, and pyrimethamine 
combination is used to treat 
malaria (uncomplicated 
malaria).  
This medicine may also be 
used to prevent malaria in 
people who are living in, or 
will be traveling to, an area 
where there is a chance of 
getting malaria. 
Artemether - lumefantrine 
combination is an antimalarial 
used to treat acute, 
uncomplicated malaria 
infections due to Plasmodium 
falciparum in patients of 5 kg 
bodyweight and above. 
It is not typically used to 
prevent malaria or treat severe 
malaria.   
It’s an effective and well-
tolerated malaria treatment, 
providing high cure rates even 
in areas of multi-drug 
resistance. It has been shown 
to be effective in geographical 
regions where resistance to 
chloroquine has been reported. 
Mode of action Pyrimethamine is an 
antiparasitic drug. It prevents 
the growth and reproduction 
of parasites. Sulfadoxine is a 
sulfa drug that fights bacteria 
in the body. The combination 
of pyrimethamine and 
sulfadoxine is used to treat 




inhibits the plasmodial form 
of dihydrofolate reductase, 
reducing the production of 
folic acid required for nucleic 
acid synthesis in the malarial 
parasite 
Artemether is administered in 
combination with lumefantrine 
for improved efficacy. 
Artemether has a rapid onset of 
action and is rapidly cleared 
from the body. It is thought 
that artemether provides rapid 
symptomatic relief by reducing 
the number of malarial 
parasites. 
 
Lumefantrine binds to hemin 
produced during hemoglobin 
breakdown, preventing 
detoxification to crystalline 
malaria pigment (hemozoin). 
During the same process, the 
perOXide group in artemether 




Description Each tablet contains 500 mg 
N1-(5,6-dimethoxy-4-
pyrimidinyl) sulfanilamide 




Each tablet also contains 
cornstarch, gelatin, lactose, 
magnesium stearate and talc. 
Each tablet contains 20 mg of 
artemether and 120 mg of 
lumefantrine.  
Each tablet is supplied as 
yellow, round, flat tablets with 
beveled edges and scored on 
one side.  
Sides effects Nausea, vomiting, diarrhoea, 
fatigue, feeling of fullness, 
dizziness, headache, mouth 
sore, skin rash. 
Headache, dizziness, fever, 
cough, feeling weak or tired, 
muscle pain, tenderness, or 
weakness, joint pain, vomiting, 






Appendix 2. Microscopy and PCR procedures 
 
Microscopy   
Blood sampling  
For each study subject, slides for thick and thin blood smears were made. During 
this study, the materials used for data collection were chosen to minimise the risks 
to participants in the study. Thus, for all blood samples, sterile single-use 
equipment was used (vaccinostyl, lancet). The sampling site was systematically 
disinfected and protected with an alcohol swab before and after sampling. 
Preparation of thick & thin smears 
Thick blood smears were made from 4 drops of peripheral blood collected from 
the fingertip by pricking with a vaccinostyl. The finger was cleaned with cotton 
wool soaked in 70oC ethanol before pricking, and the first drop of blood wiped off 
with clean toilet paper (Fig. 1). The thick drop and the blood smear were made on 
the same slide. The slide was identified by writing the patient's anonymous code, 
date and day of collection with an indelible marker; 
- Make a thick spread with the drops intended for the thick drop, spread the 
blood with the corner of another clean slide by mixing the 3 drops, until a 
homogeneous spread of about 1.5cm in diameter is obtained; 
- For the thin smear, hold the slide with one hand so that the drop is facing you. 
For the blood smear drop, hold the slide with one hand so that the drop is 
pointing towards you. With the other hand, place the edge of a clean slide just in 
front of the blood smear drop;  
- Slide the slide towards you until it touches the drop of blood; 
- Allow the blood to spread along the edge of the slide and then lift the slide to 
an angle of approximately 45°C; 
- Push the slide to the end of the spreader blade in a smooth, even motion; 
- Allow the smear to dry completely and with a pencil, transfer the same 









6- Blood smear identification   5- Making the blood drop     4- Preparing the blood smear 
 
7- Appearance of the thick drop / blood smear 






Blood spot preparation 
For each subject included in the study, blood samples were taken on filter paper 
from the fingertip. After collection, the spots were dried in a dust-free, well-
ventilated area; they were then packed with silica gel in plastic bags and sent to 
the CNRFP Molecular Biology laboratory for genotyping (Fig. 2). 
 
Blood smear fixation        Drying 5mn put the slide in the staining box   Add Giemsa 5% 
 
Microscopy reading     Drying the slides   Rinsing the slides with a tap   Coloration 45mn 
 Figure 2: Staining of slides with GIEMSA (Photo CNRFP) 
 
 




4-Drying the spot    5- spot packaging 
Figure 3: Preparation of a PCR spot on filter paper (Photo CNRFP) 
 
Laboratory analysis 
The immuno-parasitology and molecular biology laboratories are where the 
samples collected were processed and analysed.  
 
Microscopy reading 
Staining of slides 
The smears on the prepared slides were fixed with methanol (thick drops are not 
fixed) and then dried for about 5 minutes. The slides were then immersed in a 6% 
diluted Giemsa solution for 35 minutes, rinsed with buffered water and dried (Fig. 
3). 
Preparation of buffered water at pH 7.2 
Na2HPO4 1 g 
K2HPO4 0.8 g 
Distilled water 1 L 
Mix well and adjust the pH to 7.2 using a pH meter  
 
Preparation of the 6% Giemsa solution 
Pure Giemsa 12 ml 
Buffered water 188 ml 




Microscopic reading of slides 
Giemsa-stained slides were read under a microscope with a 100X objective and 
oil immersion. Parasite densities (DP), expressed as the number of parasites per 
microlitre (μl) of blood were calculated using the following method: the number of 
parasites per microlitre of blood in a thick drop is determined in relation to the 
number of leukocytes fixed at 8,000 per microlitre of blood. We used a manual 
counter. To obtain the number of parasites/μl (DP), we count in parallel a number 
n of parasites for a number X of leukocytes, i.e. the following formula:   
 
If the number of parasites of asexual forms n ≥ 10, at least X = 200 leucocytes 
are counted and the formula is applied:    
 
If the number of parasites of asexual forms n < 10 or in case of presence of sexual 
forms, the parasite density is made on the basis of 1000 leucocytes counted. 
 
If the number of asexual parasites n > 1000 before reaching 200 leukocytes, stop 
the count after reading the current field. 
If no parasite growth forms are found in 100 microscopic fields, the slide is 
declared negative. 
Slides with a defective thick drop were examined only at the thin smear level and 
the parasite density calculated from the smear. Estimating an average of 200 red 
blood cells (RBCs) per microscopic field and 4,000,000 red blood cells per 
microlitre of blood, the PD expression is as follows:   
 




PCR (Polymerase Chain Reaction) analysis 
 
The prepared blood spots were analysed at the CNRFP molecular biology 
laboratory to confirm or refute the microscopy results. The procedure used in PCR 
diagnosis was as follows: extraction of DNA, amplification of the extracted DNA 
and electrophoresis of the amplified DNA on agarose gel. 
DNA extraction using the QIAamp® Kit (QIAGEN)  
The extraction was done according to the QIAamp DNA Mini Kit protocol based on 
the principle of precipitation and column purification of DNA. It is described as 
follows by the supplier: 
- Cut 3 pellets of 3 mm diameter from a drop of dried blood using a pair of scissors 
or a hole punch and transfer them to 1.5 ml Eppendorf tubes; 
- Add 180 μl of ATL buffer, incubate for 10 minutes at 85°C and then centrifuge 
briefly to recover the droplets accumulated in the cap; 
- Add 20 μl of Proteinase K, mix by vortexing, incubate for 1 hour at 56°C then 
centrifuge briefly; 
- Add 200 μl of Buffer AL to each sample, mix vigorously for 15 seconds and 
incubate for 10 minutes at 70°C. Centrifuge briefly to recover the droplets 
accumulated in the cap. This step corresponds to the lysis of the red blood cells; 
Note: 
For effective lysis, it is important to mix the samples immediately and vigorously 
with AL buffer to obtain a homogeneous solution.  
Never add QIAGEN protease directly to AL buffer. 
A white precipitate may form after the addition of Buffer AL. This precipitate will 
mostly dissolve during the incubation time. This precipitate does not affect the 
QIAamp procedure or downstream applications. 
- Add 200μl of absolute ethanol (96-100%) to the sample and mix for 15 seconds 
by vortexing. Centrifuge briefly; the DNA will be a precipitate; 
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- Carefully place the resulting mixture into the QIAamp column (installed in a 2ml 
collection tube) without wetting the edge. Close the cap and centrifuge for 1 
minute at 8000 rpm; 
- Transfer the QIAamp column to a new 2ml collection tube (provided) and discard 
the tube containing the filtrate; 
Note: 
Close each column to prevent aerosols from forming during centrifugation. 
Centrifugation is performed at 8000 rpm for 1 minute to limit the noise of the 
centrifuge. 
 
If the solution has not completely passed through the membrane, centrifuge a 
second time at high speed until the column is completely empty. 
- Carefully open the QIAamp column and add 500 μl of Buffer AW1 diluted with 
ethanol (19 ml Buffer AW1 plus 25 ml ethanol) to each sample without wetting 
the rim. Close the cap and centrifuge for 1 minute at 8000 rpm; 
- Transfer the column to a new 2 ml collection tube (provided) and discard the 
tube containing the filtrate; 
- Open the QIAamp column and add 500 μl of Buffer AW2 diluted with ethanol (13 
ml Buffer AW2 plus 30 ml ethanol) to each sample without wetting the rim. Close 
the cap and centrifuge for 3 minutes at maximum speed 13,000 rpm;  
To avoid any risk of recovery of the AW2 buffer, empty the collection tube 
containing the filtrate and return the QIAamp column to the old 2 ml collection 
tube. Refuge for 3 min at maximum speed of 13 000 rpm. 
- Transfer the QIAamp column to a clean 1.5 ml tube. Discard the old collection 
tube containing the effluent. Carefully open the QIAamp column and add 150 μl 
of buffer AE or distilled water to the column. Incubate for 2 minutes at room 
temperature (15o to 25oC) and then centrifuge for 3 minutes at 8000 rpm;  
- Discard the QIAamp column and close the 1.5 ml tubes containing the extracted 




Amplification of specific sequences from the extracted DNA 
Nested PCR was used for the amplification of Plasmodium sp. DNA sequences.  
Nested PCR involves performing two successive amplifications (the second using 
the products of the first). It improves the specificity and efficiency of the PCR. 
Described by Mullis and his colleagues in 1985, PCR is based on the replication of 
DNA "in vitro" (Kaplan and Delpech, 1993). It allows the amplification of DNA 
sequences in a specific manner and a considerable increase in the quantity of DNA 
initially available. It requires knowledge of the sequence of the regions that delimit 
the DNA to be amplified. These sequences will be used to synthesise 
complementary oligonucleotide primers that will be used to delimit the portion of 
DNA to be amplified. 
Principle 
The principle of this molecular technique is to repeatedly use one of the properties 
of DNA polymerases, which is the ability to synthesise a complementary strand of 
DNA from a pair of primers. The reaction consists of a number of cycles, each of 
which includes three steps: denaturation, hybridisation and elongation. 
All the elements necessary for the reaction are contained in a tube which will be 
subjected to the different temperatures corresponding to each stage of the PCR. 
These temperature cycles are performed automatically by a program in a thermal 
cycler. 
Reconstitution or suspension of primers at 100 µM  
As the primers are supplied in lyophilized form and in nmol, the following formula 
is applied to obtain stock solutions at 100 µM concentration: where,  
Co = Concentration in nmol of the primer lyophilisate 
Ve = Volume of sterile distilled water in µl to be added to the lyophilisate = Co x 
10 
This gives a primer stock solution of 100 µmol/L. 
 
Dilution of the primer stock solution to 10 μM 
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o To obtain a total volume of 100 μl of working solution, simply take 
10 μl of the 100 μM primer stock solution and make up with 90 μl of 
sterile distilled water, i.e. a 1/10 dilution. 
NB: All reagents are stored at -20oC   
 
Components of the amplification mixture  
Reagents : 
10 X PCR-Buffer 
50 mM Magnesium Chloride  
dNTP: deoxyribonucleotide triphosphate 
Taq polymerase 
Sterile distilled water  
Primers : 
First amplification: rPLU5&6 




First label the tubes required for the PCR reaction and then prepare the mixture 
(reaction mix) according to the total number of samples to be processed, as shown 
in Table below: 




Co : initial Concentration; Cf : final Concentration  
For each manipulation, a calculation of the volume necessary for each reagent is 
essential. This calculation is always done on n+3, n being the number of samples 
to be analysed and the 3 additional samples are composed as follows 1 negative 
control consisting of sterile distilled water (water for injection); 1 positive control 
consisting of a recognised positive extract. The third additional sample avoids 
having an insufficient volume for the last sample due to possible pipetting losses. 
A volume of 19 μl of Mix was dispensed into each tube. Then 1 μl of DNA was 
added to each tube to give a total volume of 20 μl. The tubes were then 
immediately placed in the thermocycler for the 1st amplification following a pre-
recorded program described as follows: 
1. Initial denaturation at 95°C (5 min); 2. Hybridisation at 58°C (2 min); 3. 
Extension at 72°C (2 min); 4. Initial denaturation at 94°C (1 min); 5. 24 cycles of 
step 2 to 4; 6. Hybridisation at 58°C (2 min); 7. Final extension at 72°C (5 min); 
8. 20ºC indefinite time for completion of amplification.  
 
Second amplification 
Label the tubes for the second amplification by transferring the previous numbers 
to the new tubes (Table II). 
Table II : Volumetric composition of the amplification mix  
Reagents Co Cf vol/reaction Mix x (n+3) μl 
PCR Buffer 10X 1X 2   
MgCl2 50mM 2mM 0,8   
DNTP 2mM 0,125mM 1,25   
rPLU5 10μM 0,250μM 0,5   
rPLU6 10μM 0,250μM 0,5   
Taq 5UI 0,4UI 0,1   
H20 - - 13,85   
     
Total     19   





A volume of 19 μl of MIX was dispensed into each tube. Then 1 μl of the product 
of the first amplification was added to each tube. The tubes were then placed in 
the thermocycler for the 2nd amplification following the program pre-entered in 
the thermocycler as follows:  
1. Initial denaturation at 95°C (5 min); 2. Hybridisation at 58°C (2 min); 3. 
Extension at 72°C (2 min); 4. Initial denaturation at 94°C (1 min); 5. 30 cycles of 
step 2 to 4; 6. Hybridisation at 58°C (2 min); 7. Final extension at 72°C (5 min); 
8. 20ºC indefinite for completion of amplification. 
Agarose gel electrophoresis of the amplification product 
The DNA fragments obtained by PCR are in such quantity that they can be revealed 
directly by agarose gel electrophoresis using ethidium bromide (BET). BET is an 
intercalant that slips between the bases of nucleic acids. It fluoresces orange 
under short-wave UV illumination of approximately 300 nm. As the migration 
speed is dependent on the molecular weight, the DNA fragments are separated 
according to their size expressed in base pairs. Their identification is facilitated by 
the use of molecular weight markers. 
Preparation of T.B.E. (Tris-Borate-E.D.T.A. 0,5X) 
T.B.E. is the electrolyte or migration buffer. It is also used for the preparation of 
the migration gel. Its composition for 1 litre of solution is as follows   
Reagents Co Cf vol/reaction Mix x (n+3) μl 
PCR Buffer 10X 1X 2   
MgCl2 50mM 2mM 0,8   
DNTP 2mM 0,125mM 1,25   
rFAL1/rMAL1/rOVA1/rVIV1 10μM 0,250μM 0,5   
rFAL2/rMAL2/rOVA2/rVIV2 10μM 0,250μM 0,5   
Taq 5UI 0,4UI 0,1   
H20 - - 13,85   
     
Total     19   





Preparation of the gel 
Agarose is a purified agar-based polymer and is available in powder form. The 
weight of agarose to be used and the volume of buffer required for gel formation 
are determined by the size of the fragments to be separated. 
- Prepare the gel mould containing the combs according to the number of samples 
to be processed. The comb is used to mark the footprint of the DNA deposition 
wells. 
Prepare a 1.5% agarose gel as follows  
- Dissolve 1.5 g of agarose in 100 ml of 0.5X TBE in an Erlenmeyer flask 
- Boil this mixture in a microwave oven for 3 minutes, 
- Cool to approximately 45oC, add 3 μl of Ethidium Bromide at 10mg/ml to the 
boiled agarose. Ethidium bromide binds to the hydrogen bridges of the nucleic 
acids, making the DNA bands UV fluorescent. 
- Cast the gel into the mould and wait for it to solidify 
 
Migration 
- Immerse the gel in the migration vessel containing 0.5X TBE which is the 
migration buffer. 
- Place approximately 2 μl of the molecular weight marker in the first well. 
- Mix 10 μl of each sample with the loading buffer and place in the wells.  
- Migrate at 100 volts for 20-30 minutes. 
Revealing and interpreting electrophoresis results 
Reagents Quantity 
Tribase [(Trihydroxyméthyl) aminométhane C4H11NO3] 54 g 
EDTA (C10H14N2NaO8 2H2O) (0,5M) 20 ml 
Boric acid (BH3O3) 27,5 g 




Revealing the amplification is done by electrophoretic migration with 10L of the 
amplification product on a 1.5% TBE agarose gel containing 1.5% ethidium 
bromide in order to demonstrate the effective presence of each species on the 
basis of band size. Reading is done under UV light. 
A good reaction is indicated by the presence of bands. In this case, the conformity 
of the size of the expected product as well as the negative and positive controls 
must be assessed. 
The electrophoresis results are interpreted as follows: 
Line S: standard molecular weight marker (50-bp).   
Line 1: diagnostic band for P. vivax (120 bp).  
Line 2: diagnostic band for P. malariae (144 bp).  
Line 3: diagnostic band for P. falciparum (205 bp).  
Line 4: diagnostic band for P. ovale (800 bp). 
 
Figure 4 : Example of agarose gel separation (Snounou et al., 1993).
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  Sex Age Ethnicity Wall Ground Roof Eaves Religion Education Occupation 
Distanc






















Sex 1.0000          
        
Age 0.0039 1.0000         










   
Wall -0.098 
-





   
 Ground    
-





   
Roof 0.0197 0.0652 0.2813 
-
0.1964 
-0.4138 1.0000        
 
 
   
  Eaves   0.0141 0.0127 -0.1173 0.0904 0.0683 
-











-0.0086 0.2911 0.2124 -0.116 0.0839         
   
Religion 
-
0.0159 0.0708 -0.1659 0.1188 -0.0363 
-










0.0479 -0.1175 0.0255 0.0899 
-

















   






0.0104 0.0046 0.0653 1.0000     
   










-0.0145 -0.0064 0.0311 0.7037 1.0000    
   




0.1288 0.1146 0.0733 0.0898 0.0956 
0.1438 
0.1883 
1.0000   
 










0.0025 -0.107 -0.0955 0.0707 0.043 -0.2799 1.0000  
   









-0.0203 0.0614 0.0323 0.1756 0.0793 -0.0257 0.1946 1.0000 
   





0.1088 0.1656 -0.0201 0.077 
-
0.0417 







-0.0001 0.034 0.0297 0.053 
-
0.3803 













-0.0429 -0.019 -0.0841 -0.0867 -0.0473 -0.0859 0.0059 0.0499 -0.0172 0.0385 1.0000 
*ITN=Insecticide treated net, #SES=socioeconomic status 
Variable codes: Sex (male=0, female=1), age (5-7=0, 8-15 years=1), ethnicity (other ethnicity=0, Fulani=1), wall (mud=0, brick=1, cement=2), ground (dirt floor=0, cement/tiles=1), roof (metal=0, non-metal=1), religion (Muslim=0, Christians=1, 
Animists=2), education (illiterate=0, literate=1), occupation (farmer=0, non-farmer=1), distance to all larval habitat (<=300 m=0, >300 m=1), Distance to positive larval habitat (<=300 m=0, >300 m=1), Use of ITNs (no=0, yes=1), Electricity supply 
(no=0, yes=1), Integrity of ITNs (good=0, damaged=1, too torn=2), Presence of household animals (no=0, yes=1), SES (poorest=0, poor=1, middle=2, rich=3, richest=4), eaves (closed=0, opened=1) . 
 
 





Table 2: Linear correlations between risk factors for malaria infection related to chapter 3 














Ethnicity 1.0000                       
Religion -0.4412 1.0000           
Education -0.0405  0.0474 1.0000                   
Occupation 0.0389  -0.0701 -0.3081 1.0000         
SES# 0.1040 -0.2181 0.0532 0.0860 1.0000        
Use of ITNs* -0.1176 0.0688 -0.0768 -0.0377 -0.1357 1.0000       
Presence of 
electricity 
-0.1352 0.0903 -0.0107 -0.1045 -0.2560 0.1585 1.0000      
Use of electric 
fan 





0.0072 -0.0271 -0.0423 -0.0372 0.0010 -0.0263 0.0308 0.1207 1.0000    
Use of other 
protection 
-0.0022 -0.0525 0.0781 0.0185 0.0415 -0.0409 0.0040 0.0606 0.0307 1.0000  
 
Type of roof -0.0623 0.0054 -0.0940 0.0334 0.0215 0.0608 -0.0606 -0.0217 0.0753 -0.0892 1.0000   
Eaves 0.1498 -0.2659 -0.0011 0.0751 0.3283 0.0104 -0.2954 -0.1009 -0.0358 0.0054 0.0236 1.0000 
*ITNs=Insecticide treated net, #SES=socioeconomic status  
** Use other protection= use of mosquito coil, insecticide spray, traditional repulse 
Variable’s characteristics: Ethnicity (others ethnicity=0, Fulani=1), religion (Muslim=0, Christian=1, Animists=2), education (illiterate=0, 
literate=1), occupation (farmer=0, commercial=1, none/retired=2), Socio-economics status (poorest=0, poor=1, middle=2, rich=3, 
richest=4), use of ITNs (No=0, yes=1), use of electric fan (No=0, yes=1), Presence of electricity (No=0, yes=1), Presence of household 
animals (No=0, yes=1), Use of other protection (No=0, yes=1), type of roof (metal=0, non-metal=1), eaves (opened=0, closed=1).
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Table 2: Linear correlations between risk factors for malaria infection related to chapter 3 
















Ethnicity 1.0000                       
Religion -0.4412 1.0000           
Education -0.0405  0.0474 1.0000                   
Occupation 0.0389  -0.0701 -0.3081 1.0000         
SES# 0.1040 -0.2181 0.0532 0.0860 1.0000        
Use of ITNs* -0.1176 0.0688 -0.0768 -0.0377 -0.1357 1.0000       
Presence of 
electricity 
-0.1352 0.0903 -0.0107 -0.1045 -0.2560 0.1585 1.0000      
Use of electric 
fan 





0.0072 -0.0271 -0.0423 -0.0372 0.0010 -0.0263 0.0308 0.1207 1.0000    
Use of other 
protection 
-0.0022 -0.0525 0.0781 0.0185 0.0415 -0.0409 0.0040 0.0606 0.0307 1.0000  
 
Type of roof -0.0623 0.0054 -0.0940 0.0334 0.0215 0.0608 -0.0606 -0.0217 0.0753 -0.0892 1.0000   
Eaves 0.1498 -0.2659 -0.0011 0.0751 0.3283 0.0104 -0.2954 -0.1009 -0.0358 0.0054 0.0236 1.0000 
*ITNs=Insecticide treated net, #SES=socioeconomic status  
** Use other protection= use of mosquito coil, insecticide spray, traditional repulse 
Variable’s characteristics: Ethnicity (others ethnicity=0, Fulani=1), religion (Muslim=0, Christian=1, Animists=2), education (illiterate=0, literate=1), occupation (farmer=0, 
commercial=1, none/retired=2), Socio-economics status (poorest=0, poor=1, middle=2, rich=3, richest=4), use of ITNs (No=0, yes=1), use of electric fan (No=0, yes=1), 
Presence of electricity (No=0, yes=1), Presence of household animals (No=0, yes=1), Use of other protection (No=0, yes=1), type of roof (metal=0, non-metal=1), eaves 
(opened=0, closed=1). 
 poor=1, middle=2, rich=3, richest=4), use of ITNs (No=0, yes=1), use of electric fan (No=0, yes=1), Presence of household animals (No=0, yes=1), Use of other 
protection (No=0, yes=1), type of roof (metal=0, non-metal=1), eaves (open=0, closed=1).  
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Table 3 of correlations between risk factors for malaria related to chapter 4 




















Sex 1.0000                 
Occupation -0.0759 1.0000            
ethnicity 0.0057 0.0650 1.0000              
Religion -0.0118 -0.1110 -0.1540 1.0000          
education 0.1162 -0.3091 -0.1226 0.0599 1.0000         
Socio-economic 
status 
-0.0146 0.0775 0.0209 -0.3167 0.0187 1.0000        
Use of insecticide 
treated net 
0.0215 0.0172 -0.0457 0.1080 -0.0944 -0.1276 1.0000       
Other protection -0.0421 0.0611 -0.0473 -0.0531 0.1006 0.0142 -0.0759 1.0000      
Eaves -0.0374 0.1137 0.0321 -0.2959 -0.0213 0.3498 0.0145 -0.0076 1.0000     
Roof 0.0578 0.0248 0.1968 0.0922 -0.1295 -0.1123 0.1302 -0.1202 -0.1231 1.0000    
Electricty supply -0.0122 -0.0708 -0.0899 0.1335 -0.0214 -0.2726 0.0937 0.0227 -0.3710 0.0477 1.0000   
Use of electric fan -0.0264 -0.0259 -0.0549 -0.0934 0.0481 0.0084 0.0039 0.0190 -0.1132 0.0069 0.1339 1.0000  
Household animals 0.0995 -0.0475 -0.0100 -0.0023 -0.0603 -0.0595 0.0450 0.0369 -0.0608 0.0777 0.0644 0.1785 1.000 
Insecticide 
resistance 
-0.0564 -0.0881 -0.0731 0.1804 0.1332 -0.0140 0.0479 0.0631 -0.1208 -0.3769 0.0208 -0.0539 -0.0736 
Categorical variables: sex (male=0, female=1), occupation (farming=0, commercial and office workers=1, none or retired=2), ethnicity (Gouin/Turka=0, Karaboro=1, other 
ethnic group=2), religion (Muslim=0, Christian=1, Animist=2), education (illiterate=0, literate=1), SES (lowest=0, low=1, middle=2, high=3, highest=4), other protection 
(topic repellent=0, spatial repellent=1), eaves (closed=0, open=1), roof (metal=0, thatch/mud=1), electricity supply (no=0, yes=1), use of electric fan (no=0, yes=1).  
There is no correlation between electricity supply and roof   
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Table 4 of correlations between risk factors for malaria related to chapter 5 
 
*ITNs = Insecticide treated net 
  Age 
IPTp 
doses Gestation Gravidity 
Use of 















night Roof Eaves 
Age 1.0000                          
IPTp doses -0.1486 1.0000              
Gestation 0.0993 0.5675 1.0000             
Gravidity -0.7601 0.1164 -0.0806 1.0000            
Use of ITNs* 0.2397 -0.1801 -0.194 -0.2599 1.0000           
Education -0.4745 0.135 0.0568 0.348 -0.1702 1.0000          
Occupation -0.2388 0.0816 0.1882 0.1938 -0.1917 0.3637 1.0000         
HouseHould 
size 
0.3704 -0.0126 0.1188 -0.3304 0.0774 -0.1338 -0.0483 1.0000 
    
   
Electricity 
supply  
-0.0896 0.1589 0.1938 0.1371 0.0631 0.2131 0.0866 0.1523 1.0000 
   
   
Household 
animals 
0.086 -0.0367 0.061 -0.1756 0.2161 -0.0819 0.0826 0.1137 -0.0963 1.0000   
   
Clothes hanged 0.1336 -0.0094 0.0868 -0.1246 0.0422 -0.1246 0.0725 0.0227 -0.1024 0.1803 1.0000     
Solid wastes 0.048 0.1171 0.1986 0.031 0.1107 0.069 0.1264 0.0556 0.0747 0.1799 0.1588 1.0000    
Out bed night 0.1026 0.1102 0.1897 0.0195 0.0317 -0.2633 -0.1631 0.0756 -0.0926 -0.0222 0.0258 0.0744 1.0000   














A linear relationship between variables has been computed to identify correlation 
of variables with others risk factors have been performed and the summary of 
the results is below in the corelation table (table 4), inserted in appendix 3 
section. 
Variable’s code: 
Age (30-40=0, 20-30=1, <20=2) years old 
IPTp (0 dose=0, 1 dose=1, 2 doses=2, 3 doses or more=3) 
Gestation (3rd trimester=0, 2nd trimester=1, 1st trimester=2) 
Gravidity (multigravida=0, secundigravida=1, primigravida=2) 
Use of ITNs* (no=0, yes=1) 
Education (illiterate=0, literate=1) 
Occupation (farmer=0, trader=1, others=0) 
Household size (1-3=0, 4-5=1, ≥6=2) 
Electricity supply (no=0, yes=1) 
Household animals (no=0, yes=1) 
Clothes hanged (no=0, yes=1) 
Solid wastes (no=0, yes=1) 
Out bed night (<2=0, 2 or more=1) 
Roof (metal=0, non-metal=1) 
Eaves (closed=0, open=1) 
A linear relationship between variables has been computed to identify correlation 
of variables with others risk factors have been performed and the summary of 
the results is below in the correlation table (table 4), inserted in appendix 3 
section. 
Correlations between variables were explored and negative association was 
found between education and age (r=-0.4745), gravidity and age (r=-07601) 
and household size and gravidity (r=-0.3304). On the other hand, positive 
correlations were found between gestation and intermittent preventive treatment 
in pregnant number of doses (r=0.5675) and household size and age 
(r=0.3704). Correlations suggest that younger pregnant women were better 
educated and had fewer births than older women; Pregnant women were more 
likely to be multigravida and were lived in households with large people and IPTp 
doses increased in women with more children more advanced pregnancies; the 
larger the household, the greater it contained younger and multigravids. The 
effects on our study results overall model imply that major risk factors of interest 
were gestation and it’s association with IPTp doses (eg. for each additional dose 
of IPTp reported as being received by women, the odds of malaria infection fell 
by 44%). 
